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Understanding the etiology of complex disease remains a challenge in biology. In re-
cent years there has been an explosion in biological data, this study investigates machine
learning and network analysis methods as tools to aid candidate disease gene prioritisa-
tion, specifically relating to hypertension and cardiovascular disease.
This thesis comprises four sets of analyses: Firstly, non synonymous single nucleotide
polymorphisms (nsSNPs) were analysed in terms of sequence and structure based prop-
erties using a classifier to provide a model for predicting deleterious nsSNPs. The degree
of sequence conservation at the nsSNP position was found to be the single best attribute
but other sequence and structural attributes in combination were also useful. Predictions
for nsSNPs within Ensembl have been made publicly available.
Secondly, predicting protein function for proteins with an absence of experimental
data or lack of clear similarity to a sequence of known function was addressed. Pro-
tein domain attributes based on physicochemical and predicted structural characteristics
of the sequence were used as input to classifiers for predicting membership of large and
diverse protein superfamiles from the SCOP database. An enrichment method was in-
vestigated that involved adding domains to the training dataset that are currently absent
from SCOP. This analysis resulted in improved classifier accuracy, optimised classifiers
achieved 66.3% for single domain proteins and 55.6% when including domains from
multi domain proteins. The domains from superfamilies with low sequence similarity,
share global sequence properties enabling applications to be developed which compli-
ment profile methods for detecting distant sequence relationships.
Thirdly, a topological analysis of the human protein interactome was performed. The
results were combined with functional annotation and sequence based properties to build
models for predicting hypertension associated proteins. The study found that predicted
hypertension related proteins are not generally associated with network hubs and do
not exhibit high clustering coefficients. Despite this, they tend to be closer and better
connected to other hypertension proteins on the interaction network than would be ex-
pected by chance. Classifiers that combined PPI network, amino acid sequence and func-
tional properties produced a range of precision and recall scores according to the applied
3weights.
Finally, interactome properties of proteins implicated in cardiovascular disease and
cancer were studied. The analysis quantified the influential (central) nature of each pro-
tein and defined characteristics of functional modules and pathways in which the disease
proteins reside. Such proteins were found to be enriched 2 fold within proteins that are in-
fluential (p<0.05) in the interactome. Additionally, they cluster in large, complex, highly
connected communities, acting as interfaces between multiple processes more often than
expected. An approach to prioritising disease candidates based on this analysis was pro-
posed.
Each analyses can provide some new insights into the effort to identify novel disease
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The science of biology describes the organisation and processes of organisms at each
level ranging from the molecular up to the ecosystem (Roberts & King, 1987). Each level
has connected, complex systems and understanding the relationships and connections be-
tween the component parts is an important challenge. Key to understanding each level
has been the move away from reductionist approaches to wholist approaches (Katagiri,
2003). Reductionists focus on one element of a system with the aim to learn everything
about that element. Reductionist approaches have been rather successful and continue to
be important in understanding the details of the component parts which will facilitate a
systems level understanding since we know more about the individual building blocks. In
contrast, wholist approaches observe all the components at a specific level together.
Wholist approaches have led to a range of terms with the suffix -ome (eg. genome,
transcriptome, proteome), all are used to describe all the components of a system at a
particular level. Terms ending in -omics (eg. genomics, transcriptomics, proteomics) are
used to describe the approaches and technologies for studying each level, and allow us
to get a snapshot of these whole systems at a particular level (-omes and -omics glossary
taxonomy, 2009). Genomics technologies include genome wide linkage screens where
variable Simple Sequence Repeats (SSRs) are used as molecular markers for a range of
applications including mapping disese genes and forensics. Genome wide association
(GWA) studies are a second approach, in this case the variation in genotype frequen-
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cies of markers such as single nucleotide polymorphisms (SNPs) are compared between
cases and controls or are tested for association with a quantitative trait. SNPs are genetic
variations representing a simple single base pair difference (allele) between individuals
at a particular position within the DNA sequence, they are expected to contribute to the
causes of many complex traits. SNP arrays enable identification of SNP variation across
the genome using 1000’s of SNPs in 1000’s of people and potentially identifying associa-
tions with disease. Transcriptomics technologies include expression microarrays for iden-
tifying genes that are over or under expressed in disease affected tissue relative to normal
tissues. Other techniques include the analysis of epigenetic changes leading to phenotypic
variation through mechanisms such as DNA methylation (epigenomics) and the study of
protein-protein interactions (PPI) through approaches such as yeast two-hybrid screens,
potentially leading to improved understanding of biological functions (interactomics). At
all levels, the relationships between components of a system are of interest and can be
considered as networks where the components are vertices and the relationships are edges
(Junker & Schreiber, 2008). These large emerging datasets from each network provide
scientists with a wealth of data that has to be explored, described and understood using
approaches that include data mining and the application of machine learning and network
analysis.
A very important application is in the study of diseases, which often involves the
disruption of a functional pathway involving multiple genes and their products. In genome
wide linkage screens regions as large as 30 million bases (30cM) have been identified. In
GWA studies the associated regions tend to vary in size from a few kilobases (Kb) to
1000’s of Kb (McCarthy et al., 2008). With both types of study, investigators are left
with huge expanses of DNA which contain many hypothetical genes. There is a need
to devise strategies to aid in the identification and prioritisation of genes within these
regions. The function of hypothetical genes must also be considered. It is also important
to be able to isolate the functional SNPs from the multiple SNPs that are inherited together
in a linkage disequilibrium (LD) block. Candidate genes may also be prioritised and
knowledge of disease etiology may be acquired by biological network analysis of protein-
protein interactions contained within the human interactome.
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The work described in this thesis investigates approaches for predicting deleterious
SNPs and protein function and performing topological analysis of protein-protein interac-
tion (PPI) networks for the identification and prioritisation of candidate genes for complex
diseases. The studies are focused on datasets from cardiovascular disease (cvd), hyper-
tension and cancer, but the methods can potentially be applied to any disease phenotype.
The organisation of the thesis is as follows:
• Chapter 1 introduces the rationale for the studies and the focus areas and discusses
the applied computational principles of machine learning and graph theoretic ap-
proaches.
• Chapter 2 describes the methods and results obtained from analysing SNPs, using
supervised machine learning classifiers for predicting deleterious non-synonymous
SNPs (nsSNPs).
• Chapter 3 describes the methods and results for predicting protein superfamily us-
ing classifiers with a set of sequence based attributes. This analysis focuses on
large diverse superfamilies where it is difficult to assign function using traditional
sequence homology based methods.
• Chapter 4 describes the methods and results obtained from surveying topological
properties of hypertension related proteins within the human interactome. The re-
sultant hypertension protein network properties are combined with sequence and
functional based information to build a model for predicting novel candidate hyper-
tension related proteins.
• Chapter 5 describes interactome analysis of proteins implicated in cvd and cancer.
The influential nature of these proteins is quantified and community structures are
analysed. An approach for prioritising cvd candidate genes is shown.
• Chapter 6 highlights the primary results, compares with previous work and de-
scribes possible future work and directions within the studied fields.
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1.2 An overview of Machine Learning
The increasing amount of information from numerous genomes and the easy access on the
world wide web has led to many opportunities for bioinformatics research. Algorithms are
required to extract information, knowledge and patterns within this data. Such algorithms
can be used to search the genomic space to determine a hypothesis that fits the space. In
this chapter we provide an overview of machine learning and describe the main methods
used in this thesis.
Artificial intelligence (AI) falls within the field of computer science and engineering,
it aims to produce computer programs that can cope with problems requiring intelligent
behaviour, learning and adaptation. Machine learning is a branch of AI concerned with
the development of algorithms for learning (Michalski et al., 1983). Deductive learning
is where a conclusion is arrived at using previously known facts or fulfilling conditions.
The conclusion is always true on condition of the facts being true. In contrast, inductive
learning is where the facts may predict a conclusion with a probability, but there is no
guarantee of the conclusion being true. Machine learning methods use inductive learning
techniques to create programs by producing rules based on patterns within data sets. Sim-
ple pattern discovery alone may be more accurately classified as data mining. Machine
learning has many uses within the field of bioinformatics where patterns and rules are
used for well characterised examples to classify instances that are less well understood.
1.2.1 Supervised vs unsupervised algorithms
The three most common types of machine learning algorithms are: supervised learning,
unsupervised learning and semi-supervised learning. Supervised learning or classifica-
tion learning takes a set of examples that are classified, and creates a set of rules to classify
samples where the status is unknown. In contrast, unsupervised learning models a set of
inputs where labelled examples are not available. The algorithm finds a way of clustering
the data based upon the known features and then provides descriptions for these clusters.
Semi-supervised learning utilises both labelled and unlabelled instances in order to create
a classifier.
Predicting whether a non-synonymous SNP (nsSNP) is disease related or whether
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a protein belongs to a certain functional group are questions that can be addressed via
machine learning methods. The method of supervised learning is appropriate as the aim
is to assign an instance, either a nsSNP or an unannotated protein to one of a number of
classes. In the case of nsSNP classification it is possible to use a set of nsSNPs where
the disease status is known as a training set to form a set of rules that could be used to
make a prediction for nsSNPs where the function is unknown. The work performed in
this thesis utilises supervised learning exclusively, so the focus from this point will be on
this approach. The supervised learning classifiers, support vector machines (SVMs) and
decision trees (described below) are amongst the most commonly used classifiers within
the field of bioinformatics.
1.2.2 Support Vector Machines
Support vector machines (SVMs) are a kernel based supervised learning classifier devel-
oped by Corte & Vapnik (1995). They have been shown to be very accurate in many
disciplines including bioinformatics, benefitting from the ability to handle high dimen-
sional data with a small number of instances, finding a good balance between training set
accuracy and test data error. For a given set of training vectors labelled with two classes,
a SVM can find the optimal linear hyperplane that maximally separates instances of the
classes by maximizing the margin between the two classes (Figure 1.1).
1.2.2.1 Non-linear classification
Very often problems are not immediately linearly separable, and so the vectors must be
transformed into some higher dimensional space and the optimal hyperplane found in
this transformed feature space. Non-linear discrimination can be achieved through the
application of a range of kernel functions. The performance of the SVM is controlled by
this function and the regularization of the C parameter. The C parameter is used to trade
between training errors and larger hyperplane margins.
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Figure 1.1: Support vector machine (SVM) hyperplanes. Three hyperplanes are displayed; h1 does
not separate the two classes (orange and blue circles), h2 separates the classes with a small margin,
h3 with the maximum margin. The support vectors are circled
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1.2.2.2 MultiClass SVM
If there are more than two classes, various SVM techniques have been designed to over-
come the problem.
One-vs-Others method The one-vs-others method is a simple method for dealing with
multi-class problems containing n classes (Brown et al., 2000). The problem is trans-
formed into n 2 way classifiers. Each classifier contains a single class as ‘class 1’ and all
of the others classes combined as ‘class 2’.
For a query instance where the class is unknown the system tests against each of the 2
class models to see whether it belongs to ‘class 1’ or ‘class 2’. This leads to n scores from
the n classifiers. Ideally there will only be one case where the query is assigned to ‘class
1’. In reality there may be false positives, whereby more than one of the models assigns
the query to ‘class 1’. The complexity of ‘class 2’ may lead to the false positives.
Unique One-vs-Others method The unique one-vs-others method adds a second step
to the one-vs-others method for dealing with instances where there are false positives
(Ding & Dubchak, 2001). This step involves the creation of 2 class classifiers for each
of the false positives. The final assigned class is the class that was selected most in these
models built from the false positives. In this step false positives should be eliminated.
One-vs-One method In the unique one-vs-others method 2-way classifiers are built to
break the ties between the false positives. In the one-vs-one or pair wise coupling method,
the first step is abandoned altogether so the process is composed solely of the second step
of one against one classifiers (Hastie & Tibshirani, 1998). The final chosen class is the
one that receives the most votes from each of these pair wise classifiers. This approach is
used by implementations such as SVM SMO (Platt, 1998) and LibSVM (Chang & Lin,
2001).
1.2.3 Decision Trees
Decision trees are supervised classifiers composed of a graph (tree structure) of decisions
(Quinlan JR, 1993). Each interior node of the tree relates to a variable where a decision is
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made on which branch to take based on the value of the variable. The decisions are usually
simple single attribute tests to divide the data. A leaf represents the predicted class based
on values at the nodes on the path from the root. Decision trees have the advantage over
many classifiers in that they produce interpretable rules. Once a tree has been built new
instances can be classified by starting at the root and following a path down to a leaf.
An example of a decision tree can be seen in Figure 1.2 where an activity for the day is
chosen based on a number of attributes.
Figure 1.2: An example of a decision tree for choosing a weekend activity, showing decisions at the
nodes, and final classification at the leaves.
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When the attribute at a node is nominal, there will be one branch for each attribute
value. If the attribute is continuous then it will usually be split into 2 and a decision based
on whether the instance is above or below a threshold cut-off. There are a number of
methods for deciding which attribute should be used at each node. Information gain of the
split is a commonly used measure, which measures the information required after using
the attribute as a classifier at a node subtracted from the information required before using
the attribute as a classifier. The Gini measure calculates statistical dispersion defined as a
ratio between 0 and 1 with lower values representing equal distribution.
Decision trees apply varied criteria for halting tree growth and then pruning it back.
This is done to prevent trees being produced that are too specific to the training dataset.
The aim is to produce a tree that is general enough to be applied to any new instances
that require clasification, avoiding overfitting. The algorithms are efficient and therefore
able to handle large volumes of data due to the simple partitioning approach taken by the
algorithm. However, one drawback to this divide and conquer approach is that the divisive
partitioning can mean that interesting relationships between attributes within the data can
be separated early on.
A very popular decision tree algorithm and one used in this thesis is C4.5 (Quinlan
JR, 1993). It is a very easy to use algorithm and is commonly used within bioinformatics.
Performance of this classifier is often used as a benchmark to which other classifiers
are compared. This algorithm uses information gain to partition the data at each node.
The algorithm is capable of handling many types of attributes: empty nominal attributes,
nominal attributes, numeric attributes, unary attributes, missing values, binary attributes,
and date attributes.
Random forest (RF) is a supervised classifier consisting of multiple decision trees
(Breiman, 2001) whereby the final class selected for an instance is the mode class se-
lected by the multiple decision trees. RF combines two machine learning methods of
‘bagging’ and ‘random feature selection’. Each tree is created from a bootstrap sample of
the training data where about one-third of the cases are left out (out-of-bag (OOB) data).
OOB data is used to obtain an unbiased estimate of the error during the training. This is
known as bagging. RF extends bagging because rather than using all features, RF ran-
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domly selects a subset of input variables to decide what decision should be made at each
node of the tree. Advantages of random forest classifiers include the fact that the error can
be balanced when the class population sizes are imbalanced and there are good methods
for handling missing data and overfitting can be avoided. The algorithm can handle the
same array of attribute types as C4.5 (Quinlan, 1993).
Another decision tree based classifier used in this thesis is the PART decision list
which uses a separate-and-conquer approach. The algorithm builds a partial C4.5 decision
tree in each iteration and makes the ‘best’ leaf into a rule (Frank & Witten, 1998a). Again,
the algorithm can handle the same array of attribute types as C4.5.
1.2.4 Weka workbench
Weka is a freely available collection of machine learning algorithms for data mining tasks
(Witten & Frank, 1999) available from the web site http://www.cs.waikato.ac.
nz/ml/weka/. The work in this thesis extensively used this workbench and its im-
plementations of the various machine learning algorithms. The workbench has its own
implementation of the C4.5 algorithm called J48. The algorithms can be applied to a
dataset through a graphical user interface (GUI), using a command line interface (CLI)
or called from Java code directly. Tools are included for data pre-processing, classifica-
tion, regression, clustering, association rules, and visualization. The weka workbench is a
commonly used package within bioinformatics, with an extension library called BioWeka,
created specifically for many common bioinformatics related tasks (Frank et al., 2004).
1.2.5 Generating a classifier
In performing successful pattern recognition using classifiers there are a number of gen-
eral steps performed (Figure 1.3). Initially, the dataset of instances and features are col-
lected, feature selection is then performed, the classifiers are trained, parameters are then
tuned for the chosen algorithm and finally the performance evaluated. Feature selection
removes redundancy and noise leaving only the most discriminatory features. The choice
of algorithm is important, some can deal with a large number of instances and features bet-
ter than others. For example, SVMs are good at coping with high dimensionality datasets
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with a small number of samples, but these require a large amount of memory for large
datasets (Witten & Frank, 1999). Some, such as SVMs and decision trees are sensitive to
imbalance in the training dataset whereas others such as Naive Bayes are not (Witten &
Frank, 1999). Where possible it is preferrable to test a number of classifiers to identify
the most appropriate choice for the specific problem. Evaluation of the classifier aims
to avoid overfitting by making sure the rules are not specific to the training dataset. The
classifier will often be validated on a separate dataset after having been trained and tested.
Figure 1.3: A typical machine learning approach (Al-Shahib, 2005)
1.2.5.1 Feature selection
Genomic data can be noisy, in that it is often extremely variable with some data even
being incorrectly annotated. Also the data may not be complete and annotation may be
missing for a number of training instances. Feature selection can help to remove or reduce
the effect of noisy data.
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1.2.5.2 Balanced vs unbalanced data
The number of instances belonging to each class in the training set may be imbalanced
resulting in a danger that the classifier will have a preference for selecting the most pop-
ulated class because the classifier assumes that there is a greater chance of an instance
belonging to this class as it is more prevalent (Barandela et al., 2003). The result is that
performance is reduced for the minority dataset. However, it may be the case, such as
when detecting fraudulent telephone calls for example, that detecting the minority case is
of greater importance (Fawcett & Provost, 1997). This concern is addressed in the nsSNP
analysis (Chapter 2) and when predicting hypertension related genes based on network
topology (Chapter 4).
1.2.5.3 Evaluation of machine learning
A number of methods are available for evaluating machine learning results and showing
the results are general enough to be applied to other data (Hand et al., 2001). Some of the
most common methods are described below. The various analyses in this study used all
methods except for the bootstrap method. The choice was made depending on the size of
the dataset, the employed classifier, and whether the classifier parameters were tuned.
Independent test data: If the training dataset was used to measure overall performance
of the classifier, an over optimistic result would be obtained. Therefore it is important to
evaluate performance on an independent test data set as it is a good way to gauge perfor-
mance on future unseen datasets. Thus partitioning a dataset into training and independant
test datasets is appropriate where a dataset is large.
Cross validation: Cross validation is especially useful for smaller datasets (Kohavi,
1995). The data is divided into (n) number of ‘folds’. Each fold is treated as the test
dataset in turn, with the remaining n-1 being used as training data. The performance of
the classifier on each fold is measured and then a final accuracy is calculated based upon
the average of all n folds. Stratified cross validation ensures that the distribution of class
instances in the fold is similar to the distribution in the complete dataset. Leave-one-out
cross validation is an extreme type of cross validation whereby each individual instance
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is held out in turn meaning there are the same number of folds as there are instances. This
maximises the amount of data available for training but is computationally expensive.
Validation datasets: When performing classifier parameter tuning steps with a large
dataset, three independent data sets are required: a training set, a validation set, and a test
set. The validation set is used to evaluate the effect of changing algorithm parameters and
is used to create the classifier but not used in the final estimation of accuracy.
Bootstrap: Bootstrapping creates a training dataset through sampling with replacement
of the whole dataset meaning that the training dataset can contain repeated instances
(Efron & Tibshirani, 1993). The test set is composed of data not used in the training
set. The benefit is that a good size training set can be created. Kohavi (1995) compared
bootstrapping and cross validation and showed the best method to be ten-fold stratified
cross validation in real-world datasets.
1.3 An overview of Network Analysis
Networks can be constructed from relationships that exist between a set of entities and
can be used to represent many types of biological data at many levels, including gene ex-
pression, protein-protein interactions, signal transduction and metabolic pathways, phy-
logenetic, ecological and ecosystem data (Junker & Schreiber, 2008). Network analysis
has only recently been applied to the world wide web, biological and social networks,
and power grids. It is a rapidly growing field of research with the analysis of biologi-
cal networks involving cross disciplinary research in biology, mathematics, physics and
computer science. It is an important subject within the field of bioinformatics.
The rise of network approaches indicates a shift from a reductionist approach to a
whole systems-level approach to understanding biology. This has only been possible in
recent years due to the decrease in the cost of computation and the dramatic increase
in biological data that has become available through projects such as the human genome
sequencing project (Lander et al., 2001; Venter et al., 2001). The network based approach
aims to assemble the ‘jigsaw’ of data produced through such initiatives.
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Key work by Watts & Strogatz (1998) showed that many networks display common
properties: they contain highly connected subgraphs and short path lengths. They termed
these networks small-world networks due to the similar commonly known ‘six degrees of
separation’ phenomonen seen between every person on earth. Barabasi & Albert (1999)
created a model for these networks and called them scale-free networks. They found that
they follow a power law distribution in terms of the number of edges incident to each
node. These scale-free networks contain a small number of highly connected nodes and
are very sturdy, being resilient to the random removal of nodes. Most studied biological
networks follow these rules.
1.3.1 Graph theory
Networks are modeled as graphs in order to allow analysis. A graph is a mathematical
object representing the networks as nodes and edges. Biological networks are represented
as different types of graph models depending on the network. Networks modeled as
graphs can be directed, undirected or mixed. An undirected graph contains edges where
there is no edge direction. A protein-protein interaction (PPI) network is an example
of a biological network that can be presented as an undirected graph G = (V,E), v ∈
V, e ∈ E where the proteins are nodes (v) and the interactions are edges (e), with edge
eu,v connecting nodes u and v (Junker & Schreiber, 2008). A directed graph represents
an interaction where information passes from one node to the other, or one node has an
effect on the other. Gene regulation networks are an example of a directed network. A
mixed graph contains a combination of both types of interaction, directed and undirected.
Multigraphs are those where multiple edges exist between a pair of nodes or vertices,
which are in the same direction if the graph is directed.
When measuring properties of the graphs, the type of graph has to be considered.
For example, a pair of vertices in a directed graph are strongly connected if a path exists
between them when the direction of the edges is considered. The shortest path between a
pair of vertices is the path containing the minimal number of edges. The path length is the
number of edges. A connected component of a graph is the largest number of nodes where
a path exists between each node pairing. As an example, Figure 1.4 displays the largest
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Figure 1.4: An example of a biological network, namely the largest connected component of the
Arabidopsis protein-protein interaction network. A red node represents a protein and a connecting
edge represents an interaction between a pair of proteins. The interactions were taken from the
IntAct database (Kerrien et al., 2007).
connected component of the Arabidopsis thaliana protein-protein interaction network.
Attributes are often associated with graph nodes and edges. Weights or distances can
be applied to edges to quantify the relationship that exists between the nodes. In the
construction of gene expression networks an edge can represent the level of coexpression
between the nodes. Protein names and functional information can be added to protein
nodes in a protein-protein interaction network.
Graphs are commonly stored as adjacency lists or matrices on a computer. In an
adjacency matrix rows and columns represent nodes and a matrix element Gst = 1 if there
is an edge between nodes s and t and Gst = 0 otherwise. Biological networks are often
stored as adjacency matrices, however they are very memory intensive and adjacency lists
are more appropriate when the number of edges is low. An adjacency list comprises a row
for each node of a network. A row contains a list of all edges incident to node n.
Graph traversal algorithms are used to perform calculations on each node within a
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network. Two search methods traditionally employed by graph algorithms are depth first
searches (DFS) and breadth first searches (BFS) (Junker & Schreiber, 2008). In a depth
first search the algorithm starts off with a particular node, then follows a path outwards as
far as possible for each neighbour. A breadth first search visits each neighbour first before
moving on to another vertex. Both methods can be encased within a loop to perform the
search for each connected component.
There are a number of measurement types that can be used to describe the topology
of graph models constructed to represent biological networks. These include: global
network properties, centralities, motifs and clustering. Centralities are used to rank nodes
in terms of their importance, motif analysis is the breakdown of sets of nodes into small
units, and clustering analysis describes the organisation of the network on a number of
levels. Clustering can be used to define functional modules and pathways in biological
networks. Maybe one of the most commonly used graph measures in everyday life is the
Google PageRank algorithm which is a variation of the common eigenvector centrality
measure (Page et al., 1998). The algorithm considers each web page to be a node with
a link or edge between pages being a vote. Google looks at the number of votes a page
receives. In addition it analyses the page casting the vote, votes from important pages
(themselves having many votes) are upweighted.
The previous two sections described methods for extracting information and analysing
datasets. The following sections describe areas where these technologies can be poten-
tially applied to increase biological understanding.
1.4 An overview of Single Nucleotide Polymorphisms
A major challenge in the post-genomic era is to understand the relationship between ge-
netic and phenotypic variation. A SNP is the most common type of variant in the human
genome, they are frequently related to human diseases (Botstein & Risch, 2003). A SNP
represents a single base pair difference (allele) between individuals of the same species
at a particular position within the DNA sequence. In the world’s population, there are
thought to be about 10 million sites (one variant per 300 bases on average) where the
minor allele frequency is greater than 1% (Ng et al., 2008). These common SNPs consti-
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tute 90% of the variation in the population and are commonly used to map phenotypes to
genomic loci (Kruglyak & Nickerson, 2001; Reich et al., 2003; WTCCC, 2007; Ng et al.,
2008). SNPs can be identified in an individuals genome by ‘genotyping’ a DNA sample.
The associations between alleles in the population, is known as linkage disequilibrium
(LD). There are often strong levels of LD between markers in close proximity to each
other because the chance of a recombination event increases with distance from the SNP.
A large amount of data now exists in public repositories such as dbSNP (Sherry et al.,
2001), HGVBASE (Fredman et al., 2004) and SWISSPROT (Boeckmann et al., 2003).
When SNPs or haplotypes associated with a particular phenotype are isolated it is
necessary to identify the causative SNPs from the haplotype. This can be done using
functional experiments, but theoretical knowledge in the first instance can helpful for
both fine mapping and genotyping in the experimental design stage.
Single base changes in protein coding regions of DNA which lead to changes in an
amino acid have the potential to effect protein structure and function. These are called
non-synonymous single nucleotide polymorphisms (nsSNPs), and have been the subject
of many recent studies (Ng et al., 2008). Some nsSNPs are related to diseases but others
are not associated with any change in the phenotype due to the change in the amino acid
not being significantly disruptive and are thus regarded as neutral nsSNPs. Importantly,
nsSNPs are the most frequent type of disease mutation (60%) (Botstein & Risch, 2003).
1.4.1 SNP Databases
A number of repositories exist in the public domain with SNP and related information.
Four of the main SNP databases and their features are briefly described below:
• The dbSNP database is the most important public database of SNPs and currently
includes approx 50 million SNPs from 44 organisms (http://www.ncbi.nih.
gov/SNP/). The dbSNP database allows access to the data via a series of web
pages as well as allowing bulk download in Extensible Markup Language (XML),
FASTA format or MySQL dumps http://www.mysql.org. These SNPs have
been detected either computationally in an automated manner by sequence compar-
ison or have been determined experimentally and entered into the database via an
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online submission process.
• HGVbase (http://hgvbaseg2p.org/) is a manually curated database of se-
quence variations aiming to provide links between genotypes and disease pheno-
types (Fredman et al., 2004). Submissions are accepted online via the website.
HGVbase allows access to the data via a series of web pages and in basic tab de-
limited format for frequency and association data. There are plans to make table
dumps of the relational database available for users.
• The Human Gene Mutation Database (http://www.hgmd.cf.ac.uk/) is a
collection of locus-specific mutation and SNP databases (Stenson et al., 2003,
2008). Individual entries can be accessed via the browser but there is no public ac-
cess to a bulk download of the data. The public version of HGMD (free to academic
and non profit organisations) contains 61,447 mutations (missense substitutions, in-
sertions/deletions [indels], splicing variants etc) in 2,288 genes and provides 2,240
reference cDNA sequences as of December 2008.
• The SWISSPROT knowledgebase (http://www.expasy.ch/sprot/) is a
high quality, manually curated protein-centric database that contains the SWIS-
SPROT VARIANT pages. The SWISSPROT VARIANT pages contain detailed in-
formation related specifically to nsSNPs. The version used in this thesis contained
19,611 human nsSNPs annotated as either disease (57%), polymorphism (29%) or
unclassified (10%). The term disease refers to SNPs that are causative in relation
to disease as well as to disease-linked functional polymorphisms. The term poly-
morphism relates to mostly neutral polymorphisms. 3D structural information is
provided using experimentally derived structures (>25% of the SNPs have corre-
sponding 3D models).
1.4.2 Hapmap
The International HapMap Project (http://www.hapmap.org) aims to determine
common gene variation and elucidate the haplotypes leading to the identification of tag-
ging SNPs in the human genome by genotyping populations from Africa, Asia and Europe
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(HapMap, 2003). When two markers are in high linkage disequilibrium (LD), which is
a measure of how often alleles are inherited together, it is unnecessary to genotype both
markers. Tagging SNPs are a subset of SNPs that can be selected, based on LD, to reduce
the genotyping effort required to capture the majority of information within a region. The
project has genotyped over 3.9 million SNPs (an average coverage of 1.3 SNPs/Kb), as of
December 2008, in various populations from Africa, Americas, China, Europe and Japan.
The allele frequencies, tagging SNPs and association between SNPs is also being anno-
tated. The data is in the public domain and is available via the website and related tools
such as ‘Haploview’ (Barrett et al., 2005) and ‘Tagger’ (de Bakker et al., 2005). These
tools allow the identification of HapMap SNPs in a chosen region and selection of tagging
SNPs to capture the majority of the variation with the minimum amount of redundancy
between SNPs.
The Hapmap data is being used for association studies of candidate genes in the
genome and for further analysis of regions suggested by family-based linkage analysis.
More recently, whole genome association scans for variants that are causing common
diseases have and are still being performed (WTCCC, 2007; Spencer, 2008).
1.4.3 SNP supervised classification
Several studies have attempted to predict the functional consequences of a nsSNP, namely
whether it is disease related or neutral, based on attributes of the polymorphism. Some
attributes depend only on the sequence information, for example the type of residue found
at the SNP location. Structural attributes such as solvent accessibility can be chosen if the
protein sequence containing the nsSNP has a known 3D structure or is highly similar to
a protein sequence of known structure. As structural genomics projects gain momentum
an increasingly large amount of protein 3D structural information is becoming available.
Mapping nsSNPs onto the corresponding 3D structures or onto the structures of proteins
which are highly similar at the sequence level immediately gives a structural context to
the SNP and there are databases containing such models (Yip et al., 2004).
Prior to the work completed in this thesis, a small number of studies had been done to
try to identify rules by which a nsSNP could be predicted to be deleterious (affect protein
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function) or neutral. These included the development of empirical rules (Wang & Moult,
2001; Ramensky et al., 2002), the use of probabalistic methods (Chasman & Adams,
2001) and machine learning methods (Saunders & Baker, 2002; Krishnan & Westhead,
2003). Krishnan & Westhead (2003) compared the performance of two machine learning
methods (support vector machines (SVMs) and decision trees) against the probabalistic
methods employed by Chasman & Adams (2001) and found machine learning methods to
be generally better performing. Machine learning methods were therefore considered to
be a valuable tool in the classification of nsSNP status. The nsSNP datasets used, included
data on known nsSNPs (Wang & Moult, 2001; Saunders & Baker, 2002; Ramensky et al.,
2002; Bao & Cui, 2005) and mutation data of bacteriophage T4 lysozyme and E. coli lac
repressor (Chasman & Adams, 2001; Krishnan & Westhead, 2003). Databases of coding
nsSNPs have also been developed by Karchin et al. (2005), Cavallo & Martin (2005). All
SNPs contained within the SWISSPROT database have been manually annotated in terms
of their functional status. Bao & Cui (2005) were able to perform the largest analysis
to date using these annotated nsSNPs from SWISSPROT. They observed that structural
information is useful when there is little information from homologous sequences. Some
of the results that emerged from these approaches suggested that the majority of disease
associated nsSNPs affect protein stability (Wang & Moult, 2001), they are located in
surface pockets of protein structures (Stitziel et al., 2004) and that conservation of the
residue across species is an important predictive attribute (Saunders & Baker, 2002).
The availability of suitable datasets for analysis of annotated SNPs is constantly evolv-
ing in terms of the number of SNPs and the quality of SNP annotation. As these datasets
grow, the performance of methods that aim to predict functionality of nsSNPs will con-
tinue to improve.
Once a disease associated nsSNP has been identified, the host gene and gene products
becomes the focus of interest. If there is to be further understanding of the etiology of the
disease the function of the protein isoforms must be ascertained. The next chapter focuses
on methods for assigning function to a protein sequence.
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1.5 An overview of Protein function
Proteins are macromolecular, organic compounds synthesised from genes which are fun-
damental units of heredity made up of sections of coding DNA. They form essential main
structural components in every living cell and perform almost all cell functions.
The sequence of amino acids in a protein is defined by the DNA sequence of the
gene. Protein synthesis is initiated through a transcription stage that involves genes being
transcribed into messenger RNA (mRNA) by RNA polymerase. The mRNA is translated
into amino acid sequence by ribosomes, transfer RNA (tRNA) recognizes the amino acids
corresponding to each nucleotide triplet (codon) of the mRNA (Branden & Tooze, 1999).
The amino acids are linked together forming a chain of peptides (polypeptide).
Protein sequences are composed of ‘modular’ domains whereby each domain has a
specific function and is an independant folding unit. Some proteins are single domain
and belong to one family, whereas others are multidomain proteins that can have more
than one function and belong to more than one family (Orengo et al., 1997). Domains
belonging to a family often share function and are derived from a common ancestor. Sim-
ilarities in amino acid sequences allow proteins to be grouped into families. Conserved
amino acids within protein families are usually important for the function of a protein.
The patterns of these conserved sequences can be used to assign proteins to functional
families.
Protein structure is considered at 4 levels of organisation, the first being the primary
structure and the remaining being 3D levels of folding. Understanding how proteins fold
remains a major challenge within biology:
• The ‘primary structure’ is simply the amino acid sequence itself.
• The ‘secondary structure’ is the first level of folding and refers to the arrangement
of the secondary structure components. The most common of these components are
the alpha helix, beta sheets and coiled regions (Fletterick, 1992). Proteins can be
composed of many sections of different secondary structure components.
• The ‘tertiary structure’ is the second level of folding and refers to the overall shape
of a protein molecule produced by the combination of secondary components; the
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spatial relationship of the secondary structures to one another. This controls the
general function of the protein.
• The ‘quaternary structure’ is the resultant structure produced by a number of inter-
acting proteins, forming a complex.
Sequence comparison by database searching is the most commonly used technique
for assigning function to protein sequence, with the Gapped BLAST and PSI-BLAST
programs (Altschul et al., 1997) having a citation count of 26,793 at Google Scholar
(http://scholar.google.com, January 2009). They work on the principal that
homologous sequences will share a high level of sequence similarity and will relate to
evolutionary distance between the sequences. If the search reveals a sequence which
shares a large degree of similarity with the target sequence, an annotation can usually be
transferred with some confidence.
1.5.1 Databases
1.5.1.1 Sequence databases
There are three main nucleotide databases:
• NCBI - GenBank database based at the National Institure of Health (NIH) http:
//www.ncbi.nlm.nih.gov/Genbank/index.html
• DNA DataBank of Japan (DDBJ) http://www.ddbj.nig.ac.jp
• European Molecular Biology Laboratory (EMBL) (Galperin, 2007). http://
www.ebi.ac.uk/embl/
All three resources share their data and act as annotated collections of all publicly avail-
able DNA sequences. As of December 2008 there were over 85 billion base pairs in
over 82 million sequences within Genbank. These databases can be searched by various
BLAST tools.
The main protein databases include:
• Uniprot is a non-redundant database of amino acid sequences (Apweiler et al.,
2004). This database contains sequences from SWISSPROT, TrEMBL and PIR.
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• SWISSPROT is a manually curated database of protein sequences whose source is
the EMBL database. TrEMBL is an amino acid database from the same source but
is automatically translated from EMBL and includes sequences not yet in SWIS-
SPROT (Boeckmann et al., 2003).
• PIR is a US based protein sequence database comprising comprehensively anno-
tated non-redundant sets of sequences whereby entries are classified into family
groups (Barker et al., 1999).
1.5.1.2 Motif and Family databases
The main protein motif and family databases include the following resources:
• PROSITE is a collection of conserved motifs within protein families (Sigrist et al.,
2002). All motifs are extensively annotated with references to literature.
• The PFAM database contains multiple alignments and libraries of HMMs repre-
senting protein families (Bateman et al., 2004). PFAM-A contains manually created
protein familes whereas PFAM-B is automatically created and has greater coverage.
PFAM can detect very rare instances of a motif.
• The ProDom database is automatically constructed from SWISSPROT and is a
comprehensive collection of clustered domains. On the downside it lacks biological
annotation and some of the cluster boundaries are unreliable (Servant et al., 2002).
• The PRINTS and BLOCKS motif databases contain short multiple alignment frag-
ments (Henikoff & Henikoff, 1996; Attwood et al., 2003).
• Finally, Interpro is a database that aims to integrate data from most of the resources
discussed above (Apweiler et al., 2001; Mulder et al., 2005). Each record contains
links to the data sources in which it is present. It can be searched using InterProScan
(Zdobnov & Apweiler, 2001).
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1.5.2 Sequence comparison
It is preferrable when studying protein function to characterise the function in terms of
the domain structure. Because of the modular nature of protein sequences local alignment
methods are preferrable to global alignment methods. The latter is a term used to describe
methods whereby sequences are compared over the entire length of the two sequences
(Needleman & Wunsch, 1970). Local alignment methods were created later because of
the need for an algorithm that could identify local regions of high similarity (Smith et al.,
1985). A number of tools exist for the assignment of protein function based on sequence
comparison. As described, some databases contain annotated sequence whereas others
contain extracted common motifs from the domains of each family.
1.5.2.1 Pairwise sequence alignment
The BLAST algorithm is a fast local alignment method for optimally aligning two se-
quences using dynamic programming (Altschul et al., 1997). When performing a BLAST
search of a query sequence against a database of sequences, a report is returned with a
number of hits and associated statistical significance.
1.5.2.2 Multiple sequence alignment
Multiple sequence alignments can highlight patterns across families of sequences that are
not obvious from pairwise alignments. A consensus alignment is created using observed
residue frequencies at each position in the consensus. Sequences are usually weighted in
order to remove over representation of similar sequences. The CLUSTAL algorithms are
commonly used multiple alignment algorithms (Higgins et al., 1992; Thompson et al.,
1994).
1.5.2.3 Sequence profiles
Sequence profiles perform better than comparing individual sequences for identifiying ho-
mologs. PSI-BLAST is an example of a profile searching method (Altschul et al., 1997).
A query sequence is initially searched against a database using BLAST. After the initial
run a multiple sequence alignment is created and from this a position specific scoring
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matrix (PSSM) is calculated whereby a score is held for each amino acid at each position
within the sequence. The scores represent the observed frequencies of amino acids at
each position of the multiple alignment. This PSSM is used to search the database again
with hits being added to the PSSM. This continues for a limited number of rounds or until
convergence of results. PSI-BLAST is a very sensitive searching technique but caution is
required as unrelated sequences can be pulled in over multiple interations, distorting the
PSSM and resulting in ‘drift’.
1.5.2.4 Hidden Markov Models
Hidden Markov models can also be used to represent an alignment of proteins. Rather
than creating a PSSM, the alignment is used to design a Markov chain and the transition
probabilities are estimated (Durbin et al., 1998). A probability can then be calculated as
to whether a query sequence was emitted from a particular chain. HMMER and SAM
are commonly used implementations of HMMs (Karplus et al., 1997; Sonnhammer et al.,
1997).
1.5.2.5 Profile/profile comparisons
A recent extension to sequence/profile searching using PSI-BLAST or HMMs is pro-
file/profile searching. This is now possible using PSSM/PSSM searches (Yona & Levitt,
2002; Sadreyev & Grishin, 2003; Soding, 2005).
1.5.3 Protein function supervised classification
There have been numerous genome-wide scans performed where the linked or associated
region can be in excess of 30cM in size and thus contain hundreds of protein coding
genes. In order to select genes and SNPs from these regions, it is important to have
functional annotation for each gene and the protein it encodes in order to aid prioritisation
of candidate genes for follow up studies. In the human genome, approximately 85% of
protein coding genes are known genes (Consortium, 2004), of these 92 to 94% of human
genes experience alternative splicing, with 86% having a minor isoform frequency of at
least 15% (Wang et al., 2008). Each protein isoform may have related, distinct or even
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have opposing functions. Novel approaches to aid existing methods (described in section
1.5.2) for protein function annotation are still required as existing methods are not 100%
effective.
Wilson et al. (2000) have estimated that broad biological function can be conserved
down to about 25% sequence identity. However, there are a large number of sequences
that cannot be annotated with current methods. This lack of annotation hinders the ex-
ploitation of some genome data, it also impacts on the understanding of biological systems
as we do not have sufficient understanding of the constituent parts and how they might
interact.
Machine learning methods have recently been used to explore the problem of protein
function annotation. Rather than considering the sequences as strings to be compared
at a character by character level, most of these methods seek to identify global features
of the sequences that might be discriminative of function. Measures of function include
the enzyme commission database (IUBMB, 1992), expert classifications from Riley for
Escherichia coli (Riley, 1993), the Gene Ontology (Ashburner et al., 2000) and categories
from the Munich Information Centre for Protein Sequences (MIPS) (Mewes et al., 2004).
Ding & Dubchak (2001) have explored the use of support vector machines (SVMs) for
protein fold prediction using the SCOP protein structure database (Murzin et al., 1995) as
a benchmark. SCOP is a hierarchical categorization of protein structural domains where
levels in the hierarchy correspond to class (reflecting the overall secondary structure com-
position of the protein, all α for example), fold (a general description of the spatial ar-
rangement of the secondary structure elements), superfamily (related proteins) and family
(closely related proteins where relationships are usually obvious from sequence similarity
alone).
Support vector machines (SVM) have been used by Cai et al. (2003) to predict pro-
tein function for 54 functional families using attributes similar to those used by Ding
& Dubchak (2001). The potential of the method for the prediction of distantly related
proteins has also been explored by testing the method on 24 randomly selected distantly
related proteins. This analysis achieved a prediction accuracy of 58.3%. Related studies
on enzyme functional prediction found 72% of a set of 50 enzymes could be correctly as-
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signed where there was no known sequence homolog available (Han et al., 2004). SVMs
have also been used to distinguish enzyme structures from non-enzyme structures (Dob-
son & Doig, 2003). The most useful features included secondary structure content and
amino acid frequencies. Recently, Melvin et al. (2007) used SVMs for superfamily clas-
sification of distantly related proteins, but did not report the specific performance for each
superfamily.
Clare & King (2003) and Clare et al. (2006) used decision trees with GO and MIPS
functional categories for mining data on the Saccharomyces cerevisiae and Arabidopsis
thaliana genomes. Predictions achieved 75% accuracy in the Saccharomyces cerevisiae
study and 85% precision in the Arabidopsis thaliana study. Attributes used were those de-
rived from PSI-BLAST, phenotypic properties, expression data, sequence and secondary
structure.
Other sequence attributes that have been used for functional prediction relate to pre-
dicted properties of the sequences such as post translational modifications, subcellular
localization and secondary structure (Jensen et al., 2002) using the Riley functional clas-
sification (Riley, 1993) and Gene Ontology (Ashburner et al., 2000).
After identifying disease causing nsSNPs and determining the function of the protein
in which they reside, it becomes important to understand the environment and pathways
through which the protein acts. This involves the study of proteins in the wider context of
protein-protein interaction networks.
1.6 An overview of protein-protein interaction (PPI) net-
works
Protein-protein interaction (PPI) networks (the interactome) represent the relationships
between protein molecules, the study of which is important as proteins acting as enzymes,
channels and transporters perform almost all cell functions (Alberts et al., 2002; Hwang
et al., 2008). The study of the interactome could help improve the understanding of
complex diseases.
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1.6.1 PPI database repositories
A number of PPI data repositories now exist in the public domain. A comprehensive list
can be found at http://tiny.cc/ppidatabases. Some of the key resources are
described below (details correct as of December 2008):
• HPRD - Human Protein Reference Database is a database of human protein in-
formation manually extracted from the literature by expert biologists who read,
interpret and analyse the published data (Mishra et al., 2006). The latest version
contains 38,167 protein-protein interactions.
• IntAct - Interaction Database is a public repository of manually curated protein in-
teraction data from the literature or through user submissions (Kerrien et al., 2007).
The site contains analysis tools, currently there are 174,078 interactions of which
approximately 32,000 are human.
• DIP - Database of Interacting Proteins, combines experimentally derived interac-
tions from a number of sources. The interactions are both manually and computa-
tionally curated. Currently there are 57,146 interactions, 2,070 of which are human
interactions (Xenarios et al., 2000).
• MINT - Molecular INTeraction Database contains protein interactions that have
been verified experimentally (Chatr-aryamontri et al., 2007). The interactions are
extracted from the literature by expert curators. In total there are 111,847 interac-
tions of which 21,357 are human.
• MIPS - Mammalian Protein-Protein Interaction Database contains literature de-
rived, high-quality interaction data manually curated by experts (Pagel et al., 2005).
• BioGRID - The Biological General Repository for Interaction Datasets database
contains protein and genetic interactions from both high-throughput studies and
conventional focused studies for key model organisms (Stark et al., 2006). It cur-
rently contains over 198,000 interactions from six different species.
• BIND - Biomolecular Interaction Network Database is a database that stores details
of interactions, molecular complexes and pathways (Bader et al., 2001). BIND
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accepts individual submissions as well as interaction data from the protein data
bank (PDB) (Sussman et al., 1998) and a number of large-scale high throughput
interaction experiments.
• OPHID - Online Predicted Human Interaction Database is built by mapping high-
throughput model organism data to human proteins and integrating data from
yeast two-hybrid based, literature-based interaction and orthology-based interac-
tion sources (Brown & Jurisica, 2005). The literature-derived human PPI are ob-
tained from from BIND, HPRD and MINT. Predicted interactions are made from
Saccharomyces cerevisiae, Caenorhabditis elegans, Drosophila melanogaster and
Mus musculus. The 23,889 predicted interactions currently listed in OPHID are
evaluated using protein domains, gene co-expression and Gene Ontology terms. In
total there are 48,222 interactions listed within OPHID.
• UniHI - The Unified Human Interactome is a unified repository based on 10
major interaction sources of computational and experimental derived interactions
(Chaurasia et al., 2007). It includes more than 150,000 distinct interactions for
more than 17,000 human proteins. Scores for quality assessment are given based
on co-annotation and co-expression of the interacting proteins.
• PIP - The Potential Interactions of Proteins web server contains interacting pro-
teins constructed for the human genome using an orthology-based method (Jonsson
& Bates, 2006a). The orthologous protein interactions were taken from DIP and
MIPS. Each interaction was given a confidence score based on sequence similarity
to proteins shown experimentally to interact and the amount of available experi-
mental evidence for the interaction. There are 108,113 interactions in this database
when a confidence score cut-off is applied that provides sensitivity of 85% and
specificity of 82%.
1.6.2 Methods to identify protein-protein interactions
There are many approaches, experimental and theoretical, for detecting protein interac-
tions, each varying in sensitivity and specificity. They include high-throughput meth-
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ods such as yeast 2-hybrid experiments (Rual et al., 2005; Stelzl et al., 2005), manually
curated and literature based interaction sources such as the Human Protein Reference
Database (HPRD) (Mishra et al., 2006) and Interaction Database (IntAct) (Kerrien et al.,
2007) as well as predicted interactions based on in silico methods such as Predictome
(Mellor et al., 2002), POINT (Huang et al., 2004), Prolinks (Bowers et al., 2004) and
STRING (von Mering et al., 2007).
1.6.3 PPI software
There are now many software applications available for the analysis of biological net-
works, a comprehensive survey, was recently described by Pavlopoulos et al. (2008). A
selection of some of the popular tools are described below.
• APID - Agile Protein Interaction DataAnalyzer is a web based tool enabling the
exploration and analysis of PPI data from BIND, BioGRID, DIP, HPRD, IntAct
and MINT PPI resources (Prieto & De Las Rivas, 2006).
• Cytoscape is an open source bioinformatics Java software platform for visualizing
molecular interaction networks and integrating these interactions with gene expres-
sion profiles and other state data (Shannon et al., 2003). Many user created plugins
are available for specific analysis tasks.
• Osprey is a standalone application that runs on a range of platforms with a license
for non commercial use (Breitkreutz et al., 2003). Currently the source code is
not available and it is not appropriate for large scale network analysis. Data can
be loaded directly from BioGRID (Stark et al., 2006) and there is support for a
number of data formats. Osprey is a powerful tool for network manipulation and
has the important ability to incorporate new interactions into an already existing
network.
• VisANT is freely available (http://visant.bu.edu) and integrates, mines
and displays hierarchical bio-network and pathway information (Hu et al., 2008). It
is supported by the Predictome database where much of the interaction data comes
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from resources such as BioGRID, MIPS, BIND and HPRD. This tool is able to
handle large-scale networks with millions of nodes and edges.
• Pajek is a standalone application (Batagelj & Mrvar, 1998). It is not an open source
application and runs under Windows operating systems only, but it is free for non-
commercial use. It is suitable for large scale networks, is highly interactive and
incorporates many clustering methods. Pajek’s main strength is the variety of layout
algorithms.
• The Boost graph library (BGL) http://www.boost.org/doc/libs/1 37
0/libs/graph/doc/index.html is a C++ library for developers providing
a generic interface for traversing graphs and accessing the graph’s structure.
Other popular software includes Graphviz (http://www.graphviz.org), Net-
workX (http://networkx.lanl.gov), cFinder (Adamcsek et al., 2006), Guess
(http://graphexploration.cond.org) and igraph (http://cneurocvs.
rmki.kfki.hu/igraph/).
1.6.4 PPI networks and supervised classification of disease associ-
ated genes
Early work using decision tree based classifiers showed disease genes tend to be longer
and more conserved than non-disease genes (Lopez-Bigas & Ouzounis, 2004). Subse-
quent work constructing supervised classifiers included additional sequence based at-
tributes that included length, proximity to other genes, exon count, GC content, trans-
membrane and signal peptide domain content, CpG related properties and details of ho-
mologous and paralogous proteins (Adie et al., 2005). Other annotation related attributes
such as co-expression and similarity of Gene Ontology (GO) (Ashburner et al., 2000)
terms and text mining approaches have also been used for selection of disease gene can-
didates (Perez-Iratxeta et al., 2005; Tiffin et al., 2005; Adie et al., 2006). More recently,
attributes based on PPI have been used in supervised classification approaches (George
et al., 2006; Xu & Li, 2006).
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PPI network based approaches for studying human diseases have shown that disease
associated proteins often interact with other disease proteins or share interaction neigh-
bours (Xu & Li, 2006). Specifically, there is a 10-fold increase in the likelihood of pro-
teins interacting when they are associated with the same disease (Goh et al., 2007). Goh
et al. (2007) have also shown that ‘essential’ disease genes, in which mutations are lethal,
form hubs (highly connected nodes) whereas ‘non-essential’ disease genes do not display
this tendency. A k-nearest neighbours classifier using network features achieved a predic-
tion accuracy of 0.76 using the OMIM dataset (Xu & Li, 2006). A disease is considered to
result from the disruption of a specific cluster (functional module of interacting proteins)
and is caused by mutations in one or more of the proteins resulting in a recognised phe-
notype (Loscalzo et al., 2007). Different combinations of perturbed genes in a cluster can
lead to the same phenotype. There is also data showing that some proteins are implicated
in multiple phenotypes, that is there are disorders which can be termed connected in that
they share associated proteins (Goh et al., 2007; Loscalzo et al., 2007; Sam et al., 2007).
Cancer is regarded as one of the most connected disorders (Goh et al., 2007).
Analysis of protein-protein interaction networks has been used to explore several dis-
ease conditions including asthma (Hwang et al., 2008), neurodegenerative diseases (Goni
et al., 2008), and with transcriptomics, human heart failure (Camargo & Azuaje, 2007,
2008). PPI network properties for Alzheimers related proteins from OMIM have been
studied by Chen et al. (2006) who found these proteins form a highly connected sub-
network. They devised a metric that enabled the ranking of a protein for its biological
relevance to Alzheimers pathways. Such analyses may be helpful in suggesting important
single proteins or clusters, the disruption of which could lead to a variety of disease con-
ditions. This can be particularly useful for adding weight to candidates identified through
genome wide studies and could lead to a better understanding of the molecular basis of
disease.
To date, many of the studies have been dependent on OMIM as a source of disease
related or implicated genes. OMIM is a comprehensive catalogue of human genes and
their associated genetic phenotypes. It provides ‘full-text, referenced overviews on all
known mendelian disorders and over 12,000 genes’. Although OMIM was initially cre-
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ated to store details relating to mendelian traits its use has been extended to some ex-
tent to cover more complex traits. The resource is not available as a relational database
but is available to download as formatted text. Studies such as van Driel et al. (2006)
have created tools such as MimMiner in an effort to mine the natural language used in
each record. MimMiner searches the data on a keyword basis using words found in the
anatomy (A) and the disease (C) sections of the Medical Subject Headings vocabulary
(MeSH) http://www.nlm.nih.gov/mesh/. However, OMIM is an incomplete
resource that holds many speculative disease associations. There is a need for trait spe-
cific analyses to be performed on expertly curated datasets of disease implicated gene
products.
With cardiovascular disease (cvd) set to become the number one cause of deaths
worldwide, it is important to understand the etiologic mechanisms for cardiovascular re-
lated diseases such as hypertension, in order to identify new routes to improved treatment.
There have only been a small number of cvd focused studies to date that have exploited
the use of PPI networks. The approach of George et al. (2006) which employs PPI and
pathway data together with sequence similarity, had no success in correctly identifying
any of the putatively associated hypertension genes included in their dataset. These anal-
yses were based on a small set of 5 hypertension related proteins extracted from OMIM.
Camargo & Azuaje (2007) undertook an analysis of genes implicated with human
heart failure by studying PPI network connectivity in a human heart failure gene expres-
sion dataset. The network was constructed from interactions within the HPRD database.
Relationships between co-expression and PPI connectivity were analysed showing that
genes significantly differentially expressed were not always highly connected nodes.
Though some traditional heart failure proteins were not differentially expressed, they
sometimes interacted with differentially-expressed proteins. It was noted that network
hubs can show weak co-expression with their directly interacting partners. The ex-
ploratory study aimed to identify patterns and trends, with the constructed network being
available on request to the authors. However there was no metric or classifier described
for prioritising candidate genes. In a recent study, Camargo & Azuaje (2008) focused on
dilated cardiomyopathy, a leading cause of heart failure. Again, differentially expressed
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genes were evaluated in terms of PPI networks. In this analysis classifier models were
used to suggest novel dilated cardiomyopathy associated genes.
With cvd being such an important target, there is value in attempting to further develop
such alternative approaches to predict potentially implicated genes. Such methods may
be useful in identifying novel disease associated genes as well as complementing existing
analysis strategies such as GWA studies.
1.7 Study Aims
Studies of the etiology and genetic contribution to complex diseases require methods to
identify causative functional SNPs and the disease associated genes in which they reside.
This study explores the utility of machine learning methods for predicting functional nsS-
NPs and the function for proteins where annotation using conventional homology based
methods is absent. Such machine learning methods, combined with graph theoretic ap-
proaches are used to explore approaches to identify novel disease associated proteins and
prioritise candidate gene lists through characterising the PPI network topology of impli-
cated disease associated proteins.
1.7.1 Specific aims of thesis
1.7.1.1 nsSNP analysis
• To improve on previous methods for predicting disease associated nsSNPs by ap-
plying machine learning methods to look for patterns in the distribution of sequence
and structural based attributes related to disease and neutral SNPs.
1.7.1.2 Protein function analysis
• To utilise machine learning methods for predicting protein superfamily membership
using global sequence based attributes and a training set of protein domains from
the SCOP classification scheme. Traditional homology based approaches work well
where there is a high level of sequence similarity between the query sequence and a
sequence of known function. This study focuses on sequences in the ‘twilight zone’
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whereby sequence similarity is less than 30%.
1.7.1.3 Protein-protein interaction network analysis
• To characterise the topological properties of hypertension related proteins within
the human interactome using protein-protein interaction data from OPHID and hy-
pertension associated genes carefully selected from the OMIM database.
• To combine the identified hypertension protein network properties with simple se-
quence and functional based attributes to build a classifier for predicting novel hy-
pertension related proteins.
• To analyse the topological properties of implicated cardiovascular (cvd) and can-
cer related proteins within the human interactome using protein-protein interaction
data, and disease implicated proteins from publicly available sources.
• To quantify the influential nature of the cvd and cancer proteins, analyse community
structures and show an approach for prioritising candidate gene products based on
these network measures.
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Chapter 2
nsSNP function analysis
This chapter focuses on using machine learning methods for predicting functional nsS-
NPs. All nsSNPs described in the SWISSPROT VARIANT web pages that mapped onto
the Ensembl database (Hubbard et al., 2002) were considered, allowing the application of
Ensembl annotations to these variants. A number of sequence and structural attributes of
nsSNPs were surveyed to see if previous trends of disease and neutrality are preserved in
light of much larger datasets now available, the attribute of whether the nsSNP occurs in
a protein binding site was also included (Bader et al., 2003).
One of the problems with using the available collection of natural nsSNPs is the large
difference in numbers of disease associated and neutral examples. To address this problem
of class imbalance the effect of resampling and weighting on the prediction performance
was assessed.
2.1 nsSNP analysis methods
2.1.1 SNP database creation
In order to create a resource to facilitate the prediction of functional nsSNPs, a SNP
database was initially constructed by extracting SNP related data from the Ensembl
database (Hubbard et al., 2002) using a combination of structured query language (SQL)
and the Ensembl perl application programming interface (API). Ensembl was used as it
contains SNPs from the combined SNP resources described in section 1.4.1 and is a rich
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source of annotation. This data was loaded into a MySQL database whereby the SNP ‘rs
identifiers’ were used as keys. Pipelines were constructed in order to allow annotation
from external sources to be added to the SNPs (figure 2.1). Data was included from:
• The manually curated protein knowledgebase SWISSPROT (Yip et al., 2004).
• The interactions within the Biomolecular Interaction Network Database (BIND)
and the Molecular Modeling Database (MMDBBIND) (Bader et al., 2003).
• The Kyoto Encyclopedia of Genes and Genomes (KEGG) (Kanehisa & Goto,
2000).
• The Homology-derived Secondary Structure of Proteins database (HSSP) (Sander
& Schneider, 1993).
• The Protein Data Bank (PDB) (Berman et al., 2000).
Tools were built to parse, reformat, map and load data into the dababase from these
sources. SWISSPROT was used to add information relating to the disease status of
the SNP as well as information relating to functional sites within the protein sequence.
MMDBBIND and BIND were used to provide information relating to protein interac-
tions. BIND contains interactions/complexes and pathways but not at the atomic level.
It provides residue ranges for the interacting regions. These entries are not dependent
on structure as sequence identifiers are used. This database records in-vivo interactions
being studied and references the experimental evidence that supports or disputes the
occurrence of the interaction. MMDBBIND (www.bind.ca) contains atomic level details
of interactions. These interactions are annotated automatically from MMDB entries
(MMDB is a subset of PDB that excludes theoretical models). A contact is made when
the van der waals radii of 2 atoms are within 0.5 A˚. The KEGG database was used to
provide information relating to pathways and both HSSP and PDB were used to add
structural information relating to the SNPs.
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Figure 2.1: Overview of the nsSNP annotation pipeline for creating the SNP database.
2.1.2 nsSNP dataset
The SWISSPROT VARIANT web pages (Yip et al., 2004) provide information on single
amino acid polymorphisms associated with a given SWISSPROT entry. The variants are
labelled as disease, unclassified or polymorphism. A subset of these SNPs were used in
this study, namely those from Homo sapiens where the amino acid polymorphism was
found to map onto the Ensembl human genome protein sequence. A SNP was considered
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mapped where the amino acid was the same in both the SWISSPROT sequence and the
Ensembl protein sequence and the aligned region using BLAST had an expectation (E)
value < 1e− 10 over a region > 100 amino acids in length. Matches to known structure
and to structural homologs were obtained in the following way:
• Each sequence containing a nsSNP was searched against all the sequences in the
protein data bank using the PSI-BLAST program (Altschul et al., 1997) with ten
iterations.
• Only hits with an E value of less than 1e-10 where the amino acids at the position
of the nsSNP were the same were stored.
• Each of these nsSNP containing SWISSPROT entries was aligned with the se-
quence in a relevant HSSP (Sander & Schneider, 1993) file. Where there were
multiple PDB annotations in the SWISSPROT file, the PDB with the lowest E value
was used.
2.1.3 nsSNP features
Structurally dependent features were considered separately from the set of features that
were not dependent on structure because the subset of nsSNP containing proteins with
associated 3D structures is considerably smaller than the set of all nsSNP containing
proteins. A total of 17 features were used, 11 non structurally dependent and 6 structurally
dependent.
2.1.3.1 Non structural features
The features chosen were largely based on those used by Ramensky et al. (2002) and
Krishnan & Westhead (2003):
• The residue types of the original and mutated residues.
• The physiochemical properties of the original and mutated residues.
• Sequence conservation: is the nsSNP at a conserved position. The sequence was
matched against a protein non redundant database using the BLAST program and
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all hits with an E value less than 0.0005 were stored. A multiple alignment was
constructed and sequence variation at the position of the nsSNP was described by
calculating the position-specific independent counts (PSIC) score (Ramensky et al.,
2002).
• Point Accepted Mutation (PAM) score shift measured from the PAM120 matrix
(Dayhoff et al., 1978).
• Side chain volume change (Tsai J, 1999).
• Mass change. The molecular weights are those of the neutral, free amino acids.
• Hydrophobicity difference (Black SD, 1991).
In addition four further non structurally dependent attributes (described below) were used,
these were taken from the SWISSPROT features table, pathway information, ontology
classifications and interacting regions.
SWISSPROT features table
The SWISSPROT entry feature table may contain information about functional sites. A
survey was carried out of functional site terms across all nsSNPs in the SWISSPROT
VARIANT pages. Following Ramensky et al. (2002), nsSNPs located within the follow-
ing labelled features were considered to be termed ‘functional’ sites for the benefit of the
machine learning analysis:
• ACT SITE - amino acid(s) involved in the activity of an enzyme.
• BINDING - binding site for any chemical group (co-enzyme, prosthetic group, etc.)
• MOD RES - posttranslational modification of a residue.
• SITE - any interesting single amino-acid site on the sequence, that is not defined by
another feature key. It can also apply to an amino acid bond which is represented
by the positions of the two flanking amino acids.
• LIPID - covalent bonding of a lipid moiety.
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• METAL - binding site for a metal ion.
• DISULPHID - disulphide bond.
• CROSSLNK - posttranslationally formed amino acid bonds.
• TRANSMEM - extent of a transmembrane region.
• SIGNAL - extent of a signal sequence (prepeptide).
• PROPEP - extent of a propeptide.
• NP BIND - extent of a nucleotide phosphate-binding region.
• MUTAGEN - Site which has been experimentally altered by mutagenesis.
KEGG pathways
In order to observe the distribution of disease and neutral nsSNPs within pathways we
mapped the set of 16,352 nsSNPs to KEGG pathways (Kanehisa & Goto, 2000). For each








where N idis is the number of disease nsSNPs in pathway i and N totdis is the total number of
disease nsSNPS in our dataset and similarly for polymorphic nsSNPs.
Gene Ontology
Each nsSNP containing protein sequence belongs to a number of Gene Ontology (GO)
categories (Ashburner et al., 2000). The odds ratio of neutral and disease nsSNPs were
calculated for each of the GO categories.
Interactions
The BIND (Bader et al., 2003) database was used to map nsSNPs to interacting regions.
A potential interacting region was defined as a region from amino acid position n to amino
acid position m. These interactions were generally regions observed experimentally and
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were not considered structurally dependent annotations as the BIND database entries have
sequence identifiers. The odds ratio Pi was calculated where N idis is the number of sites
containing disease nsSNPs in either an interacting region or non-interacting region i and
N totdis is the total number of sites containing disease nsSNPS in our dataset that map to
BIND and similarly for polymorphic nsSNPs.
2.1.3.2 Structural features
Five structural attributes were extracted from the corresponding HSSP file (Sander &
Schneider, 1993):
• Secondary structure conformation: residue is in an isolated beta-bridge (single pair
beta-sheet hydrogen bond formation), 5 turn helix (pi helix), 3 turn helix (3/10
helix), 4 turn helix (alpha helix), bend, beta sheet in parallel and/or anti-parallel
sheet conformation (extended strand), hydrogen bonded turn (3, 4 or 5 turn).
• Relative solvent accessibility.
• Normalised relative accessibility.
• Exposure (relative accessibility as 3 states).
• Buried charge.
Relative accessibility and normalised relative accessibility were calculated in the same
manner as Chasman & Adams (2001). The maximum accessible surface area (A˚2) ref-
erence values are those calculated for residues in a Gly-Xaa-Gly tripeptide in extended
conformation (Miller S, 1987). In order to group the relative accessibility, it was projected
onto 3 states: buried (here defined as <9% relative accessibility), intermediate (9% ≤ rel.
acc. < 36%), exposed (rel. acc. ≥ 36%) (Rost & Sander, 1994). Buried charge is defined
as K,R,D,E,H wild type amino acid and ‘buried’ exposure class (Krishnan & Westhead,
2003).
Interactions
The MMDBBIND database (Bader et al., 2003) was used as a second source to map
nsSNPs to interacting regions. MMDBBIND contains atomic level details of interactions.
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These interactions are annotated automatically from MMDB (Chen et al., 2003) which is a
subset of experimentally determined PDB structures. This attribute is therefore dependent
on structure as it requires a PDB identifier. MMDBBIND interactions are a much more
precise interaction annotation than the BIND interactions as the BIND defined regions can
sometimes be very large in amino acid length. Again, the odds ratio Pi was calculated
where N idis is the number of sites containing disease nsSNPs in either an interacting region
or non-interacting region i andN totdis is the total number of sites containing disease nsSNPS
in our dataset that map to MMDBBIND and similarly for polymorphic nsSNPs.
2.1.4 Machine learning
All machine learning analysis was performed using the Weka package of machine learn-
ing algorithms (Witten & Frank, 1999).
2.1.4.1 Single attribute analysis
In order to identify the most effective classifier from all of the attributes, the 1R classifying
algorithm was used (Holte, 1993). This classifier creates a single level decision trees
for each attribute and measures the prediction error rate. It was used with a minimum
bucket size of 14 and 10 fold cross validation on the fully balanced dataset containing
all variables. The bucket size of 14 was chosen because bucket sizes below this value
caused overfitting and/or an increase in the error rate. The attributes were then ranked
in terms of their effectiveness as a predictor using the default ranker search method with
this 1R attribute evaluator, they were also ranked in terms of the information gain (IG)
they provide (Witten & Frank, 1999). Entropy is a measure of information and represents
the amount of information that would still be needed to classify the nsSNP having used
the attribute in question (Shannon CE, 1948). The information gain is the information
required after using the attribute as a classifier subtracted from the information required
before using the attribute as a classifier.
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2.1.4.2 Attribute set analysis
It is of value to investigate the relative importance of attributes that require structure and
those that can be obtained by sequence alone. The importance of sequence conservation
has been previously noted (Saunders & Baker, 2002) so it was also important to observe
whether the other non structurally dependent attributes could add to prediction quality
achieved with conservation score alone. Hence, we compared predictions for the follow-
ing sets of selected attributes:
• Set (1) - All variables (3821 nsSNPs).
• Set (2) - Structurally dependent variables (3821 nsSNPs).
• Set (3) - All non structurally dependent attributes (14,636 nsSNPs).
• Set (4) - Non structurally dependent variables excluding the conservation score
(14,636 nsSNPs).
• Set (5) - The conservation score alone (14,636 nsSNPs).
Decision trees have been shown to perform well in a mixed cross validated training
dataset (Krishnan & Westhead, 2003). They also provide a confidence score and intelli-
gible rules to a prediction. Based on this knowledge we decided to use the J48 decision
tree classifier to analyze the assembled sets of variables. J48 is the Weka implementation
of C4.5 and was run with the default set of parameters and 10 fold cross validation. In
performing 10 fold cross validation, the data was divided into 10 ‘folds’ and each fold was
treated as the test dataset in turn, with the remaining 9 being used as training data. The
performance of the classifier on each fold was measured, and a final accuracy calculated
based upon the average of all 10 folds.
2.1.4.2.1 Effect of imbalance There was a problem of imbalance (Al-Shahib et al.,
2005) within the dataset which would introduce skewing towards the avoidance of errors
for the disease status as there are 2.5 times more disease nsSNPs than neutral. The im-
balanced dataset applies a higher cost to getting a disease prediction wrong, meaning that
the rules inferred by the imbalanced dataset are able to predict disease status but unable to
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predict neutral nsSNPs accurately. The effect of imbalance depends on total set size, class
heterogeneity, data complexity and the classification technique. To address the problem
of imbalance in our dataset we applied cost-sensitive classification by either resampling
or reweighting (Witten & Frank, 1999). Resampling can be used to either increase the
number of the minority class (oversample) or reduce the number in the majority class
(undersample) (Weiss & Provost, 2001). Reweighting can be used to apply a cost to an
incorrectly classified minority class without altering the numbers in each class. The cost
is directly proportional to the imbalance. This study compared results using both resam-
pling and reweighting. We undersampled the disease class as oversampling would make
exact copies of the neutral class, potentially resulting in overfitting of the data. Under-
sampling results in the loss of information so it was decided to randomly undersample
at rates of 100%, 75%, 50%, 25% and 0%. This means that at each rate, ‘n% of the
excess members of the majority class were randomly removed’ (Al-Shahib et al., 2005),
resulting in a balanced dataset when undersampling at a rate of 100%.
2.1.4.2.2 Attribute redundancy Some attributes work well in combination leaving
other attributes redundant and maybe even causing a reduction in prediction quality. The
optimised subset of attributes for each attribute set at each level of imbalance was ob-
tained using wrapper-based feature selection with J48 as the learning method with default
option settings. The wrapper-based feature selection method in combination with the Ge-
netic Search algorithm (Witten & Frank, 1999) produced the lowest error rates in tests.
The genetic search algorithm was initialised with a population size of 20 and then 50
generations were evaluated.
2.1.4.2.3 Measure of prediction quality Matthews correlation coefficient (MCC)
(Matthews, 1975) was used as the measure of prediction performance. Matthews cor-
relation coefficient combines both sensitivity and specificity into one measure and lies in
the range -1 to 1 with 1 meaning complete prediction accuracy, 0 meaning every predic-
tion was randomly assigned. MCC is defined by
MCC =
(TP.TN − FP.FN)√
(TN + FN)(TN + FP )(TP + FN)(TP + FP )
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where TP is true positive, FP is false positive, TN is true negative and FN is false
negative.
This is preferrable to using the error rate (E), defined below, because in a case where
all samples are assigned to a majority class, E may still be low.
E =
FP + FN
TP + TN + FP + FN
2.2 nsSNP analysis results
2.2.1 Distribution of attributes across the normal and disease associ-
ated nsSNPs
A set of 16,352 SWISSPROT nsSNPs (out of a potential 18,812) could be mapped onto
the Ensembl database, of which 10,419 (64%) were disease associated, 4217 (26%) were
labelled as being neutral and 1716 (10%) were unclassified. These disease and neutral
nsSNPs were contained within 893 and 1256 proteins respectively. A total of 500 nsSNP-
containing proteins had structural homologs, of which 299 proteins contained disease re-
lated nsSNPs and 295 contained polymorphic nsSNPs (a protein can contain both disease
and polymorphic nsSNPs). The data is summarised in Table 2.1.
Disease Polymorphism Total
Number of nsSNPS 10,419 4217 14,636
Number of nsSNPS within proteins
with structural homologs
3212 609 3821
Number of Proteins with nsSNPs 893 1256 2149
Number of Proteins with nsSNPs
having structural homologs
299 295 594
Table 2.1: Summary of SWISSPROT VARIANT training dataset
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2.2.1.1 Analysis of non structural features
The distribution of sequence derived attributes suggests: tryptophan (W), tyrosine (Y)
and cysteine (C) in the wild and mutated residues increases the chance of the nsSNP
being disease related with odds ratios of 2.07, 2.03 and 2.03 respectively. This has pre-
viously been noted for tryptophan and cysteine by Vitkup et al. (2003). The likelihood
of the nsSNP being deleterious increases as the volume, mass and hydrophobicity dif-
ference between the wild and mutated residue increases. The mean change in volume,
mass and hydrophobicity between the wild and mutated residue was 1.29, 1.29 and 1.31
times greater for disease nsSNPs respectively. There appeared to be very little bias in the
other physiochemical properties individually towards the status of the nsSNP. As previ-
ously observed, a nsSNP is much more likely to be deleterious with an increasing PSIC
conservation score difference (Saunders & Baker, 2002). The mean PSIC conservation
score was 2.2 times greater for disease related nsSNPs.
2.2.1.1.1 SWISSPROT features table Table 2.2 shows the most discriminatory
terms from the SWISSPROT features table, namely those where over 90% of the corre-
sponding nsSNPs are disease related. The annotation of a nsSNP in the SWISSPROT
feature table is not a good discriminator between disease and polymorphic status. In
this dataset, the feature table terms which are predominantly associated with disease
related nsSNPs have very low counts, making it difficult to generalize about their utility
in predicting whether a given nsSNP is disease related.
2.2.1.1.2 KEGG pathways Analysis of nsSNPs that map to KEGG pathways re-
vealed that the odds ratio (P ) is highest for the following 4 pathways: phenylalanine,
tyrosine and tryptophan biosynthesis (15.6), methionine metabolism (15.16), carbon fixa-
tion (12.56), nucleotide sugars metabolism (12.33). Assignment to a KEGG map was not
used as an attribute for machine learning prediction as this result may simply reflect that
these are commonly studied pathways and the pathway was considered to be a property
of the protein as opposed to the nsSNP.
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Site Disease Polymorphism Percentage (odds ratio) of
nsSNPs within these sites
that are disease
ACT SITE 25 1 96.15 (10.12)
BINDING 13 0 100 (-)
DNA BIND 352 20 94.62 (7.12)
METAL 38 0 100 (-)
MOD RES 34 3 91.89 (4.59)
MUTAGEN 111 10 91.74 (4.49)
NP BIND 108 8 93.1 (5.46)
Table 2.2: The number of disease and polymorphism nsSNPs within SWISSPROT feature table
sites that contain > 90% disease nsSNPs. ACT SITE - amino acid(s) involved in the activity of
an enzyme, BINDING - binding site for any chemical group (co-enzyme, prosthetic group, etc.),
DNA BIND - Extent of a DNA-binding region, METAL - binding site for a metal ion, MOD RES -
posttranslational modification of a residue, MUTAGEN - Site which has been experimentally altered
by mutagenesis, NP BIND - extent of a nucleotide phosphate-binding region.
2.2.1.1.3 Gene Ontology The ratio of deleterious nsSNPs was found to be the highest
for the following GO biological processes: anti-inflammatory response (GO:0030236),
peroxisome organization and biogenesis (GO:0007031), and peroxisomal membrane
transport (GO:0015919). The GO cell location categories having the highest ratio of
deleterious nsSNPs are the peroxisomal membrane (GO:0005778), integral to peroxi-
somal membrane (GO:0005779) and collagen type VII (GO:0005590) categories. The
molecular function categories containing the highest ratio of disease to neutral nsSNPs
are phenylalanine 4-monooxygenase activity(GO:0004505), alpha-galactosidase activity
(GO:0004557) and pyruvate kinase activity (GO:0004743). GO categories were not used
as machine learning attributes as they were considered to be properties of the protein as
opposed to the nsSNP.
2.2.1.1.4 Interactions A total of 1,944 SWISSPROT nsSNPs mapped to proteins that
have entries in BIND. A significant number of disease nsSNPs are within interacting
regions (χ2=32.85, p=0.001) within BIND. Table 2.3 shows 71.7% (odds ratio 1.29) of
positions containing one or more nsSNPs that map to interacting regions are associated
with disease (736 sites) as opposed to 28.3% (290 sites) which contain polymorphism
nsSNPs.
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2.2.1.2 Analysis of structural features
A total of 3,821 nsSNPs could be mapped to a homologous protein of known structure.
Of the nsSNPs that could be mapped to structure, disease nsSNPs tended to be buried and
neutral nsSNPs tend to be exposed. There was also a propensity towards nsSNPs causing
disease occurring in beta sheets as previously noted (Sunyaev et al., 2000) and a trend
towards neutrality with increased accessibility.
2.2.1.2.1 Interactions A total of 3,028 SWISSPROT nsSNPs mapped to proteins that
have structures or structural homologs in MMDBBIND (Bader et al., 2003). Table 2.3
shows 86% (odds ratio 1.29) of positions containing one or more nsSNPs that map to
interacting residues are associated with disease (294 sites) but also that 82% (odds ratio
0.97) of positions containing one or more nsSNPs that map to non-interacting residues are
associated with disease. The difference between interacting sites containing disease nsS-






Disease (BIND) 71.7%(736)[1.29] 58.6%(431)[0.72]
Polymorphism (BIND) 28.3%(290) 41.4%(304)
Disease (MMDBBIND) 86.0%(294)[1.29] 82.0%(1818)[0.97]
Polymorphism (MMDBBIND) 14.0%(48) 18.0%(398)
Table 2.3: Distribution of disease and neutral nsSNPs within locations (interacting or non-
interacting) from BIND and MMDBBIND. Some sites may contain multiple nsSNPs
All attributes excluding the KEGG pathway and GO attributes were used for machine
learning analysis.
2.2.2 Machine Learning
2.2.2.1 Single attribute analysis
The 1R algorithm identified the best single attribute in terms of predicting disease status.
The attributes were ranked in terms of effectiveness as a predictor and were also ranked
in terms of the information gain that they provided (Tables 2.4 and 2.5). The PSIC con-
servation score was identified as the best classifier in a balanced dataset achieving 72%
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correctly classified instances with the rules that defined a nsSNP as being disease status
with a score difference > 0.89 and neutral with a PSIC score difference <= 0.89. These
classifiers compared favourably with the conservation score rules identified by Ramensky
et al. (2002) in their study whereby a PSIC score difference <= 0.5 was classified as
benign, 1.5 to 2.0 possibly damaging and >= 2.0 probably damaging.
1R Rank Attribute
72.82 conservation score (PSIC)








59.19 wild type residue
Table 2.4: Top 10 attributes for predicting nsSNP function using 1R with 10 fold cross validation
and bucket size 14.
Information gain (bits) Attribute
0.2 conservation score (PSIC)









Table 2.5: The information gain per attribute when predicing nsSNP function.
2.2.2.2 Attribute set analysis
The J48 decision tree algorithm was used to evaluate the predictive performance of the
following subsets of attributes:
• Set (1) - All variables.
• Set (2) - Structural variables.
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• Set (3) - Non structurally dependent variables.
• Set (4) - Non structurally dependent variables excluding the conservation score
(PSIC).
• Set (5) - Conservation score alone.
2.2.2.2.1 Effect of Imbalance Attribute sets (1) and (2) contained 3,821 nsSNPs
when imbalanced and 1,218 when balanced, both sets included structural variables.
Datasets (3), (4) and (5) contained 14,636 nsSNPs when imbalanced and 8,434 when
balanced. They contained more nsSNPs than sets (1) and (2) because they were not de-
pendent on structure.
The MCC increased with increasing balance within each of the sets of attributes.
There was a difference in the MCC score between 0% balanced and 100% balanced of
0.24 for dataset (1), 0.29 for (2), 0.08 for (3), 0.07 for (4) and 0.15 for (5). The perfor-
mance of the weighted sets lay between the level of 25% and 50% balancing for each
attribute set (Figure 2.2).
The 100% balanced dataset (1) achieved a MCC of 0.49. When weighted and imbal-
anced the MCC was 0.3 and 0.25 respectively for this same set. The balanced dataset
(3) was equal second in the rankings with a 75% balanced set (1), performing better than
dataset (2). The conservation score alone (set (5)) achieved a similar MCC score when
considered separately (MCC 0.43) as it did when it was included in set (3) (MCC 0.44)
when 100% balanced. When the conservation score is excluded there is a drop of 0.16 in
the MCC of the 100% balanced dataset (3). When set (2) is balanced it performs better
than (4) but when it is not 100% balanced it has a lower MCC. Dataset (3) actually per-
forms better than the dataset (1) when the datasets are <= 50% balanced or weighted.
The imbalanced dataset (2) achieved the lowest MCC score.
The rules learnt from the machine learning approach were then applied to make pre-
dictions on nsSNPs where the function was unknown. All nsSNPs within Ensembl (Build
27 1) were used as the unknown test dataset. The dataset was trained on the 100% bal-
anced dataset of 609 neutral and 609 disease nsSNPs using all variables. This resulted in
a predicted classification along with a confidence score for each of the ‘unseen’ nsSNPs
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Figure 2.2: nsSNP function predictive performance of five attribute subsets measured using
Matthews Correlation Coeffecient (MCC). Non struct vars excl PSIC - Non structurally dependent
variables excluding the conservation score (PSIC); Struct vars - Structural variables; Non struct vars
- Non structurally dependent variables; All vars - All variables.
within Ensembl. The predictions made for all of the Ensembl nsSNPs are available to be
viewed within Ensembl as a Distributed Annotation System (DAS) source (Figure 2.3)
(Dowell et al., 2001).
2.3 Discussion
The SNP database was created to observe how various sequence and structural based
nsSNP attributes as well as the level of balance in the training dataset affect nsSNP func-
tional prediction performance. Using the optimal set of attributes and level of balance
in the training dataset was found to increase the Matthews correlation coefficient (MCC)
and therefore increase the value of the predictions for use in the targeted studies of EH,
and other diseases.
The use of a 100% balanced dataset dramatically increased the MCC and removed any
bias towards building rules for prediction of the disease state. Complete undersampling is
a better choice than reweighting in addressing an imbalanced dataset. When imbalanced,
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Figure 2.3: Screenshot of nsSNP function predictions (labelled as the snp das track) integrated
within the Ensembl browser as a DAS source (Dowell et al., 2001)
performance using conservation alone (MCC 0.28) is close to that achieved by Bao &
Cui (2005) (MCC 0.305) yet with a balanced dataset the MCC is greatly improved (MCC
0.43).
We saw a larger spread in the MCC when using the smaller datasets that included
structural variables, because of the larger ratio of disease to neutral nsSNPs in these
datasets. This explains why the MCC for the dataset of all variables performed best
when > 50% balanced yet the performance drops below that of non structurally depen-
dent variables when the level of balance falls below this figure. It also explains the similar
pattern seen when comparing structurally dependent variables and non structurally de-
pendent variables excluding conservation, except that the cut off lies at the 75% level of
balance.
There are a number of caveats with the training dataset. The dataset may include
nsSNPs predicted to be ‘disease’ where some of the nsSNPs may only be in linkage dis-
equilibrium with the phenotype in question and may themselves not be causative. This
‘pollutes’ the training set and may lead to a higher error rate and lower MCC. Further fil-
tering of the dataset would lead to a smaller but cleaner training set that could in turn lead
to lower error rates and an increase in the MCC. Further complications could arise where
molecular phenotypic changes that don’t result in a physical phenotype and unstudied or
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unobserved phenotypic changes may result in a nsSNP being classified as neutral that
should be classified as disease. Improvements to the system could also be made if SNPs
could be graded in terms of how damaging they are as opposed to the boolean states of
disease and polymorphism that currently classifies them, in time databases may contain
this information. Decision trees were used to build models for predicting functional nsS-
NPs due to their easily interpretable rules. Running Weka with all available classifiers
and various configurations may identify a classifier that obtains improved accuracy.
Since completion of the nsSNP analysis, a number of further studies have been per-
formed, thirteen of which cited the work in this thesis. Work has included a study focus-
ing on 686 sequence based attributes (Hu & Yan, 2008) using a similar approach to that
taken in this thesis. Performance was similar to results achieved in this study. Further
work by Tian et al. (2007) created an SVM based application called Parepro which in-
cluded sequence and evolutionary information surrounding a nsSNP and did not include
structural attributes. A novel structure-based approach, Bongo (Bonds ON Graph), was
introduced whereby protein structures were considered as residue-residue interaction net-
works (Cheng et al., 2008). Graph theoretic approaches were applied to identify residues
that are critical for maintaining structural stability within the network. The effect of a
nsSNP change could then be evaluated. Performance was comparable to commonly used
PolyPhen (Sunyaev et al., 2001) and Panther (Thomas et al., 2003) approaches. A study
by Care et al. (2007) aimed to quantify effects of the different approaches used in the
field. They concluded that the SWISSPROT training datatset used in this study was the
preferred training dataset to date and some of the conclusions were based on findings from
this thesis.
Reassuringly, previously observed trends can be seen in this study of a large num-
ber of nsSNPs. Disease nsSNPs tend to affect protein stability (Wang & Moult, 2001),
are buried (Stitziel et al., 2004) and often disrupt a conserved residue (Saunders &
Baker, 2002). This work extends previous work by addressing the problems of imbal-
ance and redundancy within the attributes for a large selection of natural nsSNPs and
then goes on to make predictions on all Ensembl nsSNPs. Saunders & Baker (2002)
and Bao & Cui (2005) showed that in the absence of a conservation score, structural
Chapter 2. nsSNP function analysis 67
attributes are valuable predictors. Here it is affirmed, using machine learning meth-
ods that the sequence conservation measure is the most powerful single predictor and
it has been shown that a high level of accuracy is achieved using the conservation score
alone. It has also been shown that structural attributes in combination with the conser-
vation score improves prediction accuracy but also that there are other non structurally
dependent attributes that can reduce the error rate further and are valuable in the ab-
sence of a conservation score. The performance of all attribute subsets however, is very
much dependent on how the datasets are configured. The maximum prediction accu-
racy can be achieved by combining all attributes of the nsSNP within a balanced dataset.
The predictions based on all of these learnings are available for public use as a DAS
source http : //www.brightstudy.ac.uk/das help.html (Figure 2.3) and as an annota-
tion within the SNP function portal (Wang et al., 2006).
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Chapter 3
Protein function analysis
This chapter focuses on the performance of machine learning classifiers in predicting
function for distantly related protein sequences. Typically, two approaches are used to
address such a multi-class problem. The first involves adapting the algorithm to the multi-
class problem directly. An example of an algorithm that can be easily generalized to cope
with multi-class problems is the decision-tree classifier. The second approach involves
creating several two-class problems and a class is assigned based on the predictions ob-
tained from the two-class problems. This approach has the benefit of not requiring any
changes to the underlying algorithm. Examples of this approach include error-correcting
output codes (Dietterich & Bakiri, 1995) and pairwise classification (Fu¨rnkranz, 2002).
Here we experiment with a range of classifiers that implement varied approaches for ad-
dressing the multi-class problem.
Membership of a SCOP superfamily was used as a measure of functional relatedness
(Murzin et al., 1995). The SCOP database is a manually curated resource supported by
a host of automated methods to provide comprehensive and accurate descriptions of the
structural relationships between proteins where the structure is known. The relationship
between sequence structure and function is indefinite and a number of studies have shown
protein superfamilies within a single fold having diverse functions, an example being the
aldo-keta reductases, a large hydrolase superfamily, and the thiol protein esterases which
include the eye-lens and corneal crystallins (Hegyi & Gerstein, 1999). The TIM-barrel
fold is an extreme example of divergent evolution with the fold functioning as a generic
scaffold catalyzing 15 different enzymatic functions. Even at the superfamily level, there
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can be difficulty in inferring function from structure. An example can be seen in the
enolase superfamily where there are hundreds of sequences available. Known structures
of this superfamily catalyze eight different overall reactions (Gerlt et al., 2005). Despite
this, proteins in the same SCOP superfamily are believed to be related from structural
and other considerations and would therefore often be expected to have the same general
functional role. However, they include proteins which are very diverse at the level of
sequence similarity and for which relatedness would not be apparent from consideration
of sequence alone.
3.1 Protein function analysis methods
This study was restricted to large and diverse SCOP superfamilies, namely those with
more than 15 sequences that do not share more than 20% sequence identity. A range
of popular machine learning methods as implemented in the Weka workbench (Witten
& Frank, 1999) were employed and a web based clustered computing infrastructure was
built to enable rapid identification of optimal classifiers and configurations (Figure 3.1).
This tool parses and stores results in a MySQL database, whilst sending a summary to the
user by email. A sequence enrichment step was introduced in order to increase the number
of sequences available for training. The dataset provides a challenging benchmark but one
which is very relevant to enhanced genome annotation strategies.
3.1.1 Protein domain dataset
Two datasets were created for analysis; the first comprised domains from single domain
proteins exclusively and this was the main focus of this study. A second dataset included
domains from multi domain proteins. The inclusion of SCOP domains from multi domain
protein structures is useful for characterising domains but may present problems with the
functional characterisation of a protein. Namely, the function of a multi domain protein
(composed of 2 SCOP domains A and B for example) may not necessarily be the sum
of the functions associated with the individual constituent domains, A and B. However
including SCOP domains from multi domain protein structures does lead to many more
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Figure 3.1: Screenshot of the web based version of Weka, which is integrated with a computing
cluster.
examples.
Domain sequences were obtained from the Astral20 database which contains SCOP
domain sequences sharing less than 20% sequence identity (Brenner et al., 2000). Su-
perfamilies containing fewer than 16 domains at this level of sequence redundancy were
excluded. The datasets were split such that two thirds of instances from each superfamily
were used for training and the remaining one third of instances for testing the models.
3.1.1.1 Superfamily enrichment
The SCOP database provides a gold standard structural resource with reliable comprehen-
sive annotation, meaning that domains should be accurately classified at the level of su-
perfamily despite being diverse at the sequence level. The aim was to extend this diverse
set of domain sequences by including entries from sequence databases without known
structure and therefore missing SCOP annotation. The reason for this was to boost the
numbers of instances available for training the machine learning algorithms. It was nec-
essary to be cautious, however, because if very remote relatives were included there was
a danger they may not actually be part of the same superfamily. Sillitoe et al. (2005) have
previously described an approach to recruit sequences into CATH domain superfamilies.
The following steps were performed to enrich the number of examples in each super-
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family:
• A BLAST (Altschul et al., 1997) search using each of the domain sequences from
the diverse SCOP superfamilies was performed against the UniRef50 subset of the
Uniprot database (Apweiler et al., 2004).
• In order for a hit to be retained, the E value had to be <0.0005.
• Hits were excluded where <80% of the domain was aligned
• Hits were also excluded where the length of the aligned section of the UniRef50 hit
was <80% of the length of the aligned section of the domain (to exclude hits that
had long gaps within the alignment.)
• UniRef50 hits were further excluded that matched domains of more than one super-
family in order to reduce ambiguity in superfamily membership of the hit.
• BLASTClust (Dondoshansky, 2002) was then run against the resulting SCOP do-
mains and UniRef50 hits for each superfamily to remove redundancy. For each
cluster the SCOP domains were retained as the cluster representative when present.
• Results were compared where BLASTClust was used to remove redundant se-
quences at >20% and then >30% sequence identity. BLASTClust was set at these
levels of sequence identity because below 25% similar function can not confidently
be inferred by sequence alone (Wilson et al., 2000). It was considered that 30% was
a conservative cutoff where similar function could be more confidently inferred. At
a cutoff of 20%, confidence in assumption of function was lower but it was consid-
ered to be of interest to compare to the 30% cutoff.
3.1.2 Protein domain features
Attributes selected for machine learning were based upon the properties explored by
Dubchak et al. (1995) who analysed protein folds in the context of the SCOP classifi-
cation. These attributes relate to the hydrophobicity, Van der Waals volume, polarity,
polarizibility and predicted secondary structure of the amino acid sequence. The sec-
ondary structure (C=Coil, H=Helix, E=Strand) was predicted using PSIPRED (McGuffin
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et al., 2000). Each amino acid was labelled as belonging to one of three groups for each
of these descriptors (Table 3.1).
Property Group1 Group2 Group3
Hydrophobicity Polar Neutral Hydrophobic
R,K,E,D,Q,N G,A,S,T,P,H,Y C,V,L,I,M,F,W
Normalized Van Der Waals 0-2.78 2.95-4.0 4.43-8.08
G,A,S,C,T,P,D N,V,E,Q,I,L M,H,K,F,R,Y,W
Polarity 4.9-6.2 9.0-9.2 10.4-13.0
L,I,F,W,C,M,V,Y P,A,T,G,S H,Q,R,K,N,E,D
Polarizibility 0.0.108 0.128-0.186 0.219-0.409
G,A,S,D,T C,P,N,V,E,Q,I,L K,M,H,F,R,Y,W
Secondary structure C=Coil H=Helix E=Strand
Amino acid composition n.a n.a n.a
Amino acid length n.a n.a n.a
Table 3.1: Properties of each domain sequence that were used as attributes to predict superfamily
membership using machine learning classifiers (n.a = not applicable). (The first 5 properties were
taken from Dubchak et al. (1995))
All descriptors were analyzed in the context of their composition, distribution and
transition along the amino acid sequence. Taking hydrophobicity as an example, the
composition element comprised three attributes; the percentage composition of polar (P),
neutral (N), hydrophobic (H) amino acids in the domain sequence. The transition was
also composed of three hydrophobicity related attributes; the percentage frequency of P
followed by N or N followed by P, the percentage frequency of P followed by H or H
followed by P and the percentage frequency of N followed by H or H followed by a N.
The distribution comprised 15 hydrophobicity related attributes describing the amino acid
sequence in terms of the proportion of the length of the domain sequence that contained
the first, 25%, 50%, 75%, 100% of each of the groups of amino acids (P, N or H). In
addition to these previously studied properties, the amino acid sequence length (bins of
length 20 amino acids) and amino acid composition were added as attributes. A total of
126 attributes were included in the machine learning analysis.
3.1.3 Machine learning
All machine learning analysis was performed using the Weka collection of tools and algo-
rithms (Witten & Frank, 1999). The models were evaluated on an independent test dataset
which comprised one third of the original non-enriched dataset.
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3.1.3.1 Single attribute analysis
In order to identify the most effective attribute in the machine learning prediction, the
1R classifying algorithm (Holte, 1993) and the information gain (IG) attribute evaluator
were used. The 1R classifying algorithm creates single level decision trees for each at-
tribute and measures the prediction error rate. The IG evaluator measures the information
required after using the attribute as a classifier subtracted from the information required
before using the attribute as a classifier. In both algorithms the attributes were ranked in
terms of their effectiveness as predictors using the default ranker search method (Witten
& Frank, 1999).
3.1.3.2 Attribute set analysis
The performance of 32 machine learning classifiers in a total of 96 configurations were
compared for the prediction of protein function based on assignment to one of 24 su-
perfamilies using 126 amino acid based sequence attributes (Appendix C, Table 7). The
clustered implementation of Weka (Witten & Frank (1999)) was used to rapidly identify
the optimal classifiers and configurations.
The enrichment process was assessed by comparing the performance using the non-
enriched resources and enriched resources using a BLASTClust cut-off of 20% and 30%
sequence identity. In order to assess the performance of the length of the domain as an
attribute, the prediction performances using all variables were compared with the perfor-
mance of all variables excluding the length of the domain sequence.
3.1.3.3 Measure of performance
The performance of the machine learning methods was assessed using the number of true
positives (TP), true negatives (TN), false positives (FP) and false negatives (FN).
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SCOP superfamilies chosen as classes in this study were specifically large diverse su-
perfamilies whose domains shared no more than 20% sequence identity. It is typically
difficult to classify members of such superfamilies using conventional sequence homol-
ogy methods.
To evaluate the performance of the machine learning approach, the results of the PSI-
BLAST program were compared with models built using the non-enriched datasets. PSI-
BLAST was run using a similar method to Melvin et al. (2007). A database of UniRef90
sequences was initially used to create profiles for each of the studied SCOP domain se-
quences (Wu et al., 2006). Each profile was then matched separately against a database
composed solely of the Astral20 proteins from the studied superfamilies. Matches with
an E-value < 0.0005 over 5 iterations were identified.
A definitive comparison of PSI-BLAST with a model created by an SVM (no sequence
enrichment) was difficult as various measures of performance could be used. For each
PSI-BLAST query, we observed the number of matches with SCOP domains from the
correct superfamily and incorrect superfamily using the defined threshold. We considered
a query to be correctly assigned to a superfamily (TP) when the number of hits to domains
from the true superfamily exceeded the number of hits from a false superfamily. We
acknowledge that this approach is biased due to the size of the superfamily, but think
that it is typical of the kind of approach taken when a user attempts to assign functional
annotation.
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3.2 Protein function analysis results
3.2.1 Protein domain datasets
Two datasets were created for analysis, a primary dataset comprising domains from single
domain proteins only and a secondary dataset which included domains from multi domain
proteins.
The exclusion of multi domain protein sequences in the single domain dataset reduced
the number of domains included in the analysis from 4931 to 2867 (contained within 1136
superfamilies). Excluding superfamilies that contained fewer than 16 domains at this level
of sequence redundancy further reduced the number of domains included to 573 contained
within 24 superfamilies (columns 1 and 2 in Appendix B, Table 1). For the second dataset
(which included domains from multi domain proteins), excluding superfamilies that con-
tained fewer than 16 domains resulted in 1448 domains contained within 49 superfamilies
(columns 1 and 2 in Appendix B, Table 2).
3.2.1.1 Superfamily enrichment
Increasing the number of diverse sequence examples in the training datasets involved
taking entries from UniRef50 that showed distant homology yet similar function to a
domain sequence within the superfamily being studied (Wu et al., 2006). Appendix B
Tables 1 and 2 show the number of instances per superfamily in the single and multi
domain training datasets before and after the enrichment process using BLASTClust at
20% and 30% redundancy. The periplasmic binding protein-like II superfamily (id 53850)
exhibited the biggest increase (10.38 fold single domain, 10.13 fold multi domain) in the
number of instances after enrichment and the restriction endonuclease-like superfamily
(52980) had the smallest increase (1.15 fold single domain, 1.13 fold multi domain).
3.2.2 Machine Learning
3.2.2.1 Single attribute analysis
The top ten attributes in the non-enriched datasets and at levels of 20% and 30% enrich-
ment when using both the 1R and IG algorithms comprised attributes relating to the com-
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position, transition and distribution of secondary structure elements (coil, helix, strand)
and the length of the domain. The domain length was in the top 5 attributes in all but one
training set and algorithm combination.
3.2.2.2 Attribute set analysis
3.2.2.3 Single domain dataset
Generally performance of the classifiers in both the single and multi domain datasets
improved with the increasing level of enrichment in the training datasets. Best performing
classifiers in the single domain dataset were the END classifier achieving 64.2% correctly
classified instances on the non-enriched dataset, AdaBoostM1 obtaining 64.2% correctly
classified instances on the dataset enriched at a level of 20% and LibSVM achieving
66.3% correctly classified instances with a dataset enriched at a level of 30%. END is
a meta classifier for handling multi-class datasets with 2-class classifiers by building an
ensemble of nested dichotomies (Dong et al., 2005). AdaBoostM1 is a class for boosting a
nominal class classifier using the Adaboost M1 method (Freund & Schapire, 1996). When
excluding the domain length as an attribute, the best performing classifier was the END
classifier obtaining 64.2% correctly classified instances using the 30% enriched training
dataset.
The classifiers varied greatly in predicting each superfamily. Table 3.2 shows the
performance per superfamily in the single domain dataset using the best performing Lib-
SVM classifier and 30% enrichment. The model achieved the best performance in pre-
dicting membership to the ARM repeat superfamily (id 48371) (all alpha proteins class
(id 46456)) with an F-measure of 0.91. The poorest performing superfamily was the
nucleotide-diphospho-sugar transferases superfamily (id 53448) (alpha and beta proteins
class a/b (id 51349)) with an F-measure of 0.
3.2.2.4 Multi domain dataset
There were 49 superfamilies (1448 domains) that had more than 15 domains within As-
tral20 when including multi domain proteins. Appendix B Table 3 shows the SCOP class
and fold membership for the 49 superfamilies. The class alpha and beta proteins a+b (id
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Superfamily Precision Recall F-Measure
46458 a.1.1 sf Globin-like 0.8 0.8 0.8
46689 a.4.1 sf Homeodomain-like 0.67 0.67 0.67
46785 a.4.5 sf Winged helix DNA-binding do-
main
0.77 0.83 0.8
47266 a.26.1 sf 4-helical cytokines 0.86 0.75 0.8
48371 a.118.1 sf ARM repeat 1 0.83 0.91
49785 b.18.1 sf Galactose-binding domain-
like
0.75 0.5 0.6
49899 b.29.1 sf Concanavalin A-like
lectins/glucanases
0.67 0.57 0.62
50249 b.40.4 sf Nucleic acid-binding protein 0.57 0.89 0.7
50729 b.55.1 sf PH domain-like 0.75 0.5 0.6
51182 b.82.1 sf RmlC-like cupins 1 0.2 0.33
88633 b.121.4 sf Positive stranded ssRNA
viruses
0.57 0.8 0.67
51445 c.1.8 sf (Trans)glycosidases 1 0.43 0.6
51735 c.2.1 sf NAD(P)-binding Rossmann-
fold domains
0.8 0.67 0.73
52540 c.37.1 sf P-loop containing nucleoside
triphosphate hydrolases
0.52 0.76 0.62
52833 c.47.1 sf Thioredoxin-like 0.86 0.67 0.75
52980 c.52.1 sf Restriction endonuclease-like 1 0.14 0.25
53335 c.66.1 sf S-adenosyl-L-methionine-
dependent methyltransferases
0.35 0.46 0.4
53383 c.67.1 sf PLP-dependent transferases 0.78 0.88 0.82
53448 c.68.1 sf Nucleotide-diphospho-sugar
transferases
0 0 0
53474 c.69.1 sf alpha/beta-Hydrolases 0.75 0.82 0.78
53850 c.94.1 sf Periplasmic binding protein-
like II
0.55 0.86 0.67
55729 d.108.1 sf Acyl-CoA N-
acyltransferases (Nat)
0.56 0.71 0.63
57059 g.3.6 sf omega toxin-like 0.8 0.57 0.67
57095 g.3.7 sf Scorpion toxin-like 0.63 0.83 0.71
Table 3.2: Performance in predicting the 24 SCOP superfamilies (excluding multi domain proteins)
using Support Vector Machines (LibSVM) with enrichment at a redundancy cutoff of 30%.
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53931) is better represented in this analysis.
The same configurations and evaluation method were applied to this dataset. Best per-
forming classifiers for each dataset were AdaBoostM1 achieving 48.5% correctly classi-
fied instances using the non-enriched dataset, END obtaining 53.7% correctly classified
instances on the training dataset enriched at 20%, and AdaBoostM1 achieving 55.6% on
the training dataset enriched at 30%. The results of machine learning for each superfamily
using AdaBoostM1 and enrichment at sequence identity of 30% can be seen in Table 3.3.
When excluding the domain length as an attribute, the best performing classifier obtained
54.8% correctly classified instances using the 30% enriched training dataset and the END
classifier.
Again, the success of the machine learning methods in predicting SCOP superfamily
varied greatly depending on the superfamily with F-measure ranging from 0 to 0.92. The
top performing superfamilies were the globin-like (id 46458) (all alpha protein class (id
46456)), and C2H2 and C2HC zinc finger (id 57667) (small proteins class (id 56992)) su-
perfamilies, both with an F-measure of 0.92. The ARM repeat superfamily (id 48371) still
performed well being ranked 4th in terms of F-measure (0.82). The poorest performing
superfamilies were the restriction endonuclease-like (id 52980), the nucleotidylyl trans-
ferase (id 52374) (both belonging to the alpha and beta proteins class a/b (id 51349)) and
the cysteine proteinases (id 54001) (Alpha and beta proteins a+b (id 53931)) superfami-
lies, all with F-measures of 0.
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Table 3.3: Performance in predicting the 49 SCOP superfamilies (anal-
ysis including multi domain proteins) using AdaBoostM1 with enrich-
ment at a redundancy cutoff of 30%.
Superfamily Precision Recall F-Measure
46458 a.1.1 sf Globin-like 0.86 1 0.92
46626 a.3.1 sf Cytochrome c 0.67 0.75 0.71
46689 a.4.1 sf Homeodomain-like 0.57 0.67 0.62
46785 a.4.5 sf “Winged helix” DNA-
binding domain
0.65 0.74 0.69
47266 a.26.1 sf 4-helical cytokines 1 0.38 0.55
47473 a.39.1 sf EF-hand 0.5 0.17 0.25
48371 a.118.1 sf ARM repeat 0.78 0.88 0.82
48726 b.1.1 sf Immunoglobulin 0.68 0.83 0.75
49265 b.1.2 sf Fibronectin type III 0.42 0.5 0.46
81296 b.1.18 sf E set domains 0.22 0.15 0.18
49503 b.6.1 sf Cupredoxins 0.67 0.5 0.57
49785 b.18.1 sf Galactose-binding
domain-like
0.57 0.8 0.67
49899 b.29.1 sf Concanavalin A-like
lectins/glucanases
0.57 0.73 0.64
50249 b.40.4 sf Nucleic acid-binding pro-
teins
0.38 0.3 0.33
50729 b.55.1 sf PH domain-like 0.55 0.6 0.57
51011 b.71.1 sf Glycosyl hydrolase do-
main
0.4 0.4 0.4
51182 b.82.1 sf RmlC-like cupins 0.67 0.67 0.67
88633 b.121.4 sf Positive stranded ssRNA
viruses
0.75 0.43 0.55
Continued on Next Page. . .
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Table 3.3 – Continued
Superfamily Precision Recall F-Measure
51445 c.1.8 sf (Trans)glycosidases 0.77 0.81 0.79
51569 c.1.10 sf Aldolase 0.67 0.33 0.44
51735 c.2.1 sf NAD(P)-binding
Rossmann-fold domains
0.5 0.7 0.58
51905 c.3.1 sf FAD/NAD(P)-binding do-
main
0.6 0.27 0.38
52317 c.23.16 sf Class I glutamine
amidotransferase-like
0.5 0.4 0.44
52374 c.26.1 sf Nucleotidylyl transferase 0 0 0
52540 c.37.1 sf P-loop containing nucleo-
side triphosphate hydrolases
0.36 0.49 0.42
52833 c.47.1 sf Thioredoxin-like 0.61 0.79 0.69
52980 c.52.1 sf Restriction endonuclease-
like
0 0 0
53067 c.55.1 sf Actin-like ATPase domain 0.43 0.33 0.38
53098 c.55.3 sf Ribonuclease H-like 0.56 0.63 0.59
53335 c.66.1 sf S-adenosyl-L-methionine-
dependent methyltransferases
0.39 0.36 0.37
53383 c.67.1 sf PLP-dependent trans-
ferases
0.7 0.88 0.78
53448 c.68.1 sf Nucleotide-diphospho-
sugar transferases
0.33 0.17 0.22
53474 c.69.1 sf alpha/beta-Hydrolases 0.42 0.62 0.5
53850 c.94.1 sf Periplasmic binding
protein-like II
0.38 0.75 0.5
56784 c.108.1 sf HAD-like 0.5 0.4 0.44
54001 d.3.1 sf Cysteine proteinases 0 0 0
Continued on Next Page. . .
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Table 3.3 – Continued
Superfamily Precision Recall F-Measure
54211 d.14.1 sf Ribosomal protein S5 do-
main 2-like
0.6 0.33 0.43
54236 d.15.1 sf Ubiquitin-like 0.71 0.83 0.77
54373 d.16.1 sf FAD-linked reductases, C-
terminal domain
1 0.6 0.75








55486 d.92.1 sf Metalloproteases
(“zincins”), catalytic domain
0.5 0.5 0.5
55729 d.108.1 sf Acyl-CoA N-
acyltransferases (Nat)
0.71 0.56 0.63
56672 e.8.1 sf DNA/RNA polymerases 0.8 0.8 0.8
57059 g.3.6 sf omega toxin-like 0.5 0.29 0.36
57095 g.3.7 sf Scorpion toxin-like 0.57 0.67 0.62
57196 g.3.11 sf EGF/Laminin 0.71 1 0.83
57667 g.37.1 sf C2H2 and C2HC zinc fin-
gers
1 0.86 0.92
57716 g.39.1 sf Glucocorticoid receptor-
like (DNA-binding domain)
0.71 0.71 0.71
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3.2.3 Benchmarking
Performance of PSI-BLAST and SVMs (using the non-enriched datasets) was very vari-
able, with the two methods often differing in performance for each superfamily (Appendix
B Tables 4 and 5). We found that 8 out of 24 superfamilies achieved a better F-measure
with SVMs in the single domain analysis and 10 out of 49 obtained a greater F-measure
in the multi domain analysis. F-measures were comparable for many other superfamilies,
especially in the single domain study. SVMs outperformed PSI-BLAST for all 5 of the
studied superfamilies from the small protein class (id 56992) as well as performing bet-
ter or comparably for superfamilies of the all alpha proteins class (id 46456). The mean
performance measures per superfamily are shown in Table 3.4.
SVM PSI-BLAST
Dataset Precision Recall F-Measure Precision Recall F-Measure
Single domain 0.64 0.61 0.61 0.96 0.6 0.7
Multi domain 0.5 0.41 0.42 0.95 0.57 0.67
Table 3.4: The mean precision, recall and F-measure per superfamily produced by SVMs and PSI-
BLAST using the unenriched datasets comprising 24 (domains from single domain proteins) and 49
superfamilies (including domains from multi domain proteins).
3.3 Discussion
The SCOP database provides a gold standard structural resource with reliable compre-
hensive annotation, meaning that domains should be accurately classified at the level
of superfamily despite being diverse at the sequence level. It is desirable to be able to
build machine learning models in order to be able to assign this functional annotation to
domains where the structure is unknown and function is difficult to infer by traditional
methods.
3.3.1 Superfamily enrichment
Machine learning methods benefit from having more training data. Our seed data sets,
namely 24 and 49 large and sequence diverse (no two sequences sharing more than 20%
sequence identity) superfamilies, provide a ‘ground truth’ since we know from SCOP
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(which uses structural and other considerations) that the proteins are in fact related. How-
ever, the datasets were somewhat limited in size and the question of how to extend them
was not trivial: adding very weakly related sequences detected by PSI-BLAST might
contaminate the superfamily by introducing proteins which in fact did not belong to the
superfamily; but being very restrictive with the cut off would only add more examples of
close homologs. We observed that the performance of the machine learning algorithms
improved when the SCOP superfamily datasets were enriched and that the percentage of
sequence similarity used as a cutoff in the enrichment process effected prediction perfor-
mance. The performance at the sequence identity cutoff of 30% was better than the lower
cutoff of 20%. At the 20% level there was the possibility of contamination and alignment
errors which would affect the predicted secondary structure attributes and may have led
to lower performance. It is expected that this step could improve performance if applied
to the many published fold prediction models (Ashburner et al., 2000; Ding & Dubchak,
2001; Lin et al., 2005; Shen & Chou, 2006; Melvin et al., 2007; Shamim et al., 2007;
Damoulas & Girolami, 2008)
3.3.2 Single attribute analysis
Attributes vary in their contributions to the predictions of superfamily membership in
the machine learning models. Jensen et al. (2002) previously concluded that secondary
structure was the most important descriptor in their protein function prediction study. This
study found predicted secondary structure was important for predicting function with the
composition, transition and distribution of secondary structure elements being the most
important attributes in the single attribute analysis. Jensen et al. (2002) concluded that
protein length was not a valuable attribute in their studies. However, we found that the
length of the sequence was a valuable attribute in the single attribute analysis for the
24 superfamilies of the single domain analysis. Figure 3.2 shows many superfamilies
display a clustering with regards to length in the non-enriched single domain resource.
All four domains over 550 residues belong to the ARM repeat superfamily (48371 a.118.1
sf), with the Importin beta domain (d1qgra a.118.1.1) being the longest domain (877
residues). However, when combining all attributes for use with the 32 applied classifiers
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the models still performed well following the exclusion of domain length as an attribute.
This suggests that the classifiers were not dependent on domain length as an attribute and
other sequence properties were important in accurately classifying superfamilies.
Figure 3.2: Domain sequence length for superfamilies from Astral20 that contain >15 domains
(excluding multi domain proteins). The length is grouped into bins of 20 amino acids. This figure
highlights the clustering of superfamilies by domain sequence length. The Importin beta domain
(d1qgra a.118.1.1) from the ARM repeat superfamily (48371 a.118.1 sf) is the longest domain (877
residues).
3.3.3 Attribute set analysis
3.3.3.1 Single domain dataset
In analysis of combined attributes in the single domain resource, the best performing clas-
sifier was LibSVM, obtaining 66.3% correctly classified instances in an independent test
set using a training dataset that was enriched at a level of 30% sequence identity. The
success of the machine learning methods in predicting SCOP superfamily varied greatly
depending on the superfamily (Table 3.2). The P-loop containing nucleoside triphos-
phate hydrolases (id 52540) and S-adenosyl-L-methionine-dependent methyltransferases
Chapter 3. Protein function analysis 85
(id 53335) had a large proportion of false positives. Thirty eight percent of instances be-
longing to the 53335 superfamily were classified as 52540 and 15% of 52540 instances
were classified as 53335 suggesting that there is some similarity between these super-
families or that the diversity of both groups means that classifying the two is difficult.
Both superfamilies belong to the same alpha and beta proteins (a/b) (id 51349) class but
are members of different folds within the SCOP classification. Figure 3.3 shows clearly
(black bordered squares) that when the model misclassifies an instance, it usually classi-
fies it correctly at the SCOP class level. This may reflect that the ‘predicted secondary
structure’ attribute facilitated the correct class assignment (the SCOP class level repre-
sents the overall secondary structure composition of the protein). The alpha and beta pro-
teins a/b (id 51349) class contains the largest number of superfamilies (10) in this study,
resulting in some misclassifications among the superfamilies that it contains. The poor-
est performing superfamilies, nucleotide-diphospho-sugar transferases (id 53448) and re-
striction endonuclease-like (id 52980), both belong to this class. The 52980 superfamily
also contains the smallest number of instances (15) in the training dataset enriched at
30%. The best performing superfamily, ARM repeat (id 48371), belongs to a class (all
alpha proteins (id 46456)) containing only 5 superfamilies from this study and has 50
instances in the 30% enriched training dataset. It might be expected that there would be
many misclassifications between the homeodomain-like superfamily (id 46689) and the
“winged helix” DNA-binding domain superfamily (id 46785) as both of these superfam-
ilies belong to the same SCOP fold (DNA/RNA-binding 3-helical bundle). Whilst 33%
of 46689 instances were misclassified as 46785, only 16% of 46785 instances were mis-
classified as 46689. This may be explained by the large number instances belonging to
the 46785 superfamily, 114 at 30% enrichment, compared to 35 for the 46689 superfam-
ily (Appendix B, Table 1). The larger number of instances may have resulted in a better
model being constructed. Therefore, it appears that the diversity of superfamilies at the
class level as well as the number of instances available for training affect the performance
of the classifiers.
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Figure 3.3: Superfamily confusion matrix produced by an SVM model with a dataset enriched at
30% sequence identity (excluding multi domain proteins). Each small square represents the percent-
age of domains belonging to the superfamily on the y axis (true superfamily) that were predicted to
belong to the superfamily on the x axis (predicted superfamily). The colour of each square relates to
the predicted percentage of total instances according to the colour ramp on the right of the matrix.
Black bordered squares represent the 5 classes that the 24 superfamilies are grouped into (Appendix
B, Table 6). This figure highlights the fact that when a domain is misclassified at the superfamily
level, it is usually correctly assigned at the class level within the SCOP hierarchy.
Axis labels:
(1) 46458 a.1.1 sf Globin-like, (2) 46689 a.4.1 sf Homeodomain-like, (3) 46785 a.4.5 sf ”Winged he-
lix” DNA-binding domain, (4) 47266 a.26.1 sf 4-helical cytokines, (5) 48371 a.118.1 sf ARM repeat, (6)
49785 b.18.1 sf Galactose-binding domain-like, (7) 49899 b.29.1 sf Concanavalin A-like lectins/glucanases,
(8) 50249 b.40.4 sf Nucleic acid-binding proteins, (9) 50729 b.55.1 sf PH domain-like, (10) 51182
b.82.1 sf RmlC-like cupins, (11) 88633 b.121.4 sf Positive stranded ssRNA viruses, (12) 51445 c.1.8 sf
(Trans)glycosidases, (13) 51735 c.2.1 sf NAD(P)-binding Rossmann-fold domains, (14) 52540 c.37.1 sf
P-loop containing nucleoside triphosphate hydrolases, (15) 52833 c.47.1 sf Thioredoxin-like, (16) 52980
c.52.1 sf Restriction endonuclease-like, (17) 53335 c.66.1 sf S-adenosyl-L-methionine-dependent methyl-
transferase, (18) 53383 c.67.1 sf PLP-dependent transferases, (19) 53448 c.68.1 sf Nucleotide-diphospho-
sugar transferases, (20) 53474 c.69.1 sf alpha/beta-Hydrolases, (21) 53850 c.94.1 sf Periplasmic binding
protein-like II, (22) 55729 d.108.1 sf Acyl-CoA N-acyltransferases (Nat), (23) 57059 g.3.6 sf omega toxin-
like, (24) 57095 g.3.7 sf Scorpion toxin-like
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3.3.3.2 Multi domain dataset
The inclusion of multi domain proteins resulted in there being over twice the number of
superfamilies available for study, with superfamilies from the alpha and beta proteins a+b
class (id 53931) being better represented (Appendix B, Table 3). The AdaBoostM1 clas-
sifier obtained 55.6% accuracy with a training dataset enriched at 30%. The classifiers
still performed well despite the increase in the number of superfamilies resulting from
the inclusion of domains from multi domain proteins. Again, the success of the machine
learning methods in predicting SCOP superfamily varied greatly depending on the super-
family (Table 3.3). The restriction endonuclease-like (id 52980), nucleotidylyl transferase
(id 52374) and cysteine proteinases (id 54001) superfamilies all performed poorly with
F-measures of 0. The top performing superfamilies were the globin-like (id 46458) and
C2H2 and C2HC zinc finger (id 57667) superfamilies. The globin-like (id 46458) super-
family was ranked 3rd in the single domain analysis whereas the C2H2 and C2HC zinc
finger (id 57667) superfamily was absent. The globin-like (id 46458) superfamily was
ranked 29th in terms of the fold increase in the number of instances after the enrichment
step at 30% and was ranked 35th in terms of the total number of instances after the en-
richment. The C2H2 and C2HC zinc finger (id 57667) superfamily was ranked 19th in
terms of the fold increase in the number of instances after the enrichment step at 30%
and was ranked 29th in terms of the total number of instances after the enrichment. It
therefore seems unlikely that performance was biased towards these superfamilies due to
imbalance in the dataset. Again, the P-loop containing nucleoside triphosphate hydro-
lases (id 52540) had a large proportion of false positives (64%). Additionally 23% and
30% of domains from the superfamily E set domains (id 81296) were misclassified as su-
perfamilies Immunoglobulin (id 48726) and fibronectin type III (id 49265) respectively.
Both superfamilies belong to Immunoglobulin-like beta-sandwich fold (id 48725) which
is part of the all beta proteins class (id 48724) and were excluded from the single domain
dataset.
Generally, similar patterns were observed in the single and multi domain datasets with
misclassifications at the superfamily level being correctly assigned at the fold or class
level. Superfamilies that performed best in both the single and multi domain analysis
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belonged to either the all alpha protein (id 46456) or small protein classes (id 56992).
Poorest performers belonged to the alpha and beta classes (a/b or a+b) (ids 51349, 53931).
3.3.4 Benchmarking
For most superfamilies, PSI-BLAST did not detect unrelated domains with scores better
than the threshold, although the program failed to detect all the possible correct matches
(ie to related domains). For these superfamiles, the definition of a correct assignment,
namely that the number of hits to domains from the true superfamily exceeded the num-
ber of hits from a false superfamily, meant that the precision was 1.0 leading to a high
F-measure. A more exacting requirement for confident classification would be the identi-
fication of multiple (ideally all) related domains with scores better than the threshold. As
an example, we describe the breakdown of PSI-BLAST results for 2 superfamilies. The
globin-like superfamily (id 46458) performed well within the PSI-BLAST results in the
single domain analysis (2nd top F-measure). Fourteen out of 15 domains in this super-
family were assigned to the true superfamily. However, of these 14, four were classified
based on single matches, that is PSI-BLAST only detected a match to one other protein
in the same superfamily. The “Winged helix” DNA-binding domain superfamily (46785)
produced relatively poor results with PSI-BLAST (F-measure 0.49). Of the 37 domains
within this superfamily, only 12 were assigned to the true superfamily. Matches for 5
of these 12 were based on single hits and the maximum number of correctly returned
domains for any query was 8. So, almost half of the assignments were not confident clas-
sifications. The comparison with PSI-BLAST for the detection of these remotely related
proteins shows that there are global sequence properties that can be used to successfully
classify domains from superfamilies, with the performance in many cases depending on
the class that the superfamily belongs to. As previously stated, a definitive comparison of
PSI-BLAST with a model created by an SVM (no sequence enrichment) was difficult as
various measures of performance could be used and performance of the models is further
improved when we use BLAST as part of the enrichment process.
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3.3.5 Summary
The protein universe does not contain only 24 or 49 superfamilies and we have not al-
lowed for this possibility. The approach we describe does not allow for an extra category
‘unknown superfamily’. One area of improvement would involve providing a method for
identifying an instance that does not belong to any of the studied (24 or 49) superfamilies.
This might evolve as a pre-process step. Additionally, the employed attributes are not ex-
pected to be optimal for detecting close sequence relationships for which good solutions
already exist.
Whilst the methods described here do not provide a complete solution for superfamily
prediction they show that machine learning methods that consider simple sets of global
sequences based attributes may be useful for suggesting superfamily membership and
hence narrow down the potential functional space, especially for superfamilies belonging
to all alpha (id 46456) and small protein classes (id 56992). This study shows that ma-
chine learning approaches to predicting SCOP categories can be improved by performing
a sequence enrichment step that exploits unannotated sequences within genomic sequence
databases. As such these approaches may complement profile methods for detecting dis-
tant relationships.
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Chapter 4
Combining protein-protein interaction
network and sequence attributes for
predicting hypertension related proteins
This chapter describes an exploratory study examining the properties of 65 proteins
listed as being associated with hypertension in the Online Mendelian Inheritance in Man
database (OMIM, Hamosh et al. (2002)). The performance of a classifier which includes
protein-protein interaction (PPI) network, sequence and GO attributes for the detection
of hypertension related candidate proteins is reported. Protein-protein interactions form
networks which can be explored using graph theoretic approaches. The networks can be
thought of as undirected cyclic graphs where the proteins are nodes and the interactions
are edges. If proteins A and B directly interact then there exists an edge connecting nodes
A and B.
4.1 Hypertension PPI and sequence analysis methods
4.1.1 Dataset
OMIM is a comprehensive catalogue of human genes and their associated genetic phe-
notypes. It provides a set of positive examples for machine learning approaches to build
classifiers for predicting disease genes. Each record in the OMIM database is associ-
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ated with a unique identifier which relates to a disease, the observed symptoms and the
associated genes. The symptoms field of each OMIM entry was parsed for the term ‘hy-
pertension’ and the results were manually filtered. The genes associated with OMIM
entries displaying hypertension as a symptom were then mapped onto their SWISSPROT
protein identifiers (Boeckmann et al., 2003).
4.1.2 Protein-protein interaction network properties
Protein-protein interactions involving hypertension related SWISSPROT identifiers were
extracted from the OPHID database (Brown & Jurisica, 2005). OPHID is an on-line
database of human protein-protein interactions built by mapping high-throughput model
organism data to human proteins. It also integrates data from yeast two-hybrid, literature-
based interaction and orthology-based interaction sources. The hypertension related
SWISSPROT proteins (nodes) present in OPHID are referred to as HTd (hypertension
dataset). One thousand datasets, each containing the same number of proteins as HTd
(65), were then generated by randomly selecting proteins (nodes) from OPHID, which
included the HTd proteins. We refer to this group of datasets as Rd1..1000.
In order to investigate the PPI properties relating to hypertension, a two step approach
was taken. Firstly, the ‘general topology’ of each HTd protein was investigated whereby
PPI properties of each HTd protein were investigated in relation to all surrounding pro-
teins. Secondly, network properties were investigated specifically in relation to other HTd
proteins (‘dataset topology’). Comparisons were made with the Rd1..1000 datasets. The
aim of this analysis was to identify whether HTd proteins were better connected than
random and whether any differences could be explained by their general background con-
nectivity. For example, can short distances between HTd proteins be explained through
HTd proteins being interaction hubs? A perl module (PPI.pm) was created that enables a
graph to be created and written to disk with the benefit that the graph structure does not
have to be created and read into memory each time a script is run. This saves a signifi-
cant amount of time when performing repeated graph theoretical analysis on large graph
structures.
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4.1.2.1 General topology
Degree of nodes: The mean degree (total number of edges associated with protein (p))
was calculated for OPHID as a whole, for HTd and Rd1..1000. This measure was then
extended to identify the number of proteins within a radius of 3 interaction steps from p
(figure 4.1).
Clustering coefficient: The clustering coefficient (C) for protein p is the number of links
between the proteins that directly interact with p divided by the number of links that
could possibly exist between them (if the directly interacting proteins were a clique).
This measure originates from Watts & Strogatz (1998) who used it to determine whether
a network was ‘small-world’. The clustering coefficient was calculated for each HTd and
each Rd1..1000 protein.
Figure 4.1: Illustration showing the number of proteins within a chosen radius of a selected hyper-
tension related protein (red node). A radius of 2 is shown as an example (greyed area), the blue and
green nodes are proteins falling within this radius. The blue node indicates that the protein is not
hypertension related whereas the green node indicates a hypertension related protein.
4.1.2.2 Dataset topology
Degree of nodes: The mean degree was recalculated for each dataset (HTd, Rd1..1000)
where only interactions with proteins from the same dataset were considered. This mea-
sure was then extended to identify the number of proteins from the same dataset within a
radius of 3 interaction steps (green nodes in figure 4.1).
Geodesic distance: The length of the shortest connecting path between each pair of HTd
proteins (HTd protein A to HTd protein B), and each pair of random proteins (Rdx protein
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A to Rdx protein B) was calculated using Dijkstra’s algorithm (Dijkstra, 1959).
Interaction subnetworks: We derived expanded subnetworks for each of the datasets,
using the approach of Chen et al. (2006), whereby all the proteins and their directly inter-
acting partners were selected. The proportion of all proteins from each of these expanded
subnetwork datasets that were contained within the largest connected component were
calculated. A connected component is a set of proteins whereby each protein can be
reached from any other protein via a combination of interaction steps.
4.1.3 Hypertension pathways and protein function
To investigate pathway properties of hypertension related proteins, proteins from HTd
were mapped to identifiers from the KEGG database (Kanehisa et al., 2006). We ex-
cluded the following KEGG identifiers that related to types of interactions as opposed to
pathways, although we are aware there is some subjectivity in this selection: ABC trans-
porters, phosphotransferase system (PTS), two-component system, neuroactive ligand-
receptor interaction, cytokine-cytokine receptor interaction, ECM-receptor interaction,
cell adhesion molecules (CAMs), aminoacyl-tRNA biosynthesis, type II secretion sys-
tem, type III secretion system, type IV secretion system, SNARE interactions in vesicular
transport, ubiquitin mediated proteolysis, proteasome, cell cycle - yeast. The distribution
of HTd proteins in the remaining pathways was investigated and compared to Rd1..1000.
The semantic similarity of Gene Ontology (GO) terms from each aspect (biological
function, molecular process and cellular location) was obtained for the HTd proteins using
the program G-Sesame (Wang et al., 2007). A GO term’s semantics (biological meanings)
are encoded into a numeric value by aggregating the semantic contributions of all their
ancestor terms in the GO graph. The similarity between GO terms is presented by aggre-
gating the semantic contributions of their shared ancestor terms over the sum of the GO
term semantic scores. An algorithm has been designed to measure the functional similar-
ity of two genes based upon the semantic similarities among the GO terms that annotate
these genes. The correlation between the semantic similarity of GO terms and geodesic
distance apart in the PPI network was then measured for pairs of HTd proteins.
GO slims are cut-down versions of the GO categories containing a subset of the terms
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in the whole GO. They give a broad overview of the ontology content without the detail
of the specific fine grained terms. The distribution of GO slim (Ashburner et al., 2000)
molecular functions and biological processes were studied in order to identify categories
that were over-represented or under-represented in hypertension proteins compared to the
Rd1..1000 datasets.
4.1.4 Classification
A machine learning approach was taken to predict hypertension related proteins using a
combination of attributes from the PPI and GO analysis, combined with physicochemical
properties of the protein sequences. The training dataset comprised the proteins contained
within Rd1..30 (1950 instances) and the HTd dataset (65 instances).
The selected attributes relating PPI network properties of each protein were: the
geodesic distance to the closest known HTd protein; the average and standard deviation of
distances from each HTd protein; the number of direct interactions; the number of direct
interactions with HTd proteins; the number of proteins up to 2 interactions away (up to
one intermediary); the number of HTd proteins up to 2 interactions away; the number of
proteins up to 3 interactions away (up to two intermediaries); the number of HTd proteins
up to 3 interactions away; Attributes relating to molecular function and biological process
were selected from GO slim categories that were found to be either over or underrep-
resented within the hypertension dataset, namely, ‘response to stimulus’ (GO:0050896),
‘electron transport’ (GO:0006118) and ‘oxidoreductase activity’ (GO:0016491). Physic-
ochemical properties for each protein sequence were calculated using the Protparam
program at Expasy (www.expasy.org). A bioperl (www.bioperl.org) module
(Bio::Tools::Protparam) was created specifically for this purpose. Sequence properties
used in the classifier were: amino acid length; number of negatively charged amino acids;
number of positively charged amino acids; molecular weight; theoretical pI; number of
carbon atoms; number of hydrogen atoms; number of nitrogen atoms; number of oxygen
atoms; number of sulphur atoms; half life; instability Index; stability class; aliphatic in-
dex; GRAVY; amino acid composition; The GRAVY (Grand Average of Hydropathy)
value for a peptide or protein was calculated as the sum of hydropathy values of all
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the amino acids, divided by the number of residues in the sequence (Kyte & Doolittle,
1982). Various feature selection methods were tested using the Weka workbench (Witten
& Frank, 1999) to remove redundancy and identify key attributes.
Because there was a large imbalance in the training dataset (many more random pro-
teins than hypertension proteins), a CostSensitive classifier (Witten & Frank, 1999) was
used as a wrapper around a Bagged PART classifier (Frank & Witten, 1998b; Breiman,
1996). A cost could then be applied for an incorrect HTd protein classification during ten
fold cross validation in an attempt to address the imbalance. This weighted approach has
been shown to be a succesful method for coping with class imbalance using a similar type
of classifier and has an advantage over undersampling in that there is no loss of informa-
tion (Chen et al., 2004). Choosing a cost depends on priorities. For example, a researcher
may be prepared to accept a high false positive rate (FPR) in order to obtain a high rate
of recall for hypertension related proteins. The classifier was run 400 times with a range
of cost matrices that applied varying penalties for incorrectly predicting a HTd protein
using a key set of attributes. The bagged PART classifier is a decision list classifier that
uses a separate-and-conquer approach. A partial C4.5 decision tree is built in each itera-
tion and the ‘best’ leaf is made into a rule. It performs well in terms of speed because no
postprocessing required. The runs were repeated using the simple majority-rule approach.
When benchmarking the classifier we wished to identify any sequence similar proteins
as some of our attributes are sequence based. BLASTClust (at a level of 25% identity)
(Dondoshansky, 2002) was used to identify sequence homologs within the HTd dataset.
4.2 Hypertension protein PPI and sequence analysis re-
sults
We isolated 96 hypertension related genes from OMIM, 90 of which could be mapped to
SWISSPROT identifiers. Where an OMIM id had multiple associated proteins, we made
the assumption that all were associated with hypertension and included them in the dataset
as there was insufficient evidence to assume otherwise. Of the 90 ids, 65 were present
within OPHID. These 65 proteins were associated with 47 diseases (distinct OMIM ids)
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where hypertension was recorded as a symptom. The average number of proteins per
OMIM id was 1.5. We refer to this dataset as HTd. The OPHID database used in this
study contained 48,222 interactions.
4.2.1 Network properties
4.2.1.1 General topology
Degree of nodes: The average degree (number of direct interactions associated with a
protein) for the whole of OPHID was 9.04. The HTd proteins had an average degree of
10.0615. The average degree for OMIM genes (that are present in OPHID) was 12.91.
The number of proteins within radii of 1 (degree), 2 and 3 interactions from each protein
is shown in the top row of quantile-quantile plots in Figure 4.2. The difference in distribu-
tions between HTd and Rd1..1000 was only marginally significant for direct interactions
(degree) and was not significant for interactions within radii of 2 and 3 interactions when
using the Wilcoxon rank sum test (p-values = 0.03, 0.09, 0.08 respectively), although
there were outiers in the Rd1..1000 proteins acting as hubs.
Clustering coefficient: Figure 4.3 shows the quantile-quantile plot of clustering coeffi-
cients (C) for HTd and Rd1..1000. If they come from similar distributions, the distribu-
tions should align. Wilcoxon rank sum test with continuity correction shows that they
come from the same distribution (p-value = 0.1085). However the Bartlett’s K-squared
test shows there is heterogeneity of variance (p-value = 0.001368) with the random genes
having a wider variance of C. In terms of interacting partners that are involved in no fur-
ther interactions (C=0), there was no significant difference between the two sets; 52.3%
HTd proteins and 39% of Rd1..1000 proteins (Chi-squared = 1.857 p-value = 0.1730).
There was no significant difference in the proportion of HTd and Rd1..1000 proteins that
only have a single interacting partner with 18 HTd proteins and an average of 18.86 across
the Rd1..1000 datasets.
4.2.1.2 Dataset topology
Degree of nodes: The second row of quantile-quantile plots in Figure 4.2 show the sub-
set of interactions within radii of 1 (degree), 2, 3 interactions that belonged to the same
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Figure 4.2: Quantile-quantile plots for the number of proteins up to a distance of 3 interactions away
from HTd and Rd1..1000 proteins. The top row plots relate to all interactions and the second row
plots limit to interactions with proteins belonging to the same dataset as the protein being studied.



























































































Axis definitions: rand 1 all, rand 2 all, rand 3 all - number of proteins within radii of 1, 2, 3 interactions
of each Rdx protein (x=1 to 1000); ht 1 all, ht 2 all, ht 3 all - number of proteins within radii of 1, 2, 3
interactions of each HTd protein; rand 1 rand, rand 2 rand, rand 3 rand - number of Rdx proteins within
radii of 1, 2, 3 interactions of each Rdx protein; ht 1 ht, ht 2 ht, ht 3 ht - number of HTd proteins within
radii of 1, 2, 3 interactions of each HTd protein.
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Figure 4.3: Quantile-quantile plot of clustering coefficients (C) for the HTd and Rd1..1000 proteins.
Wilcoxon rank sum test with continuity correction shows that they come from the same distribution
(p-value = 0.1085). ht=hypertension
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dataset as the protein p under study. These plots can be compared with the first row plots
displaying all interactions within similar radii. The difference in distributions between
HTd and Rd1..1000 for these subsets of interactions up to a radius of 3 interactions is sig-
nificant when using the Wilcoxon rank sum test (p-value = 2.49e-11, 3.842e-06, 0.0003
respectively). meaning there are larger numbers of HTd proteins surrounding any given
HTd protein than there are Rdx proteins surrounding Rdx proteins (within the radii up to
3 interactions).
Geodesic distance: Figure 4.4 shows the geodesic distance between each pair of HTd pro-
teins and each pair of proteins from Rd1..100. We limited to the first 100 random datasets
due to the computationally expensive process involved in calculating the distance. The
difference in the distribution of distances was significant (Wilcoxon rank sum p=0.004).
Fifteen out of 65 (23%) HTd proteins are directly connected. In comparison, on average,
only 3 out of every 65 (6%) Rd1..100 proteins are directly connected.
Interaction subnetworks: There were 623 proteins (646 interactions) in the dataset com-
prising the HTd proteins and their direct interaction partners. The average number of
proteins and directly interacting partners for the Rd1..1000 datasets was 583 (std 109).
The largest connected component in the expanded subnetwork involving the HTd pro-
teins and their direct partners contained 550 of the 623 proteins (88%). The size of this
subnet is in the upper 5% of the distribution over Rd1..1000 (Figure 4.5).
  






















Figure 4.4: Illustration showing the geodesic distances between HTd protein pairs and Rdx protein
pairs. Infinite relates to protein pairs that are unconnected, both directly and indirectly.
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Figure 4.5: The proportion of proteins in the largest connected component for HTd and each
Rd1..1000 expanded subnetworks. In the HTd expanded subnetwork, the largest connected com-
ponent contains 88% of the proteins. ht=hypertension
4.2.2 Hypertension pathways and protein function
The HTd proteins are spread across 36 KEGG pathways. Three (8%) of these pathways
contain 3 HTd proteins, 10 (28%) contain 2 HTd proteins and the remaining pathways
(64%) contain single HTd proteins. Table 4.1 shows the pathways that contain multiple
HTd proteins. By comparison, for the subset of 22 Rd1..1000 datasets that map to the
same number of pathways (36), only 3% of the pathways contain 3 proteins, 15% contain
2 proteins and 82% contain 1 protein. The clustering of HTd proteins in KEGG pathways
is significantly different to the pattern observed in the subset of Rd1..1000 datasets that
map to 36 pathways (Wilcoxon rank sum test p=0.02).
It was important to investigate the origin of the observed high level of connectivity in
‘dataset topological’ properties of the HTd dataset. HTd proteins that clustered in path-
ways were investigated to see whether they originated from the same OMIM record. For
those that did we noted the geodesic distance separating them. This might help iden-
tify any potential biases in the HTd dataset. Of the 3 pathways that each contain 3
HTd proteins, 2 pathways contain HTd proteins that map to the same hypertension re-
lated OMIM id. The first of these pathways is the human cell communication pathway
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Pathway ID Description No. of
HTd
proteins
path:dhsa00500 Starch and sucrose metabolism 3
path:dhsa01430 Cell Communication 3
path:dhsa04610 Complement and coagulation cascades 3
path:dhsa00052 Galactose metabolism 2
path:dhsa00140 C21-Steroid hormone metabolism 2
path:dhsa00561 Glycerolipid metabolism 2
path:dhsa00600 Sphingolipid metabolism 2
path:dhsa03320 PPAR signaling pathway 2
path:dhsa04350 TGF-beta signaling pathway 2
path:dhsa04630 Jak-STAT signaling pathway 2
path:dhsa04640 Hematopoietic cell lineage 2
path:dhsa04742 Taste transduction 2
path:dhsa05216 Thyroid cancer 2
Table 4.1: The KEGG Homo sapiens pathways containing multiple HTd proteins
(path:dhsa01430). An OMIM id (215600 Cirrhosis, familial) is shared between 2 of the
3 HTd proteins in this pathway. The respective proteins are: K1C18 HUMAN [P05783]
(Keratin, type I cytoskeletal 18 (Cytokeratin-18) and K2C8 HUMAN [P05787] (Keratin,
type II cytoskeletal 8 (Cytokeratin-8). These proteins are separated by a geodesic dis-
tance of 4. The second pathway containing 3 HTd proteins is the complement and co-
agulation cascades pathway (path:dhsa04610). Again, one OMIM id (235400 hemolytic
uremic syndrome) is shared between 2 of the 3 HTd proteins in this pathway. The pro-
teins are: CFAH HUMAN [P08603] (Complement factor H precursor (H factor 1)) and
MCP HUMAN [P15529] (Membrane cofactor protein precursor (Trophoblast leukocyte
common antigen)). The geodesic distance between these proteins is 2. Only 1 of the
10 pathways that contain 2 HTd proteins have proteins that map to the same hyperten-
sion related OMIM id. This pathway is the taste transduction pathway (path:dhsa04742).
The shared OMIM id is 177200 (Liddle syndrome). The 2 proteins in this pathway that
share this OMIM id are: SCNNB HUMAN [P51168] (Amiloride-sensitive sodium chan-
nel subunit beta (Epithelial Na(+) channel subunit beta)) and SCNNG HUMAN [P51170]
(Amiloride-sensitive sodium channel subunit gamma (Epithelial Na(+) channel subunit
gamma)). These proteins directly interact in the PPI network.
There was not a strong correlation between GO semantic similarity and geodesic dis-
tance for HTd protein pairs. Correlations were calculated for each aspect of GO (molec-
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ular function, biological process and cellular component).
Most of the HTd proteins fall into GO slim categories binding (GO:0005488), pro-
tein binding (GO:0005515) and catalytic activity (GO:0003824). The difference in the
overall distribution of GO slim biological process categories between hypertension and
Rd1..1000 proteins is significant (p-value = 0.01554) whereas the distribution of molec-
ular function GO slim categories is not (p-value = 0.5369). In terms of biological pro-
cesses, specific GO slim categories ‘response to stimulus’ (GO:0050896) and ‘electron
transport’ (GO:0006118) are overrepresented within the hypertension dataset with p =
0.005277 and p = 0.0009852 repectively. In terms of molecular functions, ‘oxidoreduc-
tase activity’ (GO:0016491) is overrepresented within the hypertension dataset (p-value
= 0.01219). These categories are still significantly overrepresented following the removal
of 3 homologs in HTd.
4.2.3 Classification
The CfsSubsetEval evaluator used with the BestFirst search method identified seven key
attributes: percentage amino acid composition of G; percentage amino acid composi-
tion of K; the geodesic distance to the closest HTd protein; the standard deviation of the
geodesic distances to each HTd protein; whether the protein belonged to GO slim cate-
gories ‘response to stimulus’ (GO:0050896) and ‘electron transport’ (GO:0006118); the
number of direct connections with HTd proteins. The BestFirst approach searches the
space of attribute subsets by greedy hillclimbing augmented with a backtracking facility
(Witten & Frank, 1999). The CfsSubsetEval evaluator calculates the worth of a subset of
attributes by considering the individual predictive ability of each feature along with the
degree of redundancy between them. Subsets of features that are highly correlated with
the class while having low intercorrelation are preferred (Hall, 1998). The Bagged PART
classifier was run 400 times over a range of penalties (using a cost matrix) for incorrectly
predicting a HTd protein using the 7 key attributes. The runs were repeated using the
simple majority-rule approach but the TPR never exceeded the FPR. Figure 4.6 shows
the true positive rate (TPR) plotted against the false postive rate (FPR) when predicting
hypertension proteins.
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Figure 4.6: Illustration showing the true positive rate [TPR] against false positive rate [FPR] when
predicting hypertension proteins using a weighted Bagged PART classifer. The penalty for an incor-
rect prediction was varied by using a CostSensitive classifier
BLASTClust (at a level of 25% identity) (Dondoshansky, 2002) showed that the HTd
dataset was not heavily populated with sequence homologs. Only 2 pairs of proteins were
found to share more than 25% identity. The first protein pair was: SCNNB HUMAN
[P51168] (Amiloride sensitive sodium channel subunit beta) and SCNNG HUMAN
[P51170] (Amiloride sensitive sodium channel subunit gamma). These proteins shared
34% sequence identity (E=3e-102). The second protein pair was: C11B1 HUMAN
[P15538] (Cytochrome P450 11B1, mitochondrial precursor) and C11B2 HUMAN
[P19099] (Cytochrome P450 11B2, mitochondrial precursor). These proteins shared 85%
sequence identity (E=0.0). All proteins were included in the machine learning classifica-
tion.
4.3 Discussion
This study found there to be little difference in the general background topological proper-
ties of HTd and Rd1..1000 proteins in protein-protein interaction networks. Hypertension
related proteins do not form large hubs and they do not display high cluster coefficient
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(C) scores. Previous studies including Rual et al. (2005); Stelzl et al. (2005); Jonsson
& Bates (2006b); Xu & Li (2006) have suggested that disease genes were likely to form
hubs. However, Goh et al. (2007) recently suggested that these studies included ‘essen-
tial’ genes in which any mutations are lethal. Once these genes had been excluded it was
shown that the remaining ‘non-essential’ disease genes did not tend to form hubs. HTd are
likely to be ‘non-essential’ genes and our findings are consistent with Goh et al. (2007).
OMIM has an average degree of 13 which is higher than the hypertension proteins (10)
and OPHID (9), possibly because OMIM includes these ‘essential’ disease genes.
Despite the insignificant differences in background network topology, we find that
HTd proteins display greater connectivity in relation to each other than we might expect.
HTd protein pairs exhibit shorter geodesic distances than random and the largest expanded
subnet size lies within the top 5% of the distribution for the random datasets. This means
that 88% of the proteins are connected (directly or indirectly) when a network is created
using HTd proteins and their direct partners. It is similar to previously observed distri-
butions in Alzheimers disease proteins where the largest subnet contained 83% of the
proteins (Chen et al., 2006). There is also a significant difference from random in the
number of HTd proteins within a radius of 3 interactions from any other HTd protein.
The HTd proteins are spread over 36 KEGG pathways, reflecting the complex, locus
rich nature of hypertension related proteins. We might have expected to see HTd proteins
that cluster in the same pathway to have originated from the same OMIM id and be close
in the PPI network. We found that this was not always the case. The proteins were usually
associated with different diseases where hypertension was a symptom. Where proteins
shared a pathway, originating from the same OMIM id, only 1 of the 3 HTd protein pairs
were directly connected.
We expected to see a negative correlation between distance separating two HTd pro-
teins in the PPI network and GO semantic similarity. However, we were unable to show
this correlation in our dataset. The difference in the distribution of GO slim biological
process categories between HTd proteins and the Rd1.1000 was significant. There were
a number of notable molecular function and biological process categories that were over-
represented in the hypertension dataset, namely ‘response to stimulus’ (GO:0050896),
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‘oxidoreductase activity’ (GO:0016491), ‘nucleic acid binding’ (GO:0003676).
There are caveats with the OMIM hypertension dataset, the OMIM database is the
most complete repository of diseases and their associated genes but of course it is not
complete and is updated all the time. There was concern that the increased connectiv-
ity of the HTd proteins may be due to biases in the PPI resource. We might expect the
hypertension related proteins to have been studied more than the randomly selected pro-
teins and therefore to see a larger number of documented interactions. However, if this
were the case, we would have expected more of them to be hubs. Potential interaction
biases could be further investigated by considering interactions, such as those from high
throughput experiments, separately. Because the sources of OPHID interactions vary in
their reliability, we created a second weighted network, retaining the same proteins and
interactions but assigning a weight (or distance) to each interaction in a similar manner
to Chen et al. (2006). In this weighted network, proteins were separated by a distance
relating to annotation confidence. Interactions with high quality annotation retained their
default distance of 1, medium quality interactions were separated by a distance of 1.5
and low quality interactions a distance of 2. We then repeated the relevant analyses. Our
results did not show significant trend differences to the unweighted analyses with respect
to GO semantic similarity and geodesic distance correlations.
The methods described here could easily be applied to other disease datasets in
OMIM. The hypertension dataset itself would be improved with the addition of validated
hypertension related proteins. However, the model constructed shows that there are pat-
terns within PPI networks, shared function and sequence based properties that can be used
to aid prioritisation of candidate gene lists identified through experiments such as genome
wide association studies. We anticipate that machine learning analyses that combine such
attributes will be useful in helping to characterise disease related genes in future studies.
Chapter 5. PPI networks associated with cardiovascular disease and cancer 106
Chapter 5
Protein interaction networks associated
with cardiovascular disease and cancer:
shared network properties
The work in this chapter compares the protein-protein interaction network properties of
two major diseases, cardiovascular disease (cvd) and cancer. For both diseases there are
large curated datasets available. The study focuses on two sets of network descriptors,
namely network centralities and network clusters. Centrality measures can be used to
identify influential nodes in a graph and clustering analysis describes the organisation
of the network on a number of levels and can be used to define functional modules and
pathways in biological networks. Three measures of centrality were considered: degree
centrality which simply counts the number of edges connected to a vertex; closeness cen-
trality which considers communication to all other nodes by making use of the length of
shortest paths to all nodes from a given node and betweenness centrality which ‘mea-
sures’ how much a node is involved in communication within the network, by identifying
the number of shortest paths between pairs of nodes that pass through such a node. This
measure identifies ‘bottlenecks’ within the network. The degree centrality only captures
the local neighbourhood topology of a network and hence the influence of direct neigh-
bouring proteins, whereas betweenness also captures the indirect influences of proteins
distal to the subject protein. Betweenness is therefore a measure of importance within
the wider context of the network. High betweenness and low degree has previously been
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used to define the ‘modularity’ of various networks (Girvan & Newman, 2002; Guimera`
& Amaral, 2004; Joy et al., 2005). In addition to centrality, the following clustering prop-
erties were explored (i) whether proteins involved in cvd and cancer tended to be part of
complex or simple processes, (ii) whether these processes are small or large, (iii) how
the disease proteins are distributed across the processes and (iv) how many of the dis-
ease proteins are bridges between communities and therefore acting as interfaces between
biological processes. A combination of centrality measures and clustering were used to
describe the interactome topology of these diseases and demonstrate an approach that
could be used to aid prioritisation of candidate genes.
5.1 PPI analysis methods
5.1.1 Dataset
Proteins thought to be implicated in cardiovascular disease were taken from the Vascu-
lar Disease 50k SNP Array Consortia chip (http://bioinf.itmat.upenn.edu/
cvdsnp/query.php) (Keating et al., 2008). Proteins on this chip were carefully se-
lected as potential candidates for cardiovascular disease using information from quanti-
tative trait loci studies, consideration of pathways important to vascular disease and the
biomedical literature. The proteins were split into three categories: priority 1 proteins
included significant known mediators of vascular disease and key findings from whole
genome association studies (602 proteins). The two other categories included more spec-
ulative assignments (2015 priority 2 and 494 priority 3 proteins). We mapped these pro-
teins onto a set of human PPI from the PIP webserver created by Jonsson & Bates (2006a)
using an orthology based approach applied to the RefSeq dataset (Pruitt et al., 2007).
The cancer dataset came from a census conducted from the literature of genes that are
mutated and causally implicated in cancer development (‘cancer genes’) (Futreal et al.,
2004). Futreal et al. (2004) had mapped these cancer proteins onto their PPI dataset.
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5.1.2 Measures
The PPI network was considered as an undirected graph G = (V,E), v ∈ V, e ∈ E where
the proteins are nodes (v) and the interactions are edges (e), with edge em,n connecting
nodesm and n. We considered the following three measures of centrality using the Python
package NetworkX (https://networkx.lanl.gov):
Degree centrality: the number of edges connected to a vertex were counted and nor-
malised by dividing by the total number of possible interactions that could be made, that
is the number of nodes minus one.
Closeness centrality: This could only be calculated for nodes belonging to the same
connected component, the shortest path length for unconnected nodes is infinity. If









Shortest Path Betweenness centrality: In the following, let σmn denote the number of
shortest paths between verticesm to n and σmn(ν) be the number of shortest paths from m
to n that pass through ν (Junker & Schreiber, 2008). The rate of communication between
m and n involving ν is given by δmn(ν) = σmn(ν)/σmn. The shortest path betweenness







The average degree centrality was calculated for nodes associated with cancer and cvd
to examine the hub like properties of disease associated proteins. The nodes of the human
interactome were then ranked according to the three measures of centrality and identified
putatively functionally important nodes in the interactome.
Following Jonsson & Bates (2006a), but also using the much larger cvd dataset, net-
work clustering was investigated through the community structure with the Cfinder algo-
rithm (Adamcsek et al., 2006). This program uses the k-clique clustering method which
defines communities in terms of overlapping cliques. A k-clique is a set of k nodes where
there is an interaction between each pair of nodes. Cfinder identifies communities as the
Chapter 5. PPI networks associated with cardiovascular disease and cancer 109
union of k-cliques in which k-1 nodes are shared. Communities were identified at vari-
ous k-values and the proportion of the member proteins that were cvd or cancer related.
Generally at low values of k we would expect a large number of extensive communities
of less tightly connected proteins with a large overlap. For higher k values fewer, more
distinct communities appear. Analysis of the community structure identifies bridge nodes
as nodes belonging to more than one community. These may participate in multiple pro-
cesses and act as interfaces between processes.
5.2 Cardiovascular disease and cancer PPI analysis re-
sults
In total, there are 17,039 RefSeq protein IDs (108,113 interactions) in the PPI dataset
(Jonsson & Bates, 2006a). We were able to map 2,249 cvd implicated protein IDs to
this dataset, 19% being cvd priority 1 proteins, 63% cvd priority 2 and 18% cvd priority
3 (Keating et al., 2008). Within the network, 439 protein IDs were annotated as being
cancer from the cancer census (Futreal et al., 2004). The number of cvd proteins mapped
to the PPI network was therefore approximately 5 fold greater than the number of mapped
cancer proteins. Of the cancer RefSeq proteins IDs mapped to the PPI dataset, 120 (27%)
were also proteins implicated in cvd. Of these proteins, 28 were cvd priority 1 proteins.
5.2.1 Centrality
The betweenness, closeness and degree centrality measures were calculated for each pro-
tein within the PPI network. The average number of interactions (degree) for cvd priority
1 proteins was 19.6, cvd overall was 15.7 and cancer proteins was 22.6 (table 5.1). There
is a notable difference between the average degree of cvd priority 1 proteins (19.6) and cvd
priority 2/3 proteins (6.0). The distribution of each of the normalised centrality measures
are shown in Figure 5.1. The distribution of betweenness and degree centrality values
differ significantly when comparing each of the disease datasets against the non disease
dataset using the Wilcoxon rank sum test. In general, the degree and betweenness values
follow an exponential distribution and the closeness centrality conforms to a normal dis-
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tribution. Using the probability density function we were able to calculate the probability
for each centrality score. The proteins displaying ‘high centrality’ (p<0.05), particularly
degree and betweenness centrality, are enriched approximately 2 fold with cancer and cvd
proteins. Specifically, 24%, 26% and 18% of cvd proteins displayed high betweenness,
degree and closeness centrality and 6%, 7% and 6% of cancer proteins displayed high
betweenness, degree and closeness centrality. This compares to total presence in the in-
teractome of 13% for cvd and 3% for cancer. Table 5.2 shows the ‘top 10’ proteins for
each centrality measure, it shows that 29% of these are currently annotated as cvd pro-



















































































































































































































































































































Figure 5.1: The (a) betweenness, (b) closeness and (c) degree centrality distributions for each stud-
ied subset of proteins. Cancercvdpr1 = proteins annotated as both cancer and cvd priority 1, cancer-
cvd=proteins annotated as both cancer and cvd.
cvd non cvd cvdpr1 non cvdpr1 cancer non cancer
Average degree 15.7 6.4 19.6 6.0 22.6 9.9
Table 5.1: Connectivity of proteins: Average degree of cardiovascular (cvd), cvd priority 1 (cvdpr1)
and cancer proteins.




















Description (RefSeq Peptide ID) cancer cvd cvd pr1 bc dc cc OMIM Morbidity description
Filamin-A (Endothelial actin-binding protein) (NP 001447) y y y
Actin, cytoplasmic 1 (Beta-actin)(NP 001092) y y Dystonia, juvenile-onset
Alpha-actinin-2 (NP 001094) y y
60 kDa heat shock protein, mitochondrial precursor (Heat shock protein 60) (NP 002147) y y Spastic paraplegia 13, autosomal dominant
Calmodulin (NP 001734) y y y
Cell division protein kinase 3 (NP 001249) y y
Importin subunit alpha-7 (Karyopherin subunit alpha-6) (NP 036448) y
Transportin-1 (Importin beta-2) (Karyopherin beta-2) (NP 002261) y
Heat shock 70 kDa protein 1 (NP 005337) y y y
UDP-N-acetylglucosamine–peptide N-acetylglucosaminyltransferase 110 kDa subunit (NP 858058) y
Guanine nucleotide-binding protein G(k) subunit alpha (G(i) alpha-3) (NP 006487) y
Guanine nucleotide-binding protein subunit alpha-11 (G alpha-11) (NP 002058) y
Guanine nucleotide-binding protein G(i), alpha-2 subunit (NP 002061) y y y
Guanine nucleotide-binding protein G(q) subunit alpha (NP 002063) y y
Glucose-fructose oxidoreductase domain-containing protein 2 precursor (NP 110446) y
Transcriptional enhancer factor TEF-3 (NP 958849) y
Glycoprotein hormones alpha chain precursor (NP 000726) y
Sphingomyelin phosphodiesterase 2 (NP 003071) y y
Molybdenum cofactor biosynthesis protein 1 A(NP 620306) y
39S ribosomal protein L13, mitochondrial (NP 054797) y
Cytochrome c oxidase subunit 2 (NP 536846) y Mitochondrial complex IV deficiency
Bardet-Biedl syndrome 5 protein (NP 689597) y y Bardet-Biedl syndrome
Interleukin-17 receptor A precursor (NP 055154) y
Uridine phosphorylase 1 (NP 003355) y
Table 5.2: The ‘top ten’ most influential interactome proteins for each of the centrality mea-
sures. The ‘y’ denotes possession of the quality defined by the column. Cancer=cancer protein,
cvd=cardiovascular protein, cvdpr1=cardiovascular priority 1 protein. Of these proteins, 29% are
currently annotated as cvd related and 17% are already associated with OMIM database morbidity
identifiers (Hamosh et al., 2002). The OMIM morbidity description relates to a disease which the
protein is associated with. bc=betweeness centrality, dc=degree centrality, cc=closeness centrality.
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promiscuous nature of their domains (Table 5.3). In order to calculate the general promis-
cuity of each domain we firstly extracted domain-domain interaction frequencies from
PFAM (Bateman et al., 2004). The promiscuity p values shown in the table were calcu-
lated based on this analysis of interaction frequencies of the PFAM domains, which con-
form to a probability density function as described by Jonsson & Bates (2006a). Sixteen
of the top 20 most frequent occurring cvd domains are promiscuous and 7 are among the
top 30 most frequent occurring cancer domains. Table 5.3 shows that domain promiscuity
can generally be seen to increase with increasing cvd domain frequency. Two domains
namely, zinc finger, C4 type PF00105 and ligand-binding domain of nuclear hormone re-
ceptor PF00104 are not promiscuous domains but are common to both disease conditions.
Both families are steroid or nuclear hormone receptors implicated in DNA-dependent
transcription regulation.
Most frequently occurring cvd do-
mains (descending order)









Immunoglobulin domain PF00047 7.93E-011 ♠ ⋆
Protein tyrosine kinase PF07714 4.67E-003 ⋆
EGF-like domain PF00008 1.33E-011 ♠ ⋆
Immunoglobulin V-set domain PF07686 2.84E-009 ⋆
Pleckstrin homology domain PF00169 2.18E-005 ⋆
Zinc finger, C4 type (two domains) PF00105 1.67E-001 ♠
Ligand-binding domain of nuclear
hormone receptor
PF00104 2.79E-002 ♠
Immunoglobulin I-set domain PF07679 1.30E-004 ⋆
Fibronectin type III domain PF00041 3.64E-006 ♠ ⋆
SH2 domain PF00017 3.64E-006 ⋆
Leucine Rich Repeat PF00560 1.33E-011 ⋆
EGF-like domain PF07974 7.80E-004 ⋆
Trypsin PF00089 0.00E+000 ⋆
Collagen triple helix repeat (20
copies)
PF01391 1.67E-001
ABC transporter PF00005 7.80E-004 ⋆
SH3-domain PF00018 6.09E-007 ♠ ⋆
Calcium binding EGF domain PF07645 3.64E-006 ⋆
Variant SH3 domain PF07653 1.00E+000
Table 5.3: Promiscuity of the top 20 most frequently occurring cvd domains (in descending order).
A ♠ is present for domains that are frequently present in cancer proteins. Domains marked with a ⋆
are thought to be promiscuous domains.
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Joy et al. (2005) observed an abundance of proteins in the yeast interactome displaying
high betweenness and low connectivity (degree) (HBLC). Such a feature is not found in
randomly generated scale free networks. They suggested this was due to some modular
organization of the network. We were able to show HBLC is a feature of the studied
human PPI network (Figure 5.2) and note disease proteins seem to be evenly distributed in
this figure. This measure of modularity through HBLC is observed where a link between
modules is composed of 2 or more steps, the intermediate proteins will display low degree.
Using a cutoff of p<0.05 for high betweenness and low degree there are no proteins that
display ‘extreme’ HBLC. Identification of community bridges in the clustering analysis
provides additional evidence of modularity within the network. Such community bridges
whilst having high betweenness, may also display high degree due to the formation of
interactions with proteins from multiple communities, therefore not displaying HBLC but
still supporting the idea of modularity.
5.2.2 Clustering
The community structure of the network was then analysed with the Cfinder program.
For low k-values there are a large number of highly overlapping communities. As k in-
creases, the number of communities decreases as does the overlap between them (table
5.4). The disease proteins make up a larger proportion of the community proteins as k-
value increases suggesting a greater presence in complex, distinct communities. There is
no significant difference in the distribution of community based proteins with increasing
k-values between the disease datasets using the Wilcoxon rank sum test.
For each k-value cancer proteins tend to be in the larger communities than cvd proteins
which in turn are in larger communities than non-disease proteins (Figure 5.3). This
suggests cvd and cancer proteins also take part in large processes. Are these proteins
spread across a number of communities or do they cluster within specific communities?
Figure 5.4 shows that cvd priority 1 and cancer proteins exhibit a greater tendancy to
cluster within communities than cvd (all priorities) and non disease proteins.
Table 5.5 shows which proteins are present in multiple communities and therefore
possibly act as interfaces between multiple processes further supporting the idea of mod-
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Figure 5.2: Degree (dc) versus betweenness centrality (bc) for the studied PPI network. Six subsets
of proteins are shown; cancer and cvd priority 1 proteins, cancer and cvd priority 2 or 3 proteins,
cancer proteins, cvd priority 2 or 3 proteins, cvd priority 1 proteins, proteins not implicated in either
cvd or cancer
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Figure 5.3: The distribution of community sizes (number of proteins) for the studied PPI network.
Four types of communities are represented; those containing cvd proteins (all priorities), cvd proteins
(priority 1 only), cancer proteins and communities that do not contain either cvd or cancer proteins
(non disease).
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Figure 5.4: Illustration showing the percentage of proteins assigned to each community for 4 protein
subsets. It shows any clustering within communities. The plots represent 4 datasets; communities
containing cvd proteins (all priorities), cvd priority 1 proteins (cvdpr1), cancer proteins and commu-
nities that do not contain either cvd or cancer proteins (non disease)
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k-value Communities % cvd proteins % cvdpr1 proteins % cancer proteins
3 222 15.2(0.50) 3.1(0.45) 3.5(0.45)
4 189 17.8(0.27) 3.8(0.25) 4.9(0.29)
5 98 18.4(0.13) 4.9(0.15) 5.4(0.15)
6 37 21.2(0.06) 5.5(0.07) 6.1(0.06)
7 19 22.4(0.03) 7.0(0.04) 7.0(0.04)
8 9 27.8(0.02) 8.8(0.03) 6.3(0.02)
Table 5.4: The percentage of proteins making up communities from cvd, cvd priority 1 and cancer
protein datasets. The values in brackets represent the proportion of proteins for a chosen k-value as a
fraction of all communities. Cardiovascular disease proteins make up 15.2% of proteins in k-value =
3 communities. This percentage accounts for 0.5 of all cvd proteins assigned to communities. There
are more proteins in the larger communities (low k-value) but the disease proteins make up a larger
proportion of the community proteins as k-value increases
ularity within the network. Both cvd and cancer proteins act as bridges more often than
expected at each k-value. There is no significant difference in the distribution of pro-
teins that are bridges between cvd, cvd priority 1 and cancer across the k-values using the















3 12.29 7.95[1.55] 13.57 8.45[1.61] 12.67 8.46[1.50]
4 14.20 12.78[1.11] 9.66 13.16[0.73] 21.39 12.60[1.70]
5 14.97 9.33[1.61] 17.05 10.03[1.70] 12.37 10.26[1.21]
6 14.79 14.18[1.04] 21.62 13.88[1.56] 17.07 14.13[1.21]
7 13.51 6.64[2.03] 17.39 7.49[2.32] 17.39 7.49[2.32]
8 10.53 0.00[-] 16.67 1.60[10.43] 7.69 2.60[2.96]
Table 5.5: Community bridges - proteins that are present in multiple communities, acting as in-
terfaces between processes. The percentage of proteins belonging to more than one community is
shown for protein datasets cvd, cvd priority 1 and cancer (obs=observed). Expected (exp) values
were based on non cvd priority 1 or non cancer proteins (fd=fold difference between observed and
expected).
5.2.3 Combining centrality and clustering for novel candidate priori-
tisation
Combining measures relating to centrality and clustering may help identify or prioritise
disease candidate genes. For example, here we describe, and show in Figure 5.5 how
a set of proteins can be characterised in terms of their PPI topological environment and
hence evaluated as potential cvd related proteins. We are not suggesting they are good
candidates, merely showing how they can be evaluated. For this particular example we
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show all proteins belonging to communities for k-value 8 which represent the most com-
plex, tightly connected communities found in the interactome. The cvd proteins currently
make up 27.8% of proteins in communities at this k-value, but this only represents 2% of
all community based cvd proteins (Table 5.4). The shape of the node (protein) represents
the disease status, the size is proportionate to the degree and the colour represents the
betweenness centrality of the protein as shown in the colourbar. Of the 9 communities
present, one is notable in that 6 of its 8 proteins (a single clique) are currently annotated
as cvd proteins (Figure 5.6). The remaining 2 proteins could be of interest due to their
presence in such a highly connected, cvd rich community. The first of these proteins is
cell division cycle 37 protein CDC37 (NP 008996), which is thought to play a critical
role in directing heat shock protein 90 (HSP90) to its target kinases. HSP90 is present in
this clique, it is annotated as being both cancer and cvd related. The second protein is the
TNF receptor-associated protein 1 TRAP1 (NP 057376) which is a mitochondrial HSP90
protein. A number of proteins from other k-value=8 communities are also of potential
interest (Figure 5.5). Firstly, transportin 1 isoform 1 TNP01 (NP 002261) is currently
not annotated as being cvd or cancer related, yet it interacts directly with a large number
of cvd proteins and exhibits extremely high betweenness and degree centrality (p<0.05).
It can also be seen to be bridging 2 communities and may therefore act as an interface
between functional modules. This gene encodes the beta subunit of the karyopherin re-
ceptor complex which interacts with nuclear localization signals to target nuclear proteins
to the nucleus. Secondly, leucine zipper transcription regulator 2 SEC16B (NP 149118).
It currently has no known cvd or cancer association yet it displays very high degree and
betweenness (p<0.05) and provides a link between 2 communities through its direct in-
teraction with the nuclear factor of kappa light polypeptide gene NFKB2 (NP 002493),
which is a cvd priority 1 and cancer associated protein. SEC16B is required for secre-
tory cargo traffic from the endoplasmic reticulum to the golgi apparatus and for nor-
mal transitional endoplasmic reticulum (tER) organization. This protein is ubiquitous in
terms of tissue specificity. Finally, protein phosphatase 2 catalytic subunit beta PPP2CB
(NP 001009552) also stands out as an extremely influential interactome protein (both
degree and betweenness centrality p<0.05), it also currently has no cvd or cancer anno-
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tation. This protein is implicated in the negative control of cell growth and division, and
the gene encodes the phosphatase 2A catalytic subunit. Protein phosphatase 2A is one of
the four major serine/threonine phosphatases, and it is implicated in the negative control
of cell growth and division. This protein maps to 8p21-p12, a region associated with a
























Figure 5.5: Network showing all proteins in communities for k-value = 8. The interactions between
proteins of these communities are shown as edges linking the nodes. The node size = degree, colour
= betweenness centrality and the node shape is defined by the disease status of the protein. A number
of nodes are labelled with their protein identifiers.
5.3 Discussion
Network based approaches are providing important tools for systems biology. Simple
graph theoretic measures such as degree and betweenness centralities are useful metrics
for suggesting how influential particular proteins (nodes) in the network are, in relation
to the network as a whole. We have found that both cvd and cancer proteins are over-
represented within the set of proteins that are central to the interactome, particularly with
respect to degree and betweenness, and that generally pleiotropic proteins tend to be most


























Figure 5.6: Network showing all proteins in a cvd rich k-value = 8 community comprising a single
clique where 6 of the 8 component proteins are implicated in cvd. The node size = degree, colour
= betweenness centrality and the node shape is defined by the disease status of the protein. Nodes
are labelled with their protein identifiers. CHUK (NP 001269) is a conserved helix-loop-helix ubiq-
uitous kinase, MAP3K14 (NP 003945) is mitogen-activated protein kinase, IKBKG (NP 003630)
is an inhibitor of kappa light polypeptide gene, IKBKE (NP 054721) is a IKK-related kinase ep-
silon, IKBKB (NP 001547) is an inhibitor of kappa light polypeptide gene, CDC37 (NP 008996)
is the cell division cycle 37 protein, TRAP1 (NP 057376) is the TNF receptor-associated protein 1,
HSP90AA1 (NP 005339) is heat shock protein 90kDa alpha.
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influential (Figure 5.1). A list of influential human interactome proteins, that is proteins
with centrality scores with p <0.05, is available from http://compbio.mds.qmw.
ac.uk/centralproteins.txt. This list may be useful for the prioritisation of
candidate gene lists.
Closeness centrality can only be calculated for connected proteins which leads to high
closeness values for proteins belonging to small connected components. To overcome
this caveat the closeness centrality could have been calculated for the single largest con-
nected component with the unfortunate effect of reducing the number of proteins with
closeness scores. This may partly explain why cvd is not as over-represented in the list
of proteins exhibiting high closeness as this list contains a large number of proteins from
small components.
Barabassi et al. (2007) have shown that ‘essential’ disease genes, in which muta-
tions are lethal, often causing embryonic mortality, form hubs (highly connected nodes)
whereas ‘non-essential’ disease genes do not display this tendency (Goh et al., 2007).
Analysis performed in chapter 4 supported this claim by showing hypertension related
proteins, disruption of which would not be thought to be lethal, are generally not hub
like proteins (Dobson et al., 2008). In this study, we show that cvd and cancer proteins
display a range of centrality scores but they are over-represented in the list of proteins
displaying high degree and betweenness scores. Cardiovascular disease and cancer cover
a wide range of disease phenotypes which may partly explain varying centrality scores.
In addition, the cvd dataset contains many proteins which are thought to be good candi-
dates for association with cvd but as yet many are unproven. Priority 2 and 3 proteins
are more speculative suggestions than priority 1 proteins. Work is currently underway
testing the cvd chip (Keating et al., 2008) in a range of cardiovascular diseases including
hypertension. This data will indicate whether any are actually causal in cvd.
Our results relating to network clustering add to the findings first shown in cancer by
Jonsson & Bates (2006a). Importantly we are also able to show that similar properties
are exhibited in a much larger dataset of cvd proteins. Cardiovascular related proteins,
especially priority 1 proteins, tend to act through a small number of large, complex (tightly
connected) processes and exist as interfaces between processes more often that would be
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expected
We repeated the analysis on the cvd proteins in the I2D (previously OPHID) dataset
(Brown & Jurisica, 2005) of PPIs in order to investigate whether the findings could be
replicated. In an attempt to remove the effect of experimental bias, we only included in-
teractions obtained through high throughout approaches by excluding those sourced from
BIND, HPRD, MINT and MIPS. An obvious difference between the studied dataset and
this I2D subset was the much greater range of clique sizes, extending to k=40, compared
to k=12. It is reassuring to see the trends could be replicated in this dataset. We still
find that there is an overrepresentation of bridges in the I2D dataset for cvd and that cvd
proteins cluster together in larger communities for each k. Less obvious was the dra-
matic increase in the proportion of cvd proteins with increasing k, although the maximum
proportion of cvd proteins can be seen at k=23 for cvdpr1 and k=31, 32, 33 for cvd (all
priorities). In terms of centrality, observations were replicated with the average between-
ness and degree centralities being 2.4 and 1.3 fold greater for cvdpr1 proteins compared
to non cvd proteins.
The results presented here show that there are network properties common to both
cancer and cvd which may also be reflected in other diseases. The shared properties
relate to both network centrality and clustering. There are a number of proteins actually
associated with both conditions and these may be general disease mediators.
The strategy of combining centrality measures with analysis of community structure
is important when taking this wholeist perspective to understanding the etiological mech-
anisms of disease.
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Chapter 6
General Discussion
Advances in methods for analysing genes and proteins related to disease have provided
new opportunities for the application of biology to medical practice (Mathew et al., 2007).
The completeness, volume and interpretation of data produced by such methods, requires
novel computational biology approaches. This thesis describes four different analyses,
the results of which may aid in the interpretation and prioritisation of candidate disease
genes in large scale molecular datasets. Machine learning and graph theoretic approaches
were used. Some of the approaches combined heterogeneous data sources including such
as PPI databases and curated databases such as OMIM.
Initial work focused on developing methods for identifying deleterious nsSNPs. The
analysis found various sequence and structural properties were important. Sequence con-
servation was shown to be the most useful attribute in predicting functional nsSNPs in a
large dataset from the SWISSPROT database. Structural attributes in combination with
the conservation score improved the prediction accuracy, but other non structurally depen-
dant attributes were found to reduce the error rate further and were valuable in the absence
of a conservation score. The nsSNP function prediction analysis also showed the impor-
tance of balance within training datasets highlighting the importance of training dataset
configuration. Currently, the SNP function prediction scores are being used for prioritis-
ing nsSNPs in current BRIGHT studies (http://www.brightstudy.ac.uk), and
for the recent blood pressure meta analysis (Christopher Newton-Cheh et al., 2009). The
method could be extrapolated, by the creation of a tool to obtain on the fly predictions for
novel SNPs identified through resequencing experiments. The user would be required to
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submit a suspected SNP and its surrounding sequence. Since completion of the nsSNP
analysis, a number of further studies have been performed, thirteen of which have cited
the work in this thesis and are complementary. In light of these recent studies (described
in Section 2.3), further work could be performed, for example: some of the attributes
found to be important in studies such as those of Tian et al. (2007) and Hu & Yan (2008)
could be incorporated into the method; a meta server that collects predictions from all
prediction servers would also be useful. A classifier could then be trained which uses
predictions from each of the component servers as attributes. It is currently difficult to
evaluate the worth of such studies without performing functional work to prove that the
SNP was truly a functional SNP. These predictions should be considered a guide to help
prioritise gene candidates. With time more prediction servers may become available to
complement servers such as PolyPhen (Sunyaev et al., 2001) and SIFT (Ng & Henikoff,
2003). The focus of most SNP studies so far has been on predicting nsSNPs whereas
disease associated SNPs often fall in regulatory regions. Such SNPs have only been con-
sidered in a small number of studies such as Mottagui-Tabar et al. (2005) and Torkamani
& Schork (2008), exploring methods to predict these would also be of interest.
Machine learning approaches were also used to develop a method for the functional
annotation of proteins belonging to large diverse superfamilies. Our analysis found that
global sequence properties of protein domains are useful in determining the protein su-
perfamily. These properties have previously been used to predict protein folds (Ding
& Dubchak, 2001). Such an approach can be used to complement traditional homol-
ogy alignment based approaches. In performing the analysis an enrichment approach
step was explored, this resulted in significant improvements to the classifier performance.
The enrichment step involved carefully choosing and adding sequences to the training
dataset that are currently absent from SCOP. It is expected that this addition could im-
prove performance if applied to the many published fold prediction models (Ashburner
et al., 2000; Ding & Dubchak, 2001; Lin et al., 2005; Shen & Chou, 2006; Melvin et al.,
2007; Shamim et al., 2007; Damoulas & Girolami, 2008). To extend this work a selective
ensembling algorithm is currently under construction for multi-classifier, multi-subspace
classification tasks such as the superfamily and fold prediction problem. This should pro-
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vide improved prediction performance over single classifiers. Essentially, the approach
deploys a large number of different ‘base’ classifiers (eg. neural networks and decision
trees) that are trained with various feature subspaces (amino acid bigrams or composition
features for example) and selects the best classifier/subspace pair for each target class,
in this case the protein fold or superfamily. This is achieved rapidly through the use of
the cluster implementation of Weka. These ‘class winners’ are ordered by the number of
predictions made by the winner on the class it represents. This results in a list of rules that
are applied in sequence. This approach has been found to improve previously reported
state of the art approaches in terms of classification accuracy, reported by Lin et al. (2005)
on the SCOP PDB-40D benchmark fold dataset (Ding & Dubchak, 2001).
The PPI topology of hypertension implicated proteins was also investigated and mod-
els were produced for predicting novel hypertension proteins. The models showed there
are patterns within PPI networks, as well as shared function and sequence based proper-
ties that can be used to aid prioritisation of candidate gene lists. Predicted hypertension
related proteins are closer and better connected in the interactome than would be expected
by chance, despite not being hubs or having a highly connected local environment. We
thought that geodesic distance between hypertension protein pairs might correlate with
GO semantic similarity but were unable to find a significant correlation. In addition to the
attributes used in this study, data from other sources, such as expression data, could also
be integrated into the model. A number of recent studies have combined expression data
and literature derived data with information relating to PPI networks to perform integrated
analyses for the study of human heart failure (Camargo & Azuaje, 2007). In this study, a
PPI network was assembled representing heart failure-relevant interactions. The relation-
ships between protein connectivity and expression were analysed and co-expression and
connectivity. High connectivity did not always correlate with high differential expression
and genes may exhibit weak expression correlation with their interacting partners. The
study was very much an exploratory, hypothesis-free, data driven study. A next stage
for this study, would be to develop a web based application, to enable users to prioritise
novel candidates based on these properties. This could involve either the construction of
a pipeline to calculate the attributes required by the classifier on the fly or precalculating
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the attributes for each RefSeq protein (Pruitt et al., 2007) and storing the attributes in a
database.
Finally we performed an interactome analysis of a large dataset of manually curated
cvd and cancer implicated proteins, the data showed that these disease implicated pro-
teins tend to act through a small number of large, complex (tightly connected) processes
and exist as interfaces between processes more often that would be expected. The pro-
teins also had a tendancy to be influential proteins within the interactome and there were
network properties in common which may also be reflected in other diseases. A recent
genome wide meta analysis identified 8 loci associated with blood pressure (Christopher
Newton-Cheh et al., 2009). All the gene products from these regions are being assessed
for priority based on their centrality scores, community structure and proximity to other
cvd implicated proteins. A few of the proteins from each of the 8 loci have been found
to belong to the same community, possibly highlighting a common pathway or functional
module. These proteins are priority targets for further investigation. A useful aid to pri-
oritising candidates based upon the studied topological properties would be a metric that
combined values relating to centrality and clustering into a single score. In addition, a
tool could be developed that allows a user to enter a RefSeq protein identifier and return
a visual representation of the protein in its topological environment with cvd and cancer
implicated proteins highlighted along with the centrality and community structure dis-
played, in a similar manner to figure 5.5. Such an application could be created as a plugin
to the open source package, Cytoscape (Shannon et al., 2003).
Data integration is a rapidly growing field that combines data from wholist heteroge-
neous biological sources providing many opportunities to develop more complete models
of systems. Methods that combine and integrate data with clinical data and pathway data
enable the investigation of how perturbations lead to disease and should provide a clearer
understanding of the pathways through which they act. As such, these methods could aid
accurate diagnosis and prognosis as well as enabling better prevention and therapy in the
future. Most current cancer treatments, for example, have low specificity leading to ag-
gressive side effects (Mathew et al., 2007). Identifying cancer specific molecular changes
could lead to the identification of disease sub types, and molecular markers, this could
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help in the development of more targeted therapies with fewer side effects. Multiple drug
combinations are often used to treat hypertension, and there are varied patient responses
(Chobanian et al., 2003). A tailored drug combination for a particular patient determined
at diagnosis would improve the patient experience and reduce care costs.
Comprehensive integrated pathway information is vital for studying biological pro-
cesses and how they are affected in disease. However, pathway data exists in a range
of diverse pathway databases (http://pathguide.org). The datasets are often in-
complete and sparsely populated (Cary et al., 2005). PPIs networks created through a
combination of manual curation and high throughput screening can contribute towards
knowledge of pathway structure.
The integration of genotype and microarray data with PPI and pathway information
is an important challenge showing promise for predicting the effect of a mutation on
disease and identifying therapeutic targets through vulnerable points in particular path-
ways. In a study performed by Chuang et al. (2007), expression data was combined
with PPI networks in order to identify differentially expressed combinations of trancripts
(modules) based on interactome proximity and mutual information. The analysis showed
improved ability over single transcript markers to predict metastasis within breast cancer
patients. We are currently developing an approach for identifying disease associated mod-
ules within PPI networks based on SNP association scores from GWA studies. This could
help identify multiple SNPs that by themselves do not display significant association but
have a significant combined effect (figure 6.1). This assumes that the biological pathways
have multiple vulnerable points that can lead to the same disease phenotype (Mathew
et al., 2007). These are examples of integrated approaches that could enable significant
advances in the study and understanding of the etiology of complex diseases.
This thesis utilised static, qualitative presentation of integrated genome scale data,
through the identification and study of relationships that exist between component parts.
A quantitative analysis that aims to understand the relationships or network dynamics
(understanding the nature of the links) within a system is a bigger challenge and it is
receiving growing interest (Luscombe et al., 2004). Progress in this area is being made
by the measuring of gene expression through microarrays and pathway simulations have
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Figure 6.1: An approach that combines SNP association Chi-squared scores to identify disease
associated PPI subnetworks. In this example, SNPs were taken from the coeliac genome wide asso-
ciation study by van Heel et al. (2007). Proteins (nodes) are coloured according to their Chi-squared
value with diamonds representing proteins with Chi-squared scores having p-values< 0.05
been used in model organisms such as Escherichia coli and budding yeast to find pathway
regulators (Chen et al., 2000). The speed of advances within these key areas of computa-
tional biology suggests that such integrated, wholist approaches will extend long into the
future.
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Appendix A. Environment, Parameters and Specification
Hardware
The majority of the data processing performed in this thesis was done using Linux and
Unix computers available at the Genome Centre, St Barts and The London, Queen Mary
University of London. Both the Genome Centre and Queen Mary University of Lon-
don High Throughput Computing (HTC) clusters were used to perform analyses. Large
amounts of filespace on the Genome Centre servers were used to store data and software.
All Genome Centre servers and cluster were administered and maintained by the thesis
author.
Programming Languages and Databases
The main programming languages used for data harvesting, parsing, manipulation, re-
sults collection and evaluation were Perl 5 (http://www.perl.org) and Python
(http://www.python.org). MySQL version 5.0.5 (http://www.mysql.com)
was used to create databases for storing data and results of the analyses. R version 2.6.2
was used for statistical tests including the Wilcoxon sign rank test, Pearsons and Spear-
mans and to produce most of the plots within the thesis (R Development Core Team,
2008).
Software and Operating Systems
• Linux and Unix operating systems including Ubunbtu, CentOS, Debian, Scientific
Linux and Sun Solaris 8 distributions were used throughout this thesis. All pro-
grams were written and tested using these operating systems.
• The Weka machine learning workbench was used for machine learning classifica-
tion (Witten & Frank, 1999). It consists of Java implementations of many ma-
chine algorithms, that can be applied directly to a dataset. Weka contains tools for
data pre-processing, classification, regression, clustering, association rules, and vi-
sualisation. LibSVM was integrated into the Weka Environment using WLSVM
(EL-Manzalawy & Honavar, 2005).
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• The Apache 2 web server (http://www.apache.org/) and Perl CGI mod-
ules (http://perldoc.perl.org/CGI.html) were used to create the web
based, cluster implementation of Weka.
• The PSIC (position-specific independent counts) program was used to calculate
conservation at the position of a nsSNP (Ramensky et al., 2002). Profiles are ex-
tracted from sequence alignments with position-specific counts of independent ob-
servations.
• The LDAS (Lightweight Distributed Annotation Server) framework was used for
implementing the DAS server to server up nsSNP function predictions (Dowell
et al., 2001)
• PSI-BLAST and BLAST were used for various analyses that required sequences
to be aligned. This included the enrichment step of the protein function analysis
(Altschul et al., 1997).
• BLASTClust was used to cluster sequences based on their sequence similarity
(Dondoshansky, 2002).
• Secondary structure prediction of a protein was performed with PSIPRED (McGuf-
fin et al., 2000).
• The Python API implemented by Casbon et al. (2006) as part of the Biopython
project was used to manipulate and parse ASTRAL and SCOP files to construct
datasets for the protein superfamily analysis.
• G-Sesame was used to calculate the semantic similarity of GO terms associated
with sets proteins (Wang et al., 2007).
• The NetworkX Python routines were used to calculate centrality scores and produce
network figures (https://networkx.lanl.gov)
• The Cfinder program was used to identify communities for the analysis of cvd and
cancer implicated proteins (Adamcsek et al., 2006). This program uses the k-clique
clustering method.
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46458 a.1.1 sf Globin-like 11 22 31 2.82
46689 a.4.1 sf Homeodomain-like 12 35 35 2.92
46785 a.4.5 sf “Winged helix” DNA-
binding domain
25 81 114 4.56
47266 a.26.1 sf 4-helical cytokines 15 19 27 1.8
48371 a.118.1 sf ARM repeat 11 35 50 4.55
49785 b.18.1 sf Galactose-binding
domain-like
13 17 21 1.62
49899 b.29.1 sf Concanavalin A-like
lectins/glucanases
14 19 28 2
50249 b.40.4 sf Nucleic acid-binding
proteins
19 37 58 3.05
50729 b.55.1 sf PH domain-like 11 27 27 2.45
51182 b.82.1 sf RmlC-like cupins 11 16 20 1.82
88633 b.121.4 sf Positive stranded ss-
RNA viruses
11 23 23 2.09
51445 c.1.8 sf (Trans)glycosidases 15 30 45 3
51735 c.2.1 sf NAD(P)-binding
Rossmann-fold domains
13 24 56 4.31
52540 c.37.1 sf P-loop containing nu-
cleoside triphosphate hydrolases
43 89 138 3.21
52833 c.47.1 sf Thioredoxin-like 17 36 41 2.41
52980 c.52.1 sf Restriction
endonuclease-like
13 14 15 1.15
53335 c.66.1 sf S-adenosyl-L-
methionine-dependent methyltrans-
ferases
25 71 92 3.68
53383 c.67.1 sf PLP-dependent trans-
ferases
15 36 72 4.8
53448 c.68.1 sf Nucleotide-diphospho-
sugar transferases
11 20 45 4.09
53474 c.69.1 sf alpha/beta-Hydrolases 23 41 130 5.65
53850 c.94.1 sf Periplasmic binding
protein-like II
13 31 135 10.38
55729 d.108.1 sf Acyl-CoA N-
acyltransferases (Nat)
15 37 49 3.27
57059 g.3.6 sf omega toxin-like 15 19 19 1.27
57095 g.3.7 sf Scorpion toxin-like 12 22 22 1.83
Table 1: Number of domains per superfamily (in the analysis that excluded multi domain proteins)
from Astral20 before enrichment (D) and after enrichment at 20% (20E) and 30% (30E) sequence
identity cutoffs
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Table 2: Number of domains per superfamily (in the analysis that in-
cluded multi domain proteins) from Astral20 before enrichment (D) and
after enrichment at 20% (20E) and 30% (30E) sequence identity cutoffs
Superfamily D 20E 30E 30E/D
46458 a.1.1 sf Globin-like 11 19 24 2.18
46626 a.3.1 sf Cytochrome c 15 20 20 1.33
46689 a.4.1 sf Homeodomain-like 23 114 115 5
46785 a.4.5 sf “Winged helix” DNA-
binding domain
55 144 175 3.18
47266 a.26.1 sf 4-helical cytokines 15 20 24 1.6
47473 a.39.1 sf EF-hand 13 25 34 2.62
48371 a.118.1 sf ARM repeat 17 43 53 3.12
48726 b.1.1 sf Immunoglobulin 36 103 105 2.92
49265 b.1.2 sf Fibronectin type III 21 60 61 2.9
81296 b.1.18 sf E set domains 26 52 53 2.04
49503 b.6.1 sf Cupredoxins 15 33 40 2.67
49785 b.18.1 sf Galactose-binding
domain-like
21 37 43 2.05
49899 b.29.1 sf Concanavalin A-like
lectins/glucanases
22 41 56 2.55
50249 b.40.4 sf Nucleic acid-binding
proteins
39 68 91 2.33
50729 b.55.1 sf PH domain-like 19 47 48 2.53
51011 b.71.1 sf Glycosyl hydrolase do-
main
19 24 24 1.26
51182 b.82.1 sf RmlC-like cupins 12 19 22 1.83
88633 b.121.4 sf Positive stranded ss-
RNA viruses
15 23 23 1.53
Continued on Next Page. . .
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Table 2 – Continued
Superfamily D 20E 30E 30E/D
51445 c.1.8 sf (Trans)glycosidases 33 64 99 3
51569 c.1.10 sf Aldolase 12 16 36 3
51735 c.2.1 sf NAD(P)-binding
Rossmann-fold domains
47 87 137 2.91
51905 c.3.1 sf FAD/NAD(P)-binding
domain
21 37 42 2
52317 c.23.16 sf Class I glutamine
amidotransferase-like
11 19 23 2.09
52374 c.26.1 sf Nucleotidylyl trans-
ferase
13 24 31 2.38
52540 c.37.1 sf P-loop containing nu-
cleoside triphosphate hydrolases
70 150 227 3.24
52833 c.47.1 sf Thioredoxin-like 28 56 71 2.54
52980 c.52.1 sf Restriction
endonuclease-like
15 16 17 1.13
53067 c.55.1 sf Actin-like ATPase do-
main
17 27 36 2.12
53098 c.55.3 sf Ribonuclease H-like 15 28 37 2.47
53335 c.66.1 sf S-adenosyl-L-
methionine-dependent methyltrans-
ferases
29 69 110 3.79
53383 c.67.1 sf PLP-dependent trans-
ferases
16 32 66 4.13
53448 c.68.1 sf Nucleotide-diphospho-
sugar transferases
12 19 45 3.75
53474 c.69.1 sf alpha/beta-Hydrolases 27 54 145 5.37
Continued on Next Page. . .
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Table 2 – Continued
Superfamily D 20E 30E 30E/D
53850 c.94.1 sf Periplasmic binding
protein-like II
15 33 152 10.13
56784 c.108.1 sf HAD-like 11 23 47 4.27
54001 d.3.1 sf Cysteine proteinases 18 28 33 1.83
54211 d.14.1 sf Ribosomal protein S5
domain 2-like
11 21 23 2.09
54236 d.15.1 sf Ubiquitin-like 11 21 24 2.18
54373 d.16.1 sf FAD-linked reductases,
C-terminal domain
11 19 19 1.73
54593 d.32.1 sf Glyoxalase/Bleomycin
resistance protein/Dihydroxybiphenyl
dioxygenase
12 19 19 1.58
55347 d.81.1 sf Glyceraldehyde-
3-phosphate dehydrogenase-like,
C-terminal domain
11 23 32 2.91
55486 d.92.1 sf Metalloproteases
(“zincins”), catalytic domain
18 44 54 3
55729 d.108.1 sf Acyl-CoA N-
acyltransferases (Nat)
11 25 41 3.73
56672 e.8.1 sf DNA/RNA polymerases 11 23 56 5.09
57059 g.3.6 sf omega toxin-like 15 19 19 1.27
57095 g.3.7 sf Scorpion toxin-like 12 20 20 1.67
57196 g.3.11 sf EGF/Laminin 11 55 55 5
57667 g.37.1 sf C2H2 and C2HC zinc
fingers
15 40 40 2.67
57716 g.39.1 sf Glucocorticoid
receptor-like (DNA-binding domain)
13 22 22 1.69
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Table 3: The 49 superfamilies in the multi domain analysis with their
respective folds and classes within the SCOP hierarchy. False positive
superfamily predictions are often correctly assigned at the level of protein
class.
Class Fold Superfamily
46456 a cl All alpha proteins 46457 a.1 cf Globin-like 46458 a.1.1 sf Globin-like
46625 a.3 cf Cytochrome c 46626 a.3.1 sf Cytochrome c
46688 a.4 cf DNA/RNA-
binding 3-helical bundle
46689 a.4.1 sf Homeodomain-
like
46785 a.4.5 sf “Winged helix”
DNA-binding domain
47265 a.26 cf 4-helical cy-
tokines
47266 a.26.1 sf 4-helical cy-
tokines
47472 a.39 cf EF Hand-like 47473 a.39.1 sf EF-hand
48370 a.118 cf alpha-alpha su-
perhelix
48371 a.118.1 sf ARM repeat
48724 b cl All beta proteins 48725 b.1 cf Immunoglobulin-
like beta-sandwich
48726 b.1.1 sf Immunoglobulin
49265 b.1.2 sf Fibronectin type
III
81296 b.1.18 sf E set domains
49379 b.6 cf Cupredoxin-like 49503 b.6.1 sf Cupredoxins
49784 b.18 cf Galactose-
binding domain-like
49785 b.18.1 sf Galactose-
binding domain-like
49898 b.29 cf Concanavalin A-
like lectins/glucanases
49899 b.29.1 sf Concanavalin
A-like lectins/glucanases
50198 b.40 cf OB-fold 50249 b.40.4 sf Nucleic acid-
binding proteins
Continued on Next Page. . .
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Table 3 – Continued
Class Fold Superfamily
50728 b.55 cf PH domain-like 50729 b.55.1 sf PH domain-like
51010 b.71 cf Glycosyl hydro-
lase domain
51011 b.71.1 sf Glycosyl hydro-
lase domain
51181 b.82 cf Double-stranded
beta-helix
51182 b.82.1 sf RmlC-like cu-
pins
88632 b.121 cf Nucleoplasmin-
like/VP (viral coat and capsid
proteins)
88633 b.121.4 sf Positive
stranded ssRNA viruses
51349 c cl Alpha and beta pro-
teins (a/b)




51569 c.1.10 sf Aldolase
51734 c.2 cf NAD(P)-binding
Rossmann-fold domains
51735 c.2.1 sf NAD(P)-binding
Rossmann-fold domains
51904 c.3 cf FAD/NAD(P)-
binding domain
51905 c.3.1 sf FAD/NAD(P)-
binding domain
52171 c.23 cf Flavodoxin-like 52317 c.23.16 sf Class I glu-
tamine amidotransferase-like
52373 c.26 cf Adenine nu-
cleotide alpha hydrolase-like
52374 c.26.1 sf Nucleotidylyl
transferase
52539 c.37 cf P-loop containing
nucleoside triphosphate hydro-
lases
52540 c.37.1 sf P-loop contain-
ing nucleoside triphosphate hy-
drolases
52832 c.47 cf Thioredoxin fold 52833 c.47.1 sf Thioredoxin-
like
52979 c.52 cf Restriction
endonuclease-like
52980 c.52.1 sf Restriction
endonuclease-like
Continued on Next Page. . .
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Table 3 – Continued
Class Fold Superfamily
53066 c.55 cf Ribonuclease H-
like motif
53067 c.55.1 sf Actin-like AT-
Pase domain
53098 c.55.3 sf Ribonuclease
H-like
53334 c.66 cf S-adenosyl-L-
methionine-dependent methyl-
transferases
53335 c.66.1 sf S-adenosyl-L-
methionine-dependent methyl-
transferases
53447 c.68 cf Nucleotide-
diphospho-sugar transferases
53448 c.68.1 sf Nucleotide-
diphospho-sugar transferases
53473 c.69 cf alpha/beta-
Hydrolases
53474 c.69.1 sf alpha/beta-
Hydrolases
53849 c.94 cf Periplasmic bind-
ing protein-like II
53850 c.94.1 sf Periplasmic
binding protein-like II
56783 c.108 cf HAD-like 56784 c.108.1 sf HAD-like
53931 d cl Alpha and beta pro-
teins (a+b)
54000 d.3 cf Cysteine pro-
teinases
54001 d.3.1 sf Cysteine pro-
teinases
54210 d.14 cf Ribosomal pro-
tein S5 domain 2-like
54211 d.14.1 sf Ribosomal pro-
tein S5 domain 2-like
54235 d.15 cf beta-Grasp
(ubiquitin-like)
54236 d.15.1 sf Ubiquitin-like
54372 d.16 cf FAD-linked re-
ductases, C-terminal domain
54373 d.16.1 sf FAD-linked re-
ductases, C-terminal domain
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Table 3 – Continued
Class Fold Superfamily







55485 d.92 cf Zincin-like 55486 d.92.1 sf Metallopro-
teases (“zincins”), catalytic do-
main
55728 d.108 cf Acyl-CoA N-
acyltransferases (Nat)
55729 d.108.1 sf Acyl-CoA N-
acyltransferases (Nat)
56572 e cl Multi domain pro-
teins (alpha and beta)
56671 e.8 cf DNA/RNA poly-
merases
56672 e.8.1 sf DNA/RNA poly-
merases
56992 g cl Small proteins 57015 g.3 cf Knottins (small in-
hibitors, toxins, lectins)
57059 g.3.6 sf omega toxin-like
57095 g.3.7 sf Scorpion toxin-
like
57196 g.3.11 sf EGF/Laminin
57666 g.37 cf C2H2 and C2HC
zinc fingers
57667 g.37.1 sf C2H2 and
C2HC zinc fingers
57715 g.39 cf Glucocorticoid
receptor-like (DNA-binding do-
main)
57716 g.39.1 sf Glucocorticoid
receptor-like (DNA-binding do-
main)
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Table 4: The precision, recall and F-measure produced by PSI-BLAST
and SVMs on the unenriched dataset containing 24 superfamilies (do-
mains from multi domain proteins excluded).
SVM PSI-BLAST
Superfamily Precision Recall F-Measure Precision Recall F-Measure
46458 a.1.1 sf Globin-like 0.71 1 0.83 1 0.94 0.97
46689 a.4.1 sf
Homeodomain-like
0.67 0.67 0.67 1 0.33 0.5
46785 a.4.5 sf “Winged he-
lix” DNA-binding domain
0.71 0.83 0.77 1 0.32 0.49
47266 a.26.1 sf 4-helical cy-
tokines
1 0.63 0.77 1 0.3 0.47
48371 a.118.1 sf ARM re-
peat
0.8 0.67 0.73 1 0.65 0.79
49785 b.18.1 sf Galactose-
binding domain-like
0.4 0.67 0.5 1 0.32 0.48
49899 b.29.1 sf Con-
canavalin A-like
lectins/glucanases
0.5 0.57 0.53 1 0.67 0.8
50249 b.40.4 sf Nucleic
acid-binding proteins
0.75 0.33 0.46 1 0.32 0.49
50729 b.55.1 sf PH domain-
like
0.5 0.5 0.5 1 0.59 0.74
51182 b.82.1 sf RmlC-like
cupins
0.75 0.6 0.67 1 0.81 0.9
88633 b.121.4 sf Positive
stranded ssRNA viruses
0.8 0.8 0.8 1 0.63 0.77
Continued on Next Page. . .
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Table 4 – Continued
Superfamily Precision Recall F-Measure Precision Recall F-Measure
51445 c.1.8 sf
(Trans)glycosidases
0.8 0.57 0.67 1 0.59 0.74
51735 c.2.1 sf NAD(P)-
binding Rossmann-fold do-
mains
0.8 0.67 0.73 1 0.95 0.97
52540 c.37.1 sf P-loop con-
taining nucleoside triphos-
phate hydrolases
0.5 0.71 0.59 1 0.75 0.86
52833 c.47.1 sf
Thioredoxin-like
0.86 0.67 0.75 1 0.85 0.92
52980 c.52.1 sf Restriction
endonuclease-like
0.5 0.57 0.53 1 0.1 0.18
53335 c.66.1 sf S-adenosyl-
L-methionine-dependent
methyltransferase
0.2 0.23 0.21 1 0.84 0.91
53383 c.67.1 sf PLP-
dependent transferases
0.56 0.63 0.59 1 1 1
53448 c.68.1 sf Nucleotide-
diphospho-sugar trans-
ferases
0 0 0 1 0.59 0.74
53474 c.69.1 sf alpha/beta-
Hydrolases
0.55 0.55 0.55 1 0.91 0.95
53850 c.94.1 sf Periplasmic
binding protein-like II
0.71 0.71 0.71 1 0.8 0.89
55729 d.108.1 sf Acyl-CoA
N-acyltransferases (Nat)
0.67 0.29 0.4 1 0.95 0.98
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Table 4 – Continued
Superfamily Precision Recall F-Measure Precision Recall F-Measure
57059 g.3.6 sf omega toxin-
like
0.86 0.86 0.86 0 0 0
57095 g.3.7 sf Scorpion
toxin-like
0.83 0.83 0.83 1 0.11 0.2
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Table 5: The precision, recall and F-measure produced by PSI-BLAST
and SVMs on the unenriched dataset containing 49 superfamilies (do-
mains from multi domain proteins included).
SVM PSI-BLAST
Superfamily Precision Recall F-Measure Precision Recall F-Measure
46458 a.1.1 sf Globin-like 0.78 0.82 0.8 1 0.94 0.97
46626 a.3.1 sf Cytochrome c 0.76 0.7 0.73 1 0.83 0.9
46689 a.4.1 sf
Homeodomain-like
0.51 0.63 0.56 1 0.43 0.6
46785 a.4.5 sf “Winged he-
lix” DNA-binding domain
0.72 0.77 0.74 1 0.35 0.52
47266 a.26.1 sf 4-helical cy-
tokines,
0.74 0.61 0.67 1 0.3 0.47
47473 a.39.1 sf EF-hand, 0.63 0.26 0.37 1 0.58 0.73
48371 a.118.1 sf ARM re-
peat,
0.64 0.64 0.64 1 0.44 0.61
48726 b.1.1 sf Immunoglob-
ulin
0.54 0.7 0.61 1 0.78 0.88
49265 b.1.2 sf Fibronectin
type III
0.58 0.48 0.53 1 0.71 0.83
81296 b.1.18 sf E set do-
mains
0.19 0.18 0.18 1 0.28 0.44
49503 b.6.1 sf Cupredoxins 0.07 0.04 0.05 1 0.78 0.88
49785 b.18.1 sf Galactose-
binding domain-like
0.43 0.48 0.46 1 0.42 0.59
49899 b.29.1 sf Con-
canavalin A-like
lectins/glucanases
0.37 0.49 0.42 1 0.64 0.78
Continued on Next Page. . .
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Table 5 – Continued
Superfamily Precision Recall F-Measure Precision Recall F-Measure
50249 b.40.4 sf Nucleic
acid-binding proteins
0.33 0.49 0.39 1 0.39 0.56
50729 b.55.1 sf PH domain-
like
0.63 0.59 0.61 1 0.59 0.74
51011 b.71.1 sf Glycosyl hy-
drolase domain
0.59 0.55 0.57 0.89 0.28 0.42
51182 b.82.1 sf RmlC-like
cupins
0.14 0.06 0.08 1 0.78 0.88
88633 b.121.4 sf Positive
stranded ssRNA virus
0.64 0.41 0.5 1 0.5 0.67
51445 c.1.8 sf
(Trans)glycosidases
0.53 0.82 0.65 1 0.71 0.83
51569 c.1.10 sf Aldolase 0 0 0 1 0.72 0.84
51735 c.2.1 sf NAD(P)-
binding Rossmann-fold do-
mains




0.46 0.47 0.46 0.97 0.91 0.94
52317 c.23.16 sf Class I
glutamine amidotransferase-
like
0.6 0.19 0.29 1 0.88 0.93
52374 c.26.1 sf Nucleotidy-
lyl transferase
0 0 0 1 0.89 0.94
52540 c.37.1 sf P-loop con-
taining nucleoside triphos-
phate hydrolases
0.34 0.75 0.46 1 0.82 0.9
Continued on Next Page. . .
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Table 5 – Continued
Superfamily Precision Recall F-Measure Precision Recall F-Measure
52833 c.47.1 sf
Thioredoxin-like
0.77 0.57 0.66 1 0.83 0.91
52980 c.52.1 sf Restriction
endonuclease-like
0.33 0.09 0.14 1 0.09 0.16
53067 c.55.1 sf Actin-like
ATPase domain
0.57 0.46 0.51 1 0.27 0.42
53098 c.55.3 sf Ribonucle-
ase H-like
0.52 0.48 0.5 1 0.57 0.72
53335 c.66.1 sf S-adenosyl-
L-methionine-dependent
methyltransferases
0.23 0.33 0.27 1 0.86 0.93
53383 c.67.1 sf PLP-
dependent transferases
0.67 0.42 0.51 1 1 1
53448 c.68.1 sf Nucleotide-
diphospho-sugar trans-
ferases
0 0 0 1 0.61 0.76
53474 c.69.1 sf alpha/beta-
Hydrolases
0.59 0.58 0.58 1 0.93 0.96
53850 c.94.1 sf Periplasmic
binding protein-like II
1 0.35 0.52 1 0.74 0.85
56784 c.108.1 sf HAD-like 1 0.06 0.12 1 0.19 0.32
54001 d.3.1 sf Cysteine pro-
teinases
0 0 0 1 0.59 0.74
54211 d.14.1 sf Ribosomal
protein S5 domain 2-like
0.31 0.19 0.23 1 0.53 0.69
54236 d.15.1 sf Ubiquitin-
like
0.33 0.12 0.17 1 0.31 0.48
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Table 5 – Continued
Superfamily Precision Recall F-Measure Precision Recall F-Measure
54373 d.16.1 sf FAD-linked
reductases, C-terminal do-
main
0.57 0.25 0.35 1 0.94 0.97









0.31 0.22 0.26 1 0.41 0.58
55486 d.92.1 sf Metallopro-
teases (“zincins”), catalytic
domain
0.8 0.24 0.36 0.96 0.85 0.9
55729 d.108.1 sf Acyl-CoA
N-acyltransferases (Nat)
0.5 0.37 0.43 0.92 0.75 0.83
56672 e.8.1 sf DNA/RNA
polymerases
0 0 0 1 0.81 0.9
57059 g.3.6 sf omega toxin-
like
0.5 0.55 0.52 0 0 0
57095 g.3.7 sf Scorpion
toxin-like
0.63 0.56 0.59 1 0.11 0.2
57196 g.3.11 sf
EGF/Laminin
0.71 0.63 0.67 1 0.06 0.12
57667 g.37.1 sf C2H2 and
C2HC zinc fingers
0.9 0.82 0.86 1 0.14 0.24
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Table 5 – Continued
Superfamily Precision Recall F-Measure Precision Recall F-Measure
57716 g.39.1 sf Glucocor-
ticoid receptor-like (DNA-
binding domain)
0.5 0.35 0.41 0 0 0
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Table 6: The 24 superfamilies in this study with their respective folds
and classes within the SCOP hierarchy. False positive superfamily pre-
dictions are often correctly assigned at the level of protein class.
Class Fold Superfamily
46456 a cl All alpha proteins 46457 a.1 cf Globin-like 46458 a.1.1 sf Globin-like




46785 a.4.5 sf “Winged he-
lix” DNA-binding domain
47265 a.26 cf 4-helical cy-
tokines
47266 a.26.1 sf 4-helical cy-
tokines
48370 a.118 cf alpha-alpha
superhelix
48371 a.118.1 sf ARM re-
peat
48724 b cl All beta proteins 49784 b.18 cf Galactose-
binding domain-like
49785 b.18.1 sf Galactose-
binding domain-like
49898 b.29 cf Concanavalin
A-like lectins/glucanases
49899 b.29.1 sf Con-
canavalin A-like
lectins/glucanases
50198 b.40 cf OB-fold 50249 b.40.4 sf Nucleic
acid-binding proteins
50728 b.55 cf PH domain-
like
50729 b.55.1 sf PH domain-
like
51181 b.82 cf Double-
stranded beta-helix




(viral coat and capsid
proteins)
88633 b.121.4 sf Positive
stranded ssRNA viruses
Continued on Next Page. . .
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Table 6 – Continued
Class Fold Superfamily
51349 c cl Alpha and beta
proteins (a/b)




1734 c.2 cf NAD(P)-binding
Rossmann-fold
51735 c.2.1 sf NAD(P)-
binding Rossmann-fold do-
mains
52539 c.37 cf P-loop con-
taining nuceoside triphos-
phate hydrolases
52540 c.37.1 sf P-loop con-
taining nucleoside triphos-
phate hydrolases




52979 c.52 cf Restriction
endonuclease-like
52980 c.52.1 sf Restriction
endonuclease-like
53334 c.66 cf S-adenosyl-
L-methionine-dependent
methyltransferases
53335 c.66.1 sf S-adenosyl-
L-methionine-dependent
methyltransferases
53382 c.67 cf PLP-
dependent transferases
53383 c.67.1 sf PLP-
dependent transferases
53447 c.68 cf Nucleotide-
diphospho-sugar trans-
ferases
53448 c.68.1 sf Nucleotide-
diphospho-sugar trans-
ferases
53473 c.69 cf alpha/beta-
Hydrolases
53474 c.69.1 sf alpha/beta-
Hydrolases
53849 c.94 cf Periplasmic
binding protein-like II
53850 c.94.1 sf Periplasmic
binding protein-like II
53931 d cl Alpha and beta
proteins (a+b)
55728 d.108 cf Acyl-CoA
N-acyltransferases Nat)
55729 d.108.1 sf Acyl-CoA
N-acyltransferases (Nat)
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Table 6 – Continued
Class Fold Superfamily
56992 g cl Small proteins 57015 g.3 cf Knottins (small
inhibitors, toxins, ectins)
57059 g.3.6 sf omega toxin-
like
57095 g.3.7 sf Scorpion
toxin-like
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Appendix C. Weka classifier lineup
Table 7: The lineup of classifiers and configurations chosen to run as
a batch job on the clustered implementation of Weka. This lineup was
used to identify the best classifier configuration for predicting SCOP su-
perfamily.
Classifier
weka.classifiers.functions.SMO – -C 1.0 -L 0.0010 -P 1.0E-12 -N 0 -V -1 -W 1 -K
’weka.classifiers.functions.supportVector.PolyKernel -C 250007 -E 1.0’
weka.classifiers.bayes.BayesNet – -D -Q weka.classifiers.bayes.net.search.local.K2 – -P 1 -S
BAYES -E weka.classifiers.bayes.net.estimate.SimpleEstimator – -A 0.5
weka.classifiers.bayes.BayesNet – -D -Q weka.classifiers.bayes.net.search.local.HillClimber – -P 1
-S BAYES -E weka.classifiers.bayes.net.estimate.SimpleEstimator – -A 0.5
weka.classifiers.meta.END – -S 1 -I 10 -W weka.classifiers.meta.nestedDichotomies.ClassBalancedND
– -S 1 -W weka.classifiers.meta.Bagging – -P 100 -S 1 -I 10 -W weka.classifiers.rules.PART
weka.classifiers.functions.SMO – -C 1.0 -L 0.0010 -P 1.0E-12 -N 0 -V -1 -W 1 -K
’weka.classifiers.functions.supportVector.PolyKernel -C 250007 -E 2.0’
weka.classifiers.functions.SMO – -C 1.0 -L 0.0010 -P 1.0E-12 -N 0 -V -1 -W 1 -K
’weka.classifiers.functions.supportVector.PolyKernel -C 250007 -E 4.0’
weka.classifiers.functions.SMO – -C 1.0 -L 0.0010 -P 1.0E-12 -N 0 -V -1 -W 1 -K
’weka.classifiers.functions.supportVector.RBFKernel -C 250007 -G 0.01’
weka.classifiers.functions.SMO – -C 1.0 -L 0.0010 -P 1.0E-12 -N 0 -V -1 -W 1 -K
’weka.classifiers.functions.supportVector.RBFKernel -C 250007 -G 0.1’
weka.classifiers.functions.SMO – -C 1.0 -L 0.0010 -P 1.0E-12 -N 0 -V -1 -W 1 -K
’weka.classifiers.functions.supportVector.RBFKernel -C 250007 -G 0.05’
weka.classifiers.functions.SMO – -C 1.0 -L 0.0010 -P 1.0E-12 -N 0 -V -1 -W 1 -K
’weka.classifiers.functions.supportVector.RBFKernel -C 250007 -G 0.001’
weka.classifiers.meta.END – -S 1 -I 10 -W weka.classifiers.meta.nestedDichotomies.ClassBalancedND
– -S 1 -W weka.classifiers.meta.Bagging – -P 100 -S 1 -I 30 -W weka.classifiers.rules.PART
Continued on Next Page. . .
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Table 7 – Continued
Classifier
weka.classifiers.meta.END – -S 1 -I 10 -W weka.classifiers.meta.nestedDichotomies.ClassBalancedND
– -S 1 -W weka.classifiers.meta.Bagging – -P 100 -S 1 -I 50 -W weka.classifiers.rules.PART
weka.classifiers.meta.END – -S 1 -I 10 -W weka.classifiers.meta.nestedDichotomies.ClassBalancedND
– -S 1 -W weka.classifiers.meta.Bagging – -P 100 -S 1 -I 10 -W weka.classifiers.trees.J48
weka.classifiers.meta.END – -S 1 -I 10 -W weka.classifiers.meta.nestedDichotomies.ClassBalancedND
– -S 1 -W weka.classifiers.meta.Bagging – -P 100 -S 1 -I 30 -W weka.classifiers.trees.J48
weka.classifiers.meta.END – -S 1 -I 10 -W weka.classifiers.meta.nestedDichotomies.ClassBalancedND
– -S 1 -W weka.classifiers.meta.Bagging – -P 100 -S 1 -I 50 -W weka.classifiers.trees.J48
weka.classifiers.meta.END – -S 1 -I 10 -W weka.classifiers.meta.nestedDichotomies.ClassBalancedND
– -S 1 -W weka.classifiers.meta.Bagging – -P 100 -S 1 -I 10 -W weka.classifiers.trees.REPTree
weka.classifiers.bayes.BayesNet – -D -Q weka.classifiers.bayes.net.search.local.RepeatedHillClimber
– -U 10 -A 1 -P 1 -S BAYES -E weka.classifiers.bayes.net.estimate.SimpleEstimator – -A 0.5
weka.classifiers.meta.END – -S 1 -I 10 -W weka.classifiers.meta.nestedDichotomies.ClassBalancedND
– -S 1 -W weka.classifiers.meta.Bagging – -P 100 -S 1 -I 30 -W weka.classifiers.trees.REPTree
weka.classifiers.meta.END – -S 1 -I 10 -W weka.classifiers.meta.nestedDichotomies.ClassBalancedND
– -S 1 -W weka.classifiers.meta.Bagging – -P 100 -S 1 -I 50 -W weka.classifiers.trees.REPTree
weka.classifiers.meta.END – -S 1 -I 10 -W weka.classifiers.meta.nestedDichotomies.ClassBalancedND
– -S 1 -W weka.classifiers.meta.Bagging – -P 100 -S 1 -I 10 -W weka.classifiers.trees.RandomForest
– -I 10 -K 107 -S 1
weka.classifiers.meta.END – -S 1 -I 10 -W weka.classifiers.meta.nestedDichotomies.ClassBalancedND
– -S 1 -W weka.classifiers.meta.Bagging – -P 100 -S 1 -I 10 -W weka.classifiers.trees.RandomForest
– -I 10 -K 87 -S 1
weka.classifiers.meta.END – -S 1 -I 10 -W weka.classifiers.meta.nestedDichotomies.ClassBalancedND
– -S 1 -W weka.classifiers.meta.Bagging – -P 100 -S 1 -I 10 -W weka.classifiers.trees.RandomForest
– -I 10 -K 67 -S 1
weka.classifiers.meta.END – -S 1 -I 10 -W weka.classifiers.meta.nestedDichotomies.DataNearBalancedND
– -S 1 -W weka.classifiers.meta.Bagging – -P 100 -S 1 -I 10 -W weka.classifiers.rules.PART
Continued on Next Page. . .
Appendix C. Weka classifier lineup 160
Table 7 – Continued
Classifier
weka.classifiers.meta.END – -S 1 -I 10 -W weka.classifiers.meta.nestedDichotomies.DataNearBalancedND
– -S 1 -W weka.classifiers.meta.Bagging – -P 100 -S 1 -I 30 -W weka.classifiers.rules.PART
weka.classifiers.meta.END – -S 1 -I 10 -W weka.classifiers.meta.nestedDichotomies.DataNearBalancedND
– -S 1 -W weka.classifiers.meta.Bagging – -P 100 -S 1 -I 50 -W weka.classifiers.rules.PART
weka.classifiers.meta.END – -S 1 -I 10 -W weka.classifiers.meta.nestedDichotomies.DataNearBalancedND
– -S 1 -W weka.classifiers.meta.Bagging – -P 100 -S 1 -I 10 -W weka.classifiers.trees.J48
weka.classifiers.meta.END – -S 1 -I 10 -W weka.classifiers.meta.nestedDichotomies.DataNearBalancedND
– -S 1 -W weka.classifiers.meta.Bagging – -P 100 -S 1 -I 30 -W weka.classifiers.trees.J48
weka.classifiers.meta.END – -S 1 -I 10 -W weka.classifiers.meta.nestedDichotomies.DataNearBalancedND
– -S 1 -W weka.classifiers.meta.Bagging – -P 100 -S 1 -I 50 -W weka.classifiers.trees.J48
weka.classifiers.meta.END – -S 1 -I 10 -W weka.classifiers.meta.nestedDichotomies.DataNearBalancedND
– -S 1 -W weka.classifiers.meta.Bagging – -P 100 -S 1 -I 10 -W weka.classifiers.trees.REPTree
weka.classifiers.meta.END – -S 1 -I 10 -W weka.classifiers.meta.nestedDichotomies.DataNearBalancedND
– -S 1 -W weka.classifiers.meta.Bagging – -P 100 -S 1 -I 30 -W weka.classifiers.trees.REPTree
weka.classifiers.meta.END – -S 1 -I 10 -W weka.classifiers.meta.nestedDichotomies.DataNearBalancedND
– -S 1 -W weka.classifiers.meta.Bagging – -P 100 -S 1 -I 50 -W weka.classifiers.trees.REPTree
weka.classifiers.meta.END – -S 1 -I 10 -W weka.classifiers.meta.nestedDichotomies.ClassBalancedND
– -S 1 -W weka.classifiers.meta.AdaBoostM1 – -P 100 -S 1 -I 10 -W
weka.classifiers.trees.RandomForest – -I 10 -K 0 -S 1
weka.classifiers.meta.END – -S 1 -I 10 -W weka.classifiers.meta.nestedDichotomies.ClassBalancedND
– -S 1 -W weka.classifiers.meta.AdaBoostM1 – -P 100 -S 1 -I 10 -W weka.classifiers.trees.J48 – -C
0.25 -M 2
weka.classifiers.meta.END – -S 1 -I 10 -W weka.classifiers.meta.nestedDichotomies.ClassBalancedND
– -S 1 -W weka.classifiers.meta.AdaBoostM1 – -P 100 -S 1 -I 10 -W weka.classifiers.rules.PART –
-M 2 -C 0.25 -Q 1
weka.classifiers.bayes.BayesNet – -D -Q weka.classifiers.bayes.net.search.local.TabuSearch – -L 5
-U 10 -P 1 -S BAYES -E weka.classifiers.bayes.net.estimate.SimpleEstimator – -A 0.5
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Table 7 – Continued
Classifier
weka.classifiers.meta.END – -S 1 -I 10 -W weka.classifiers.meta.nestedDichotomies.ClassBalancedND
– -S 1 -W weka.classifiers.meta.AdaBoostM1 – -P 100 -S 1 -I 10 -W weka.classifiers.trees.REPTree
– -M 2 -V 0.0010 -N 3 -S 1 -L -1
weka.classifiers.meta.AdaBoostM1 – -P 100 -S 1 -I 10 -W weka.classifiers.rules.PART – -M 2 -C
0.25 -Q 1
weka.classifiers.meta.AdaBoostM1 – -P 100 -S 1 -I 30 -W weka.classifiers.rules.PART – -M 2 -C
0.25 -Q 1
weka.classifiers.meta.AdaBoostM1 – -P 100 -S 1 -I 50 -W weka.classifiers.rules.PART – -M 2 -C
0.25 -Q 1
weka.classifiers.meta.AdaBoostM1 – -P 100 -S 1 -I 10 -W weka.classifiers.trees.J48
weka.classifiers.meta.AdaBoostM1 – -P 100 -S 1 -I 30 -W weka.classifiers.trees.J48
weka.classifiers.meta.AdaBoostM1 – -P 100 -S 1 -I 50 -W weka.classifiers.trees.J48
weka.classifiers.meta.AdaBoostM1 – -P 100 -S 1 -I 10 -W weka.classifiers.trees.REPTree
weka.classifiers.meta.AdaBoostM1 – -P 100 -S 1 -I 30 -W weka.classifiers.trees.REPTree
weka.classifiers.meta.AdaBoostM1 – -P 100 -S 1 -I 50 -W weka.classifiers.trees.REPTree
weka.classifiers.meta.END – -S 1 -I 10 -W weka.classifiers.meta.nestedDichotomies.ClassBalancedND
– -S 1 -W weka.classifiers.meta.AdaBoostM1 – -P 100 -S 1 -I 10 -W
weka.classifiers.trees.SimpleCart – -S 1 -M 2.0 -N 5 -C 1.0
weka.classifiers.meta.AdaBoostM1 – -P 100 -S 1 -I 10 -W weka.classifiers.trees.RandomForest – -I
10 -K 107 -S 1
weka.classifiers.meta.AdaBoostM1 – -P 100 -S 1 -I 10 -W weka.classifiers.trees.RandomForest – -I
10 -K 87 -S 1
weka.classifiers.meta.AdaBoostM1 – -P 100 -S 1 -I 10 -W weka.classifiers.trees.RandomForest – -I
10 -K 67 -S 1
weka.classifiers.functions.LibSVM – -S 0 -K 0 -D 1 -G 1.0 -R 0.0 -N 0.5 -M 40.0 -C 1.0 -E 0.0010
-P 0.1 -B
Continued on Next Page. . .
Appendix C. Weka classifier lineup 162
Table 7 – Continued
Classifier
weka.classifiers.functions.LibSVM – -S 0 -K 0 -D 1 -G 1.0 -R 0.0 -N 0.5 -M 40.0 -C 1.0 -E 0.0010
-P 0.1 -B
weka.classifiers.functions.LibSVM – -S 0 -K 0 -D 1 -G 1.0 -R 0.0 -N 0.5 -M 40.0 -C 0.1 -E 0.0010
-P 0.1 -B
weka.classifiers.functions.LibSVM – -S 0 -K 0 -D 1 -G 1.0 -R 0.0 -N 0.5 -M 40.0 -C 10.0 -E 0.0010
-P 0.1 -B
weka.classifiers.functions.LibSVM – -S 0 -K 1 -D 2 -G 1.0 -R 0.0 -N 0.5 -M 40.0 -C 1.0 -E 0.0010
-P 0.1 -B
weka.classifiers.functions.LibSVM – -S 0 -K 1 -D 2 -G 1.0 -R 0.0 -N 0.5 -M 40.0 -C 0.1 -E 0.0010
-P 0.1 -B
weka.classifiers.functions.LibSVM – -S 0 -K 1 -D 2 -G 1.0 -R 0.0 -N 0.5 -M 40.0 -C 10.0 -E 0.0010
-P 0.1 -B
weka.classifiers.functions.LibSVM – -S 0 -K 1 -D 4 -G 1.0 -R 0.0 -N 0.5 -M 40.0 -C 1.0 -E 0.0010
-P 0.1 -B
weka.classifiers.functions.LibSVM – -S 0 -K 2 -D 1 -G 0.005 -R 0.0 -N 0.5 -M 40.0 -C 1.0 -E 0.0010
-P 0.1 -B
weka.classifiers.functions.LibSVM – -S 0 -K 2 -D 1 -G 0.001 -R 0.0 -N 0.5 -M 40.0 -C 1.0 -E 0.0010
-P 0.1 -B
weka.classifiers.functions.LibSVM – -S 0 -K 2 -D 1 -G 0.01 -R 0.0 -N 0.5 -M 40.0 -C 1.0 -E 0.0010
-P 0.1 -B
weka.classifiers.functions.LibSVM – -S 0 -K 2 -D 1 -G 0.1 -R 0.0 -N 0.5 -M 40.0 -C 1.0 -E 0.0010
-P 0.1 -B
weka.classifiers.functions.MultilayerPerceptron – -L 0.3 -M 0.2 -N 500 -V 0 -S 0 -E 20 -H a
weka.classifiers.functions.MultilayerPerceptron – -L 0.6 -M 0.2 -N 500 -V 0 -S 0 -E 20 -H a
weka.classifiers.functions.MultilayerPerceptron – -L 0.8 -M 0.2 -N 500 -V 0 -S 0 -E 20 -H a
weka.classifiers.functions.RBFNetwork – -B 2 -S 1 -R 1.0E-8 -M -1 -W 0.1
weka.classifiers.functions.RBFNetwork – -B 2 -S 1 -R 1.0E-8 -M -1 -W 0.3
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Table 7 – Continued
Classifier
weka.classifiers.functions.RBFNetwork – -B 4 -S 1 -R 1.0E-8 -M -1 -W 0.1
weka.classifiers.functions.RBFNetwork – -B 4 -S 1 -R 1.0E-8 -M -1 -W 0.3
weka.classifiers.functions.SimpleLogistic – -I 0 -M 500 -H 50 -W 0.0
weka.classifiers.functions.SimpleLogistic – -I 0 -M 500 -H 50 -W 0.0 -A
weka.classifiers.trees.LMT – -I -1 -M 5 -W 0.0
weka.classifiers.trees.LMT – -I -1 -M 5 -W 0.0 -A
weka.classifiers.bayes.BayesNet – -D -Q weka.classifiers.bayes.net.search.local.TAN – -S BAYES
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